Sanmina (SANM) 10-K/A19 May 232022 FY Annual report (amended)Financial data

Company Profile

Document and entity information

Document and entity information Document - USD ($)	12 Months Ended
Document and entity information Document - USD ($)	Oct. 01, 2022	May 03, 2023	Apr. 02, 2022
Document and entity information Document
Document Type	10-K/A
Document Annual Report	true
Document Period End Date	Oct. 01, 2022
Document Transition Report	false
Entity File Number	0-21272
Entity Registrant Name	Sanmina Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0228183
Entity Address, Address Line One	2700 N. First St.,
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	964-3500
Title of 12(b) Security	Common Stock
Trading Symbol	SANM
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 1,453,429,173
Entity Common Stock, Shares Outstanding		58,168,859
Entity Central Index Key	0000897723
Amendment Flag	true
Amendment Description	Amendment No. 1
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--10-01

Audit Information

Audit Information	12 Months Ended
Audit Information	Oct. 01, 2022
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	San Jose, California
Auditor Firm ID	238

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Oct. 03, 2020	Sep. 28, 2019
Current assets:
Cash and cash equivalents	$ 529,857	$ 493,305	$ 559,893	$ 627,717	$ 650,026	$ 623,844	$ 575,176	$ 516,030
Accounts receivable, net of allowances of approximately $8 million and $7 million as of October 1, 2022 and October 2, 2021, respectively	1,138,894	1,229,864	1,271,100	1,299,014	1,193,437	1,155,253	1,124,838	1,112,925
Contract assets	475,721	444,796	399,282	347,583	332,190	333,438	321,947	357,989
Inventories	1,684,099	1,590,123	1,443,621	1,253,697	1,041,790	892,633	785,406	819,474
Prepaid expenses and other current assets	62,044	63,827	61,525	59,188	53,952	50,446	38,584	48,851
Total current assets	3,890,615	3,821,915	3,735,421	3,587,199	3,271,395	3,055,614	2,845,951	2,855,269
Property, plant and equipment, net	575,170	545,673	525,362	525,159	532,985	535,685	515,203	526,645
Deferred income tax assets, net	209,554	222,080	229,574	235,031	242,261	248,060	266,592	271,187
Other	160,192	149,608	156,867	157,533	156,953	160,004	137,998	140,410
Total assets	4,835,531	4,739,276	4,647,224	4,504,922	4,203,594	3,999,363	3,765,744	3,793,511
Current liabilities:
Accounts payable	2,041,434	1,984,374	1,830,044	1,708,222	1,472,257	1,296,005	1,108,994	1,143,431
Accrued liabilities	281,599	326,212	332,431	253,962	177,203	171,365	195,839	209,581
Accrued payroll and related benefits	130,892	133,319	116,794	115,738	117,648	123,365	114,704	120,469
Short-term debt, including current portion of long-term debt	17,500	18,750	18,750	18,750	18,750	18,750	18,750	18,750
Total current liabilities	2,471,425	2,462,655	2,298,019	2,096,672	1,785,858	1,609,485	1,438,287	1,492,231
Long-term liabilities:
Long-term debt	329,237	298,345	302,751	307,160	311,572	315,987	320,405	324,825
Other	215,333	209,716	241,416	248,326	253,532	260,132	296,121	303,514
Total long-term liabilities	544,570	508,061	544,167	555,486	565,104	576,119	616,526	628,339
Commitments and Contingencies
Stockholders' equity:
Preferred stock, $0.01 par value, authorized 5,000 shares, none issued and outstanding	0				0
Common stock, $0.01 par value, authorized 166,667 shares; 110,160 and 108,734 shares issued and 57,394 and 64,307 shares outstanding as of October 1, 2022 and October 2, 2021, respectively	574				643
Treasury stock, 52,766 and 44,427 shares as of October 1, 2022 and October 2, 2021, respectively, at cost	(1,378,159)				(1,047,202)
Additional paid-in capital	6,380,774				6,338,863
Accumulated other comprehensive income	56,325				40,690
Accumulated deficit	(3,239,978)				(3,480,362)
Total stockholders' equity	1,819,536	1,768,560	1,805,038	1,852,764	1,852,632	1,813,759	1,710,931	1,672,941	$ 1,623,372	$ 1,647,073
Total liabilities and stockholders' equity	$ 4,835,531	$ 4,739,276	$ 4,647,224	$ 4,504,922	$ 4,203,594	$ 3,999,363	$ 3,765,744	$ 3,793,511

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Millions	Oct. 01, 2022	Oct. 02, 2021
CONSOLIDATED BALANCE SHEETS
Accounts receivable allowances	$ 8	$ 7
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	166,667,000	166,667,000
Common Stock, Shares, Issued	110,160,000	108,734,000
Common Stock, Shares, Outstanding	57,394,000	64,307,000
Treasury Stock, Shares	52,766,000	44,427,000

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
CONSOLIDATED STATEMENTS OF INCOME
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396		$ 5,694,757		$ 7,919,622	$ 6,738,356	$ 6,950,208
Cost of sales		1,861,176	1,768,575	1,615,029					3,383,604		5,244,780		7,297,416	6,211,915	6,433,044
Gross profit	172,229	162,185	146,495	141,297	130,039	135,066	120,985	140,351	287,792		449,977		622,206	526,441	517,164
Operating expenses:
Selling, general and administrative		61,506	61,817	61,475					123,292		184,798		244,569	234,537	240,931
Research and development		5,071	5,472	4,777					10,249		15,320		21,343	20,911	22,564
Restructuring and other		3,994	2,932	1,414					4,346		8,340		11,425	15,057	27,916
Goodwill impairment															6,609
Gain on sale of long-lived assets				(4,610)					(4,610)		(4,610)		(4,610)
Total operating expenses		70,571	70,221	63,056					133,277		203,848		272,727	270,505	298,020
Operating income	103,350	91,614	76,274	78,241	65,910	72,741	42,610	74,675	154,515		246,129		349,479	255,936	219,144
Interest income		540	349	309					658		1,198		1,628	925	2,322
Interest expense		(5,615)	(4,870)	(4,877)					(9,747)		(15,362)		(22,473)	(19,551)	(28,903)
Other income (expense), net		(7,774)	(1,408)	2,072					664		(7,110)		(26,314)	44,331	(348)
Interest and other, net		(12,849)	(5,929)	(2,496)					(8,425)		(21,274)		(47,159)	25,705	(26,929)
Income before income taxes		78,765	70,345	75,745					146,090		224,855		302,320	281,641	192,215
Provision for income taxes		1,543	21,724	19,568					41,292		42,835		61,936	32,095	59,046
Net income	$ 58,364	$ 77,222	$ 48,621	$ 56,177	$ 55,925	$ 116,195	$ 27,868	$ 49,558	$ 104,798	$ 77,426	$ 182,020	$ 193,621	$ 240,384	$ 249,546	$ 133,169
Net income per share:
Basic	$ 1.01	$ 1.29	$ 0.77	$ 0.87	$ 0.86	$ 1.78	$ 0.43	$ 0.76	$ 1.65		$ 2.92		$ 3.92	$ 3.82	$ 1.93
Diluted	$ 0.98	$ 1.25	$ 0.76	$ 0.85	$ 0.83	$ 1.73	$ 0.42	$ 0.74	$ 1.60		$ 2.83		$ 3.81	$ 3.72	$ 1.88
Weighted-average shares used in computing per share amounts:
Basic													61,310	65,318	69,041
Diluted													63,117	67,084	70,793

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net income	$ 240,384	$ 249,546	$ 133,169
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(12,191)	(9,223)	(925)
Derivative financial instruments:
Change in net unrealized amount	8,414	3,034	(8,146)
Amount reclassified into net income	10,003	4,863	1,332
Defined benefit plans:
Changes in unrecognized net actuarial losses and unrecognized transition cost	5,884	4,713	(6,240)
Amortization of actuarial losses and transition cost	3,525	2,417	2,106
Total other comprehensive income (loss)	15,635	5,804	(11,873)
Comprehensive income	$ 256,019	$ 255,350	$ 121,296

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Number of shares	Common Stock And Additional Paid in Capital	Treasury Stock	Accumulated Other Comprehensive Income	Accumulated Deficit	Total
Balance at Sep. 28, 2019		$ 6,267,509	$ (804,118)	$ 46,759	$ (3,863,077)	$ 1,647,073
Common Stock, Shares, Issued at Sep. 28, 2019	105,551
Treasury Stock, Shares at Sep. 28, 2019			(35,831)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans	2,078
Issuances Under Stock Plans, Value		7,793				7,793
Stock-based compensation		26,235				26,235
Repurchases of Treasury Stock, Shares			(6,799)
Repurchases of Treasury Stock, Value			$ (179,025)			(179,025)
Other comprehensive income (loss)				(11,873)		(11,873)
Net income					133,169	133,169
Treasury Stock, Shares at Oct. 03, 2020			(42,630)
Common Stock, Shares, Issued at Oct. 03, 2020	107,629
Balance at Oct. 03, 2020		6,301,537	$ (983,143)	34,886	(3,729,908)	1,623,372
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						49,558
Balance at Jan. 02, 2021						1,672,941
Balance at Oct. 03, 2020		6,301,537	$ (983,143)	34,886	(3,729,908)	1,623,372
Common Stock, Shares, Issued at Oct. 03, 2020	107,629
Treasury Stock, Shares at Oct. 03, 2020			(42,630)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						77,426
Balance at Apr. 03, 2021						1,710,931
Balance at Oct. 03, 2020		6,301,537	$ (983,143)	34,886	(3,729,908)	1,623,372
Common Stock, Shares, Issued at Oct. 03, 2020	107,629
Treasury Stock, Shares at Oct. 03, 2020			(42,630)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						193,621
Balance at Jul. 03, 2021						1,813,759
Balance at Oct. 03, 2020		6,301,537	$ (983,143)	34,886	(3,729,908)	1,623,372
Common Stock, Shares, Issued at Oct. 03, 2020	107,629
Treasury Stock, Shares at Oct. 03, 2020			(42,630)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans	1,105
Issuances Under Stock Plans, Value		2,993				2,993
Stock-based compensation		34,976				34,976
Repurchases of Treasury Stock, Shares			(1,797)
Repurchases of Treasury Stock, Value			$ (64,059)			(64,059)
Other comprehensive income (loss)				5,804		5,804
Net income					249,546	$ 249,546
Treasury Stock, Shares at Oct. 02, 2021			(44,427)			(44,427)
Common Stock, Shares, Issued at Oct. 02, 2021	108,734					108,734
Balance at Oct. 02, 2021		6,339,506	$ (1,047,202)	40,690	(3,480,362)	$ 1,852,632
Balance at Jan. 02, 2021						1,672,941
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						27,868
Balance at Apr. 03, 2021						1,710,931
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						116,195
Balance at Jul. 03, 2021						1,813,759
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						$ 55,925
Treasury Stock, Shares at Oct. 02, 2021			(44,427)			(44,427)
Common Stock, Shares, Issued at Oct. 02, 2021	108,734					108,734
Balance at Oct. 02, 2021		6,339,506	$ (1,047,202)	40,690	(3,480,362)	$ 1,852,632
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						56,177
Balance at Jan. 01, 2022						1,852,764
Balance at Oct. 02, 2021		6,339,506	$ (1,047,202)	40,690	(3,480,362)	$ 1,852,632
Common Stock, Shares, Issued at Oct. 02, 2021	108,734					108,734
Treasury Stock, Shares at Oct. 02, 2021			(44,427)			(44,427)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						$ 104,798
Balance at Apr. 02, 2022						1,805,038
Balance at Oct. 02, 2021		6,339,506	$ (1,047,202)	40,690	(3,480,362)	$ 1,852,632
Common Stock, Shares, Issued at Oct. 02, 2021	108,734					108,734
Treasury Stock, Shares at Oct. 02, 2021			(44,427)			(44,427)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						$ 182,020
Balance at Jul. 02, 2022						1,768,560
Balance at Oct. 02, 2021		6,339,506	$ (1,047,202)	40,690	(3,480,362)	$ 1,852,632
Common Stock, Shares, Issued at Oct. 02, 2021	108,734					108,734
Treasury Stock, Shares at Oct. 02, 2021			(44,427)			(44,427)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans	1,426
Issuances Under Stock Plans, Value		2,378				$ 2,378
Stock-based compensation		39,608				39,608
Repurchases of Treasury Stock, Shares			(8,339)
Repurchases of Treasury Stock, Value		(144)	$ (330,957)			(331,101)
Other comprehensive income (loss)				15,635		15,635
Net income					240,384	$ 240,384
Treasury Stock, Shares at Oct. 01, 2022			(52,766)			(52,766)
Common Stock, Shares, Issued at Oct. 01, 2022	110,160					110,160
Balance at Oct. 01, 2022		6,381,348	$ (1,378,159)	56,325	(3,239,978)	$ 1,819,536
Balance at Jan. 01, 2022						1,852,764
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						48,621
Balance at Apr. 02, 2022						1,805,038
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						77,222
Balance at Jul. 02, 2022						1,768,560
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income						$ 58,364
Treasury Stock, Shares at Oct. 01, 2022			(52,766)			(52,766)
Common Stock, Shares, Issued at Oct. 01, 2022	110,160					110,160
Balance at Oct. 01, 2022		$ 6,381,348	$ (1,378,159)	$ 56,325	$ (3,239,978)	$ 1,819,536

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income	$ 240,384	$ 249,546	$ 133,169
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	108,783	109,656	114,218
Stock-based compensation expense	39,608	34,976	26,235
Deferred income taxes	27,910	28,375	11,772
Impairment of goodwill and other assets	1,848		8,409
Loss (Gain) on sale of intellectual property	7,000	(15,000)
Gain on liquidation of foreign entity		(8,263)
Other, net	1,260	(1,371)	(239)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable	47,483	(145,810)	81,914
Contract assets	(143,531)	54,479	9,631
Inventories	(651,118)	(157,278)	24,377
Prepaid expenses and other assets	(31,700)	(5,780)	17,092
Accounts payable	558,828	243,834	(106,640)
Accrued liabilities	124,099	(49,022)	(19,383)
Cash provided by operating activities	330,854	338,342	300,555
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(138,639)	(73,296)	(65,982)
Proceeds from sales of property, plant and equipment	8,425	1,084	1,573
Purchases of investments	(2,000)	(2,705)	(30,000)
Sale of investments			30,000
Cash paid for business acquisition, net of cash acquired		(21,408)
Proceeds from sale of intellectual property		5,000
Cash used in investing activities	(132,214)	(91,325)	(64,409)
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES:
Proceeds from revolving credit facility borrowings	1,874,000	399,600	1,909,000
Repayments of revolving credit facility borrowings	(1,874,000)	(399,600)	(1,909,000)
Repayments of long-term debt	(332,814)	(18,752)	(39,048)
Proceeds from issuance of long-term debt	350,000
Debt issuance costs	(3,263)
Net proceeds from stock issuances	2,379	2,993	7,793
Repurchases of common stock	(331,101)	(64,059)	(179,025)
Proceeds from collection of notes receivable	500	2,500
Cash used in financing activities	(314,299)	(77,318)	(210,280)
Effect of exchange rate changes	(4,510)	(199)	(81)
Increase (decrease) in cash and cash equivalents	(120,169)	169,500	25,785
Cash and cash equivalents at beginning of year	650,026	480,526	454,741
Cash and cash equivalents at end of year	529,857	650,026	480,526
Cash paid during the year:
Interest, net of capitalized interest	18,243	15,264	20,477
Income taxes, net of refunds	48,131	33,358	30,700
Unpaid purchases of property, plant and equipment at end of period	$ 38,570	$ 20,929	$ 12,371

Organization of Sanmina

Organization of Sanmina	12 Months Ended
Organization of Sanmina	Oct. 01, 2022
Organization of Sanmina
Organization of Sanmina	Note 1. Organization of Sanmina Sanmina Corporation (“Sanmina,” or the “Company”) was incorporated in Delaware in 1989. The Company is a leading global provider of integrated manufacturing solutions, components, products and repair, logistics and after-market services. The Company provides these comprehensive solutions primarily to original equipment manufacturers (OEMs) that serve the industrial, medical, defense and aerospace, automotive, communications networks and cloud infrastructure industries. The Company’s operations are managed as two businesses: 1) Integrated Manufacturing Solutions (IMS). IMS is a single operating segment consisting of printed circuit board assembly and test, high-level assembly and test and direct-order-fulfillment. 2) Components, Products and Services (CPS). Components include printed circuit boards, backplanes and backplane assemblies, cable assemblies, fabricated metal parts, precision machined parts, and plastic injected molded parts. Products include memory solutions from our Viking Technology division; high-performance storage platforms for hyperscale and enterprise solutions from our Viking Enterprise Solutions (VES) division; optical, radio frequency (RF) and microelectronic (microE) design and manufacturing services from Advanced Microsystems Technologies; defense and aerospace products from SCI Technology; and cloud-based manufacturing execution software from the Company’s 42Q division. Services include design, engineering and logistics and repair. The Company’s only reportable segment is IMS, which represented approximately 80% of total revenue in 2022. CPS consists of multiple operating segments which do not individually meet the quantitative thresholds for being presented as reportable segments. Therefore, financial information for these operating segments is combined and presented in a single category entitled “Components, Products and Services”. Basis of Presentation Fiscal Year. Principles of Consolidation.

Restatement of Consolidated Fin

Restatement of Consolidated Financial Statements	12 Months Ended
Restatement of Consolidated Financial Statements	Oct. 01, 2022
Restatement of Consolidated Financial Statements
Restatement of Consolidated Financial Statements	Note 2. Restatement of Consolidated Financial Statements During the preparation of its unaudited consolidated financial statements for the fiscal quarter ended April 1, 2023, the Company determined that certain personnel in one of its divisions had failed to properly substantiate and update cost estimates for materials and other costs over the life of certain contracts. As a result, the Company conducted an independent investigation (the “Investigation”) under the direction of the Audit Committee of the Company’s Board of Directors (the “Audit Committee”). The division, like other Company divisions, has a stand-alone finance organization, which reports directly to the Company finance organization and indirectly to the management of the division. References in the findings below refer solely to this division unless otherwise noted. The Investigation found that: ● In connection with the preparation and review of quarterly contract cost and other estimates, an internal control in the Company’s accounting process for the division’s contracts with customers, certain division personnel made inappropriate and unsupported adjustments to reduce certain cost estimates and failed to appropriately evaluate and increase other cost estimates to reflect cost overruns and other costs associated with delays in completing certain contracts. ● The division had a culture that did not recognize or emphasize the importance of rigor in the division’s quarterly contract estimate review process or its significance to the Company’s internal control over financial reporting and accounting and financial reporting determinations with respect to the division’s contracts with customers. Instead, the division’s tone at the top and other control weaknesses enabled participants in the quarterly contract estimate review process to tolerate, place undue reliance on or otherwise fail to challenge unsupported adjustments and assumptions to contract cost estimates that had been made based on unsubstantiated optimism and/or a desire to avoid adverse outcomes. ● The division had an ineffective finance function that did not provide sufficient oversight on financial accounting and reporting matters or effectively challenge adjustments or other improper practices in the quarterly contract estimate review process. ● Certain division personnel lacked sufficient understanding of the division’s policies and procedures for the quarterly contract estimate review process as well as the relevant cost and contract accounting practices and requirements. ● Certain division personnel provided materially inaccurate and incomplete information to, including in response to inquiries from, Company management and the Company’s internal and independent auditors concerning contract cost estimates and related items. The following tables present the impact of the financial statement adjustments on the Company’s previously reported consolidated financial statements for the fiscal year ended October 1, 2022, October 2, 2021 and October 3, 2020. The “Previously Reported” amounts in the following tables are amounts derived from the Original Form 10-K for the fiscal year ended October 1, 2022. The amounts in columns labeled “Investigation Adjustments” represent the effect of adjustments resulting from the Investigation and the amounts in columns labeled “Other Adjustments” represent the effect of other adjustments that relate primarily to uncorrected balance sheet misstatements in previously filed financial statements and were not material, individually or in the aggregate, to those previously filed financial statements. The effects of the restatement, including the related income tax impacts, have been corrected in all impacted tables and footnotes throughout these consolidated financial statements. The only impact to the Consolidated Statements of Comprehensive Income and Consolidated Statements of Stockholders’ Equity was to net income. Investigation Adjustments correct misstatements that resulted primarily from 1) increases to estimated costs at completion of a contract that previously did not properly reflect estimated costs remaining to be incurred to complete a contract, 2) reductions in the amount of transaction consideration expected to be received under a contract, and 3) segmentation of contracts that had previously been combined. The adjustments primarily affected net sales, cost of sales, contract assets and inventory. Other Adjustments primarily correct balance sheet misstatements related to inventory cut-off, advance payments from customers and long-term leases of land. The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Balance Sheets for the fiscal year ended October 1, 2022 and October 2, 2021. As of As of October 1, 2022 October 2, 2021 Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 529,857 $ — $ — $ 529,857 $ 650,026 $ — $ — $ 650,026 Accounts receivable, net of allowances 1,138,894 — — 1,138,894 1,192,434 — 1,003 1,193,437 Contract assets 503,674 (27,953) — 475,721 348,741 (28,708) 12,157 332,190 Inventories 1,691,081 (21,705) 14,723 1,684,099 1,036,511 (2,285) 7,564 1,041,790 Prepaid expenses and other current assets 62,044 — — 62,044 53,952 — — 53,952 Total current assets 3,925,550 (49,658) 14,723 3,890,615 3,281,664 (30,993) 20,724 3,271,395 Property, plant and equipment, net 575,170 — — 575,170 532,985 — — 532,985 Deferred tax assets 198,588 10,966 — 209,554 235,117 7,144 — 242,261 Other 160,192 — — 160,192 156,953 — — 156,953 Total assets $ 4,859,500 (38,692) 14,723 $ 4,835,531 $ 4,206,719 $ (23,849) $ 20,724 $ 4,203,594 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 2,029,534 $ — $ 11,900 $ 2,041,434 $ 1,464,693 $ — $ 7,564 $ 1,472,257 Accrued liabilities 275,735 1,441 4,423 281,599 161,896 2,147 13,160 177,203 Accrued payroll and related benefits 130,892 — — 130,892 117,648 — — 117,648 Short-term debt, including current portion of long-term debt 17,500 — — 17,500 18,750 — — 18,750 Total current liabilities 2,453,661 1,441 16,323 2,471,425 1,762,987 2,147 20,724 1,785,858 Long-term liabilities: Long-term debt 329,237 — — 329,237 311,572 — — 311,572 Other 215,333 — — 215,333 253,532 — — 253,532 Total long-term liabilities $ 544,570 $ — $ — $ 544,570 $ 565,104 $ — $ — $ 565,104 Commitments and Contingencies (Note 11) Stockholders' equity: Preferred stock, $0.01 par value, authorized 5,000 shares, none issued and outstanding — — — — — — — — Common stock, $0.01 par value, authorized 166,667 shares; 110,160 and 108,734 shares issued and 57,394 and 64,307 shares outstanding as of October 1, 2022 and October 2, 2021, respectively 574 — — 574 643 — — 643 Treasury stock, 52,766 and 44,427 shares as of October 1, 2022 and October 2, 2021, respectively, at cost (1,378,159) — — (1,378,159) (1,047,202) — — (1,047,202) Additional paid-in capital 6,380,774 — — 6,380,774 6,338,863 — — 6,338,863 Accumulated other comprehensive income 56,325 — — 56,325 40,690 — — 40,690 Accumulated deficit (3,198,245) (40,133) (1,600) (3,239,978) (3,454,366) (25,996) — (3,480,362) Total stockholders’ equity 1,861,269 (40,133) (1,600) 1,819,536 1,878,628 (25,996) — 1,852,632 Total liabilities and stockholders’ equity $ 4,859,500 $ (38,692) $ 14,723 $ 4,835,531 $ 4,206,719 $ (23,849) $ 20,724 $ 4,203,594 The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Income for the fiscal year ended October 1, 2022, October 2, 2021 and October 3, 2020. Year Ended Year Ended October 1, 2022 October 2, 2021 Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (In thousands, except per share amounts) Net sales $ 7,890,475 $ 23,265 $ 5,882 $ 7,919,622 $ 6,756,643 $ (18,287) $ — $ 6,738,356 Cost of sales 7,249,961 41,573 5,882 7,297,416 6,204,838 7,077 — 6,211,915 Gross profit 640,514 (18,308) — 622,206 551,805 (25,364) — 526,441 Operating expenses: Selling, general and administrative 244,569 — — 244,569 234,537 — — 234,537 Research and development 21,343 — — 21,343 20,911 — — 20,911 Restructuring and other 11,425 — — 11,425 15,057 — — 15,057 Gain on sale of long-lived assets (4,610) — — (4,610) — — — — Total operating expenses 272,727 — — 272,727 270,505 — — 270,505 Operating income 367,787 (18,308) — 349,479 281,300 (25,364) — 255,936 Interest income 1,628 — — 1,628 925 — — 925 Interest expense (22,473) — — (22,473) (19,551) — — (19,551) Other income (expense), net (26,314) — — (26,314) 44,331 — — 44,331 Interest and other, net (47,159) — — (47,159) 25,705 — — 25,705 Income before income taxes 320,628 (18,308) — 302,320 307,005 (25,364) — 281,641 Provision for income taxes 64,507 (4,171) 1,600 61,936 38,007 (5,912) — 32,095 Net income $ 256,121 $ (14,137) $ (1,600) $ 240,384 $ 268,998 $ (19,452) $ — $ 249,546 Net income per share: Basic $ 4.18 $ (0.23) $ (0.03) $ 3.92 $ 4.12 $ (0.30) $ — $ 3.82 Diluted $ 4.06 $ (0.23) $ (0.03) $ 3.81 $ 4.01 $ (0.29) $ — $ 3.72 Weighted-average shares used in computing per share amounts: Basic 61,310 — — 61,310 65,318 — — 65,318 Diluted 63,117 — — 63,117 67,084 — — 67,084 Year Ended October 3, 2020 Previously Investigation Reported Adjustments Other Adjustments As Restated (In thousands, except per share amounts) Net sales $ 6,960,370 $ (10,162) $ — $ 6,950,208 Cost of sales 6,434,663 (1,619) — 6,433,044 Gross profit 525,707 (8,543) — 517,164 Operating expenses: Selling, general and administrative 240,931 — — 240,931 Research and development 22,564 — — 22,564 Restructuring and other 27,916 — — 27,916 Goodwill impairment 6,609 — — 6,609 Total operating expenses 298,020 — — 298,020 Operating income 227,687 (8,543) — 219,144 Interest income 2,322 — — 2,322 Interest expense (28,903) — — (28,903) Other expense, net (348) — — (348) Interest and other, net (26,929) — — (26,929) Income before income taxes 200,758 (8,543) — 192,215 Provision for income taxes 61,045 (1,999) 59,046 Net income $ 139,713 $ (6,544) $ — $ 133,169 Net income per share: Basic $ 2.02 $ (0.09) $ — $ 1.93 Diluted $ 1.97 $ (0.09) $ — $ 1.88 Weighted-average shares used in computing per share amounts: Basic 69,041 — — 69,041 Diluted 70,793 — — 70,793 The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Cash Flows for the fiscal year ended October 1, 2022, October 2, 2021 and October 3, 2020. There were no adjustments to cash flows provided by (used in) investing or financing activities for the fiscal year ended October 1, 2022, October 2, 2021 and October 3, 2020. Year Ended Year Ended October 1, 2022 October 2, 2021 Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (In thousands) CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 256,121 $ (14,137) $ (1,600) $ 240,384 $ 268,998 $ (19,452) $ — $ 249,546 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 108,783 — — 108,783 109,656 — — 109,656 Stock-based compensation expense 39,608 — — 39,608 34,976 — — 34,976 Deferred income taxes 31,733 (3,823) — 27,910 33,724 (5,349) — 28,375 Gain on sale of intellectual property — — — — (15,000) — — (15,000) Gain on liquidation of foreign entity — — — — (8,263) — — (8,263) Impairment of goodwill and other assets 1,848 — — 1,848 — — — — Loss on sale of intellectual property 7,000 — — 7,000 — — — — Other, net 1,260 — — 1,260 (1,371) — — (1,371) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable 46,480 — 1,003 47,483 (146,516) — 706 (145,810) Contract assets (154,933) (755) 12,157 (143,531) 47,842 4,272 2,365 54,479 Inventories (663,379) 19,420 (7,159) (651,118) (167,186) 17,472 (7,564) (157,278) Prepaid expenses and other assets (31,700) — — (31,700) (6,486) 706 — (5,780) Accounts payable 554,492 — 4,336 558,828 236,270 — 7,564 243,834 Accrued liabilities 133,541 (705) (8,737) 124,099 (48,302) 2,351 (3,071) (49,022) Cash provided by operating activities $ 330,854 $ — $ — $ 330,854 $ 338,342 $ — $ — $ 338,342 Year Ended October 3, 2020 Previously Investigation Other Reported Adjustments Adjustments As Restated (In thousands) CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 139,713 $ (6,544) $ — $ 133,169 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 114,218 — — 114,218 Stock-based compensation expense 26,235 — — 26,235 Deferred income taxes 13,567 (1,795) — 11,772 Gain on sale of intellectual property — — — — Gain on liquidation of foreign entity — — — — Impairment of goodwill and other assets 8,409 — — 8,409 Loss on sale of intellectual property — — — — Other, net (239) — — (239) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable 83,623 — (1,709) 81,914 Contract assets (283) 24,436 (14,522) 9,631 Inventories 39,564 (15,187) — 24,377 Prepaid expenses and other assets 17,798 (706) — 17,092 Accounts payable (106,640) — — (106,640) Accrued liabilities (35,410) (204) 16,231 (19,383) Cash provided by operating activities $ 300,555 $ — $ — $ 300,555

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Oct. 01, 2022
Significant Accounting Policies
Significant Accounting Policies	Note 3. Summary of Significant Accounting Policies Management Estimates and Uncertainties. Financial Instruments and Concentration of Credit Risk. Cash and Cash Equivalents. Accounts Receivable and Other Related Allowances. Accounts Receivable Sales. In addition to the RPA, the Company has the option to participate in trade receivables sales programs that have been implemented by certain of the Company’s customers, as in effect from time to time. The Company does not service trade receivables sold under these other programs. Under each of the programs noted above, the Company sells its entire interest in a trade receivable for 100% of face value, less a discount. Accounts receivable balances sold are removed from the consolidated balance sheets and the related proceeds are reported as cash provided by operating activities in the consolidated statements of cash flows. Inventories. Provisions are made to reduce excess and obsolete inventories to their estimated net realizable values. The ultimate realization of inventory carrying amounts is primarily affected by changes in customer demand. Inventory provisions are established based on forecasted demand, past experience with specific customers, the age and nature of the inventory, the ability to redistribute inventory to other programs or back to suppliers, and whether customers are contractually obligated and have the ability to pay for the related inventory. Certain payments received from customers for inventory held by the Company are recorded as a reduction of inventory. Long-lived Assets. buildings and 3 to 15 years for machinery, equipment, furniture and fixtures. Leasehold improvements are amortized on a straight-line basis over the shorter of the lease term or useful life of the asset. The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. An asset group is the unit of accounting which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets. An asset or asset group is considered impaired if its carrying amount exceeds the undiscounted future net cash flows the asset or asset group is expected to generate. If an asset or asset group is considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset or asset group exceeds its fair value. For asset groups for which the primary asset is a building, the Company estimates fair value based on data provided by commercial real estate brokers. For other asset groups, the Company estimates fair value based on projected discounted future net cash flows. Foreign Currency Translation. Derivative Instruments and Hedging Activities. The Company accounts for derivative instruments and hedging activities in accordance with ASC Topic 815, Derivatives and Hedging, which requires each derivative instrument to be recorded on the consolidated balance sheets at its fair value as either an asset or a liability. If a derivative is designated as a cash flow hedge, the Company excludes time value from its assessment of hedge effectiveness and recognizes the amount of time value in earnings over the life of the derivative. Gains or losses on the derivative not caused by changes in time value are recorded in Accumulated Other Comprehensive Income (“AOCI”), a component of equity, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is designated as a fair value hedge, changes in the fair value of the derivative and of the item being hedged are recognized in earnings in the current period. Derivative instruments are entered into for periods of time consistent with the related underlying exposures and are not entered into for speculative purposes. At the inception of a hedge, the Company documents all relationships between derivative instruments and related hedged items, as well as its risk-management objectives and strategies for the hedging transaction. The Company’s foreign currency forward contracts and interest rate swaps potentially expose the Company to credit risk to the extent the counterparties may be unable to meet the terms of the agreement. The Company minimizes such risk by seeking high quality counterparties. Leases. The Company’s lease liability and ROU assets represent the present value of future lease payments which are a combination of lease components and non-lease components such as maintenance and utilities. Operating lease expense is recognized on a straight line basis over the term of the lease. Certain of the Company’s lease payments are variable because such payments adjust periodically based on changes in consumer price and other indexes. Variable payments are expensed as incurred and not included in the measurement of lease liabilities and ROU assets. Since the Company’s leases generally do not provide an implicit rate, the Company uses an incremental borrowing rate based on information available at the lease commencement date for purposes of determining the present value of lease payments. The Company’s incremental borrowing rate is based on the term of the lease, the economic environment of the lease and the effect of collateralization, if any. Revenue Recognition. For purposes of determining when to recognize revenue, and in what amount, the Company applies a 5-step model: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the Company satisfies a performance obligation. Each of these steps may involve the use of significant judgments. The Company recognizes revenue for the majority of its contracts on an over time basis. This is due to the fact that 1) the Company does not have an alternative use for the end products it manufactures for its customers and has an enforceable right to payment, including a reasonable profit, for work-in-progress upon a customer’s cancellation of a contract for convenience or 2) the Company’s customer simultaneously receives and consumes the benefits provided by the Company’s services. For these contracts, revenue is recognized on an over time basis using the cost-to-cost method (ratio of costs incurred to date to total estimated costs at completion) which the Company believes best depicts the transfer of control to the customer. Revenue streams for which revenue is recognized on an over time basis include sales of vertically integrated manufacturing solutions (integrated manufacturing solutions and components); global services (logistics and repair); design, development and engineering services; and defense and aerospace programs. Application of the cost-to-cost method for government contracts in the Company’s Defense and Aerospace division requires the use of significant judgments with respect to estimated materials, labor and subcontractor costs included in the total estimated costs at completion. Additionally, the Company evaluates whether contract modifications for claims have been approved and, if so, estimates the amount, if any, of variable consideration that can be included in the transaction price of the contract. This division is an operating segment whose results are combined with eleven other operating segments and reported under Components, Products and Services (“CPS”) for segment reporting purposes. In 2022, CPS revenue and gross profit were $1.5 billion and $176 million, respectively. Estimates of materials, labor and subcontractor costs expected to be incurred to satisfy a performance obligation are updated on a quarterly basis. These estimates consider costs incurred to date and estimated costs to be incurred over the remaining expected period of performance to satisfy a performance obligation. Such estimates are reviewed each quarter by a group of employees that includes representatives from numerous functions such as engineering, materials, contracts, manufacturing, program management, finance and senior management. If a change in estimate is deemed necessary, the impact of the change is recognized in the period of change. Additionally, contract modifications for claims are assessed each quarter to determine whether the claims have been approved. If it is determined that a claim has been approved, the amount of the claim, if any, that can be included in transaction price is estimated considering a number of factors such as the length of time expected to lapse until uncertainty about the claim has been resolved and the extent to which our experience with claims for similar contracts has predictive value. For contracts for which revenue is required to be recognized at a point-in-time, the Company recognizes revenue when it has transferred control of the related goods, which generally occurs upon shipment or delivery of the goods to the customer. Revenue streams for which revenue is recognized at a point-in-time include Company-proprietary products and sales of raw materials. Refer to Note 5 for further discussion. Income taxes. . The Company’s tax rate is dependent upon the geographic distribution of its worldwide income or losses, the tax regulations and tax holidays in each geographic region, the availability of tax credits and carryforwards, including net operating losses, and the effectiveness of its tax planning strategies. The Company makes an assessment of whether each income tax position is “more likely than not” of being sustained on audit, including resolution of related appeals or litigation, if any. For each income tax position that meets the “more likely than not” recognition threshold, the Company then assesses the largest amount of tax benefit that is greater than 50% likely of being realized upon effective settlement with the tax authority. Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense. Recent Accounting Pronouncement Adopted In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848)”, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform. The amendments are effective for all entities as of March 12, 2020 through December 31, 2022. The Company adopted this ASU during the fourth quarter of 2022. The impact of adoption was not material.

Balance Sheet and Income Statem

Balance Sheet and Income Statement Details	12 Months Ended
Balance Sheet and Income Statement Details	Oct. 01, 2022
Balance Sheet and Income Statement Details
Balance Sheet and Income Statement Details	Note 4. Balance Sheet and Income Statement Details Property, Plant and Equipment, net Property, plant and equipment consisted of the following: As of October 1, October 2, 2022 2021 (In thousands) Machinery and equipment $ 1,523,598 $ 1,491,156 Land and buildings 656,839 645,639 Leasehold improvements 42,793 44,899 Furniture and fixtures 24,805 25,394 Construction in progress 91,928 40,524 2,339,963 2,247,612 Less: Accumulated depreciation and amortization (1,764,793) (1,714,627) Property, plant and equipment, net $ 575,170 $ 532,985 Depreciation expense was $108 million, $109 million and $113 million for 2022, 2021 and 2020, respectively. Other Income (Expense), net The Company terminated its frozen U.S. defined benefit plan (the “Plan”) effective July 3, 2022 and recorded a pension settlement charge of $2 million during the fourth quarter of 2022 which includes the reclassification of unrecognized pension losses from accumulated other comprehensive income to other income (expense), net on the consolidated statements of income. Refer to Note 17 for discussion. The Company recorded a loss on extinguishment of debt of $1 million during the fourth quarter of 2022, consisting of a write-off of unamortized debt issuance costs arising from the amendment and restatement of the Fourth Amended and Restated Loan Agreement, dated as of November 30, 2018. Refer to Note 7 for discussion. In 2021, the Company sold intellectual property for $15 million, of which $8 million has been received in cash. The sale of intellectual property was included in other income (expense), net on the consolidated statements of income. During the fourth quarter of 2022, the Company concluded it expected to incur credit losses with the counterparty for the remaining $7 million due under the arrangement. A foreign entity of the Company was substantially liquidated in 2021 and the Company reclassified $8 million of cumulative translation adjustments associated with this entity from accumulated other comprehensive income to other income (expense), net on the consolidated statements of income in 2021. The Company received $16 million of cash in 2021 in connection with settlements of certain anti-trust class action matters.

Revenue Recognition

Revenue Recognition	12 Months Ended
Revenue Recognition	Oct. 01, 2022
Revenue Recognition
Revenue Recognition	Note 5. Revenue Recognition The Company is a leading global provider of integrated manufacturing solutions, components, products and repair, logistics and after-market services. For purposes of determining when to recognize revenue, and in what amount, the Company applies a 5-step model: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the Company satisfies a performance obligation. Each of these steps may involve the use of significant judgments, as discussed below. Step 1 - Identify the contract with a customer A contract is defined as an agreement between two parties that creates enforceable rights and obligations. The Company generally enters into a master supply agreement (“MSA”) with its customers that provides the framework under which business will be conducted, and pursuant to which a customer will issue purchase orders or other binding documents to specify the quantity, price and delivery requirements for products or services the customer wishes to purchase. The Company generally considers its contract with a customer to be a firm commitment, consisting of the combination of an MSA and a purchase order or any other similar binding document. Step 2 - Identify the performance obligations in the contract A performance obligation is a promised good or service that is material in the context of the contract and is both capable of being distinct (customer can benefit from the good or service on its own or together with other readily available resources) and distinct within the context of the contract (separately identifiable from other promises). The Company reviews its contracts to identify promised goods or services and then evaluates such items to determine which of those items are performance obligations. The majority of the Company’s contracts have a single performance obligation since the promise to transfer an individual good or service is not separately identifiable from other promises in the contract. The Company’s performance obligations generally have an expected duration of one year or less. Step 3 - Determine the transaction price The Company’s contracts with its customers may include certain forms of variable consideration such as early payment discounts, volume discounts and shared cost savings. The Company includes an estimate of variable consideration when determining the transaction price and the appropriate amount of revenue to be recognized. This estimate is limited to an amount which will not result in a significant reversal of revenue in a future period. Factors considered in the Company’s estimate of variable consideration are the potential amount subject to these contract provisions, historical experience and other relevant facts and circumstances. Step 4 - Allocate the transaction price to the performance obligations in the contract A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. In the event that more than one performance obligation is identified in a contract, the Company is required to allocate a portion of the transaction price to each performance obligation. This allocation would generally be based on the relative standalone price of each performance obligation, which most often would represent the price at which the Company would sell similar goods or services separately. Step 5 - Recognize revenue when (or as) a performance obligation is satisfied The Company is required to assess whether control of a product or services promised under a contract is transferred to the customer at a point-in-time or over time as the product is being manufactured or the services are being provided. If the criteria in ASC 606 for recognizing revenue on an over time basis are not met, revenue must be recognized at the point-in-time determined by the Company at which its customer obtains control of a product or service. The Company has determined that revenue for the majority of its contracts is required to be recognized on an over time basis. This determination is based on the fact that 1) the Company does not have an alternative use for the end products it manufactures for its customers and has an enforceable right to payment, including a reasonable profit, for work-in-progress upon a customer’s cancellation of a contract for convenience or 2) the Company’s customer simultaneously receives and consumes the benefits provided by the Company’s services. For these contracts, revenue is recognized on an over time basis using the cost-to-cost method (ratio of costs incurred to date to total estimated costs at completion) which the Company believes best depicts the transfer of control to the customer. At least 95% of the Company’s revenue is recognized on an over time basis, which is as products are manufactured or services are performed. Because of this, and the fact that there is no work-in-process or finished goods inventory associated with contracts for which revenue is recognized on an over-time basis, 99% or more of the Company’s inventory at the end of a given period is in the form of raw materials. For contracts for which revenue is required to be recognized at a point-in-time, the Company recognizes revenue when it has transferred control of the related goods, which generally occurs upon shipment or delivery of the goods to the customer. Application of the cost-to-cost method for government contracts in the Company’s Defense and Aerospace division requires the use of significant judgments with respect to estimated materials, labor and subcontractor costs included in the total estimated costs at completion. Additionally, the Company evaluates whether contract modifications for claims have been approved and, if so, estimates the amount, if any, of variable consideration that can be included in the transaction price of the contract. This division is an operating segment whose results are combined with eleven other operating segments and reported under Components, Products and Services (“CPS”) for segment reporting purposes. In 2022, CPS revenue and gross profit were $1.5 billion and $176 million, respectively. Estimates of materials, labor and subcontractor costs expected to be incurred to satisfy a performance obligation are updated on a quarterly basis. These estimates consider costs incurred to date and estimated costs to be incurred over the remaining expected period of performance to satisfy a performance obligation. Such estimates are reviewed each quarter by a group of employees that includes representatives from numerous functions such as engineering, materials, contracts, manufacturing, program management, finance and senior management. If a change in estimate is deemed necessary, the impact of the change is recognized in the period of change. Additionally, contract modifications for claims are assessed each quarter to determine whether the claims have been approved. If it is determined that a claim has been approved, the amount of the claim, if any, that can be included in transaction price is estimated considering a number of factors such as the length of time expected to lapse until uncertainty about the claim has been resolved and the extent to which our experience with claims for similar contracts has predictive value. Contract Assets A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice to its customer for payment. Contract assets are classified separately on the consolidated balance sheets and transferred to accounts receivable when rights to payment become unconditional. Because of the Company’s short manufacturing cycle times, the transfer from contract assets to accounts receivable generally occurs within the next fiscal quarter. Other Taxes assessed by governmental authorities that are both imposed on and concurrent with a specific revenue-producing transaction, and are collected by the Company from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control of a product has transferred to a customer are accounted for as fulfillment costs and are included in cost of sales. The Company applies the following practical expedients or policy elections under ASC 606: ● The promised amount of consideration under a contract is not adjusted for the effects of a significant financing component because, at inception of a contract, the Company expects the period between when a good or service is transferred to a customer and when the customer pays for that good or service will generally be one year or less. ● The Company has elected to not disclose information about remaining performance obligations that have original expected durations of one year or less, which is substantially all of the Company’s remaining performance obligations. ● Incremental costs of obtaining a contract are not capitalized if the period over which such costs would be amortized to expense is less than one year. Disaggregation of revenue In the following table, revenue is disaggregated by segment, market sector and geography. Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands) Segments: IMS $ 6,378,324 $ 5,454,269 $ 5,685,751 CPS 1,541,298 1,284,087 1,264,457 Total $ 7,919,622 $ 6,738,356 $ 6,950,208 End Markets: Communications Networks and Cloud Infrastructure $ 3,175,534 $ 2,866,602 $ 2,832,650 Industrial, Defense, Medical and Automotive 4,744,088 3,871,754 4,117,558 Total $ 7,919,622 $ 6,738,356 $ 6,950,208 Geography: Americas (1) $ 3,748,643 $ 3,164,562 $ 3,440,365 APAC 3,007,904 2,517,963 2,514,005 EMEA 1,163,075 1,055,831 995,838 Total $ 7,919,622 $ 6,738,356 $ 6,950,208 (1) Mexico represents approximately 60% of the Americas revenue and the U.S. represents approximately 35% .

Financial Instruments

Financial Instruments	12 Months Ended
Financial Instruments	Oct. 01, 2022
Financial Instruments [Abstract]
Financial Instruments	Note 6. Financial Instruments Fair Value Measurements Fair Value of Financial Instruments The fair values of cash equivalents (generally 10% or less of cash and cash equivalents), accounts receivable, accounts payable and short-term debt approximate carrying value due to the short-term duration of these instruments. Additionally, the fair value of variable rate long-term debt approximates carrying value as of October 1, 2022. Assets and Liabilities Measured at Fair Value on a Recurring Basis The Company’s primary financial assets and financial liabilities measured at fair value on a recurring basis are deferred compensation plan assets and defined benefit plan assets, which are both measured using Level 1 inputs. Deferred compensation plan assets were $37 million and $46 million as of October 1, 2022 and October 2, 2021, respectively. Defined benefit plan assets were $17 million and $40 million as of October 1, 2022 and October 2, 2021, respectively. Other financial assets and financial liabilities measured at fair value on a recurring basis include foreign exchange contracts and interest rate swaps, which are both measured using Level 2 inputs. Foreign exchange contracts were not material as of October 1, 2022 or October 2, 2021 . Offsetting Derivative Assets and Liabilities The Company has entered into master netting arrangements with each of its derivative counterparties that allows net settlement of derivative assets and liabilities under certain conditions, such as multiple transactions with the same currency maturing on the same date. The Company presents its derivative assets and derivative liabilities on a gross basis on the consolidated balance sheets. The amount that the Company had the right to offset under these netting arrangements was not material as of October 1, 2022 or October 2, 2021 . Non-Financial Assets Measured at Fair Value on a Nonrecurring Basis Other non-financial assets, such as intangible assets, goodwill and other long-lived assets, are measured at fair value as of the date such assets are acquired or in the period an impairment is recorded. During 2020, commodity prices in the oil and gas market experienced a sharp decline due to a combination of an oversaturated supply and a decrease in demand caused by the COVID-19 pandemic. This commodity price decline resulted in a negative impact to the projected cash flows of the Company’s oil and gas reporting unit that is part of the Company’s Components, Products and Services (“CPS”) operating segment and, therefore, the Company performed a goodwill impairment test for this particular reporting unit. The Company concluded that the fair value of the reporting unit was below its carrying value, resulting in a goodwill impairment charge of $7 million. The fair value of the reporting unit was estimated based on the present value of future discounted cash flows. The Company also recorded an impairment charge of $2 million in 2022 and 2020 for certain long-lived assets. Derivative Instruments Foreign Exchange Rate Risk The Company is exposed to certain risks related to its ongoing business operations. The primary risk managed by using derivative instruments is foreign currency exchange risk. Forward contracts on various foreign currencies are used to manage foreign currency risk associated with forecasted foreign currency transactions and certain monetary assets and liabilities denominated in non-functional currencies. The Company’s primary foreign currency cash flows are in certain Asian and European countries, Brazil, Israel and Mexico. The Company had the following outstanding foreign currency forward contracts that were entered into to hedge foreign currency exposures: As of October 1, October 2, 2022 2021 Derivatives Designated as Accounting Hedges: Notional amount (in thousands) $ 123,172 $ 110,098 Number of contracts 50 48 Derivatives Not Designated as Accounting Hedges: Notional amount (in thousands) $ 531,558 $ 353,108 Number of contracts 43 46 The Company utilizes foreign currency forward contracts to hedge certain operational (“cash flow”) exposures resulting from changes in foreign currency exchange rates. Such exposures generally result from (1) forecasted non-functional currency sales and (2) forecasted non-functional currency materials, labor, overhead and other expenses. These contracts are designated as cash flow hedges for accounting purposes and are generally one to two months in duration but, by policy, may be up to twelve months in duration. For derivative instruments that are designated and qualify as cash flow hedges, the Company excludes time value from its assessment of hedge effectiveness and recognizes the amount of time value in earnings over the life of the derivative instrument. Gains or losses on the derivative not caused by changes in time value are recorded in Accumulated Other Comprehensive Income (“AOCI”), a component of equity, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The amount of gain or loss recognized in Other Comprehensive Income on derivative instruments and the amount of gain or loss reclassified from AOCI into income were not material for any period presented herein. The Company enters into short-term foreign currency forward contracts to hedge currency exposures associated with certain monetary assets and liabilities denominated in non-functional currencies. These contracts have maturities of up to two months and are not designated as accounting hedges. Accordingly, these contracts are marked-to-market at the end of each period with unrealized gains and losses recorded in other income (expense), net, in the consolidated statements of income. The amount of gains or losses associated with these forward contracts was not material for any period presented herein. From an economic perspective, the objective of the Company’s hedging program is for gains and losses on forward contracts to substantially offset gains and losses on the underlying hedged items. In addition to the contracts disclosed in the table above, the Company has numerous contracts that have been closed from an economic and financial accounting perspective and will settle early in the first month of the following quarter. Since these offsetting contracts do not expose the Company to risk of fluctuations in exchange rates, these contracts have been excluded from the above table. Interest Rate Risk The Company enters into forward interest rate swap agreements with independent counterparties to partially hedge the variability in cash flows due to changes in Secured Overnight Financing Rate benchmark interest rate (“SOFR”) associated with anticipated variable rate borrowings. These interest rate swaps have a maturity date of December 1, 2023, and effectively convert the Company’s variable interest rate obligations to fixed interest rate obligations. These swaps are accounted for as cash flow hedges under ASC Topic 815, Derivatives and Hedging. Interest rate swaps with an aggregate notional amount of $350 million were outstanding as of October 1, 2022 and October 2, 2021. The aggregate effective interest rate of these swaps as of October 1, 2022 was approximately 4.1%. Given the recent rise in interest rates and the likelihood of additional rate increases, these interest rate swaps had a positive value of $6 million as of October 1, 2022, of which the majority is included in prepaid expenses and other current assets and the remaining amount is included in other assets on the consolidated balance sheets.

Financial Instruments and Conce

Financial Instruments and Concentration of Credit Risk	12 Months Ended
Financial Instruments and Concentration of Credit Risk	Oct. 01, 2022
Financial Instruments and Concentration of Credit Risk
Financial Instruments and Concentration of Credit Risk	Note 7. Financial Instruments and Concentration of Credit Risk Financial instruments that potentially subject the Company to credit risk consist primarily of cash, cash equivalents, trade accounts receivable, foreign currency forward contracts and interest rate swap agreements. The carrying value of assets such as cash, cash equivalents and accounts receivable is expected to approximate fair value due to the short duration of the assets. The Company maintains its cash and cash equivalents with recognized financial institutions that management believes to be of high credit quality. One of the Company’s most significant credit risks is the ultimate realization of accounts receivable. This risk is mitigated by ongoing credit evaluations of, and frequent contact with, the Company’s customers, especially its most significant customers, thus enabling it to monitor changes in business operations and respond accordingly. The Company generally does not require collateral for sales on credit. The Company considers these concentrations of credit risks when estimating its allowance for doubtful accounts. Foreign currency forward contracts and interest rate swaps are maintained with high quality counterparties to reduce the Company’s credit risk and are recorded on the Company’s balance sheets at fair value. Nokia and Motorola each represented more than 10% of the Company’s net sales in 2022. Nokia represented more than 10% of the Company’s net sales in 2021 and 2020. Motorola represented 10% or more of the Company’s gross accounts receivable as of October 1, 2022 and Nokia represented 10% or more of the Company’s gross accounts receivable as of October 2, 2021.

Debt

Debt	12 Months Ended
Debt	Oct. 01, 2022
Debt
Debt	Note 8. Debt Long-term debt consisted of the following: As of October 1, October 2, 2022 2021 (In thousands) Term loan due 2023, net of issuance costs $ — $ 330,322 Term loan due 2027, net of issuance costs 346,737 — Less: Current portion of long-term debt 17,500 18,750 Long-term debt $ 329,237 $ 311,572 Revolving Credit Facility. On September 27, 2022 (the “Closing Date”), the Company entered into a Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) that amended and restated the Company’s existing Fourth Amended and Restated Loan Agreement, dated as of November 30, 2018 (the “Existing Credit Agreement”) by, among other things: (i) increasing the revolving commitments amount, (ii) providing for a term loan facility and (iii) replacing LIBOR with SOFR for purposes of determining the interest rate payable for borrowings under the Credit Agreement. The Credit Agreement provides for an $800 million revolving credit facility and a $350 million secured term loan (“Term Loan Due 2027”). Subject to the satisfaction of certain conditions, including obtaining additional commitments from existing and/or new lenders, the Company may increase the revolving commitment up to an additional $200 million. Costs incurred in connection with the amendment of the Existing Credit Agreement of $3 million are classified as long-term debt and are being amortized to interest expense over the life of the Term Loan Due 2027 using the effective interest method. The Term Loan Due 2027 was fully drawn on the Closing Date and the proceeds were used to repay the term loan outstanding under the Existing Credit Agreement. Upon repayment, the Company recorded a loss on extinguishment of debt of $1 million consisting of a write-off of unamortized debt issuance costs of the Existing Credit Agreement. Loans under the Credit Agreement bear interest, at the Company’s option, at either the SOFR or a base rate, in each case plus a spread determined based on the Company’s credit rating. Interest on the loans is payable quarterly in arrears with respect to base rate loans and at the end of an interest period (and at three month intervals if the interest period exceeds three months) in the case of SOFR loans. The outstanding principal amount of all loans under the Credit Agreement, including, the Term Loan Due 2027, together with accrued and unpaid interest, is due on September 27, 2027. The Company is required to repay a portion of the principal amount of the Term Loan Due 2027 equal to 1.25% of the principal in quarterly installments. Maturities of the Term Loan Due 2027 as of October 1, 2022 by fiscal year are as follows: (In Thousands) 2023 $ 17,500 2024 13,125 2025 17,500 2026 21,875 2027 280,000 $ 350,000 Certain of the Company’s domestic subsidiaries are guarantors in respect of the Credit Agreement. The Company and the subsidiary guarantors’ obligations under the Credit Agreement are secured by a lien on substantially all of their respective assets (excluding real property), including cash, accounts receivable and the shares of certain Company subsidiaries, subject to certain exceptions. As of October 1, 2022, no borrowings and $9 million of letters of credit were outstanding under the Credit Agreement, under which $791 million was available to borrow. There were no borrowings outstanding under the Credit Agreement as of October 2, 2021. Foreign Short-term Borrowing Facilities Debt Covenants The Company’s Credit Agreement requires the Company to comply with certain financial covenants, namely a maximum consolidated leverage ratio and a minimum interest coverage ratio, in both cases measured on the basis of a trailing 12 month look-back period. In addition, the Company’s debt agreements contain a number of restrictive covenants, including restrictions on incurring additional debt, making investments and other restricted payments, selling assets and paying dividends, subject to certain exceptions. The Company was in compliance with these covenants as of October 1, 2022.

Leases

Leases	12 Months Ended
Leases	Oct. 01, 2022
Leases
Leases	Note 9. Leases ROU assets and lease liabilities recorded in the consolidated balance sheet are as follows: As of October 1, October 2, 2022 2021 (In thousands) Other assets $ 79,495 $ 68,012 Accrued liabilities $ 16,695 $ 17,219 Other long-term liabilities 48,566 38,587 Total lease liabilities $ 65,261 $ 55,806 Weighted average remaining lease term (in years) 15.74 14.46 Weighted average discount rate 2.4 % 2.72 % Lease expense and supplemental cash flow information related to operating leases are as follows: Year Ended October 1, October 2, October 3, 2022 2021 2020 Operating lease expense (1) $ 23,978 $ 21,455 $ 20,670 As of October 1, October 2, 2022 2021 (In thousands) Cash paid for operating lease liabilities $ 19,249 $ 19,531 (1) Includes immaterial amounts of short term leases, variable lease costs and sublease income. Future lease payments under non-cancelable operating leases as of October 1, 2022, by fiscal year, are as follows: Operating Leases (In thousands) 2023 $ 18,109 2024 15,350 2025 12,450 2026 8,907 2027 5,724 Thereafter 10,412 Total lease payments 70,952 Less: imputed interest 5,691 Total $ 65,261

Accounts Receivable Sale Progra

Accounts Receivable Sale Program	12 Months Ended
Accounts Receivable Sale Program	Oct. 01, 2022
Accounts Receivable Sale Program
Accounts Receivable Sale Program	Note 10. Accounts Receivable Sale Program The Company is a party to a Receivable Purchase Agreement (the “RPA”) with certain third-party banking institutions for the sale of trade receivables generated from sales to certain customers, subject to acceptance by, and a funding commitment from, the banks that are party to the RPA. Trade receivables sold pursuant to the RPA are serviced by the Company. In addition to the RPA, the Company has the option to participate in trade receivables sales programs that have been implemented by certain of the Company’s customers, as in effect from time to time. The Company does not service trade receivables sold under these other programs. Under each of the programs noted above, the Company sells its entire interest in a trade receivable for 100% of face value, less a discount. For the years ended October 1, 2022 and October 2, 2021, the Company sold approximately $1.9 billion and approximately $0.5 billion, respectively, of accounts receivable under these programs. Upon sale, these receivables are removed from the consolidated balance sheets and cash received is presented as cash provided by operating activities in the consolidated statements of cash flows. Discounts on sold receivables were not material for any period presented. As of October 1, 2022 and October 2, 2021, $194 million and $7 million, respectively, of accounts receivable sold under the RPA and subject to servicing by the Company remained outstanding and had not yet been collected. The Company’s sole risk with respect to receivables it services is with respect to commercial disputes regarding such receivables. Commercial disputes include billing errors, returns and similar matters. To date, the Company has not been required to repurchase any receivable it has sold due to a commercial dispute. Additionally, the Company is required to remit amounts collected as servicer under the RPA on a weekly basis to the financial institutions that purchased the receivables. As of October 1, 2022 and October 2, 2021, $49 million and $18 million, respectively, had been collected but not yet remitted. This amount is classified in accrued liabilities on the consolidated balance sheets.

Contingencies

Contingencies	12 Months Ended
Contingencies	Oct. 01, 2022
Contingencies
Contingencies	Note 11. Contingencies From time to time, the Company is a party to litigation, claims and other contingencies, including environmental, regulatory and employee matters and examinations and investigations by governmental agencies, which arise in the ordinary course of business. The Company records a contingent liability when it is probable that a loss has been incurred and the amount of loss is reasonably estimable in accordance with ASC Topic 450, Contingencies, Legal Proceedings Environmental Matters The Company is subject to various federal, state, local and foreign laws and regulations and administrative orders concerning environmental protection, including those addressing the discharge of pollutants into the environment, the management and disposal of hazardous substances, the cleanup of contaminated sites, the materials used in products, and the recycling, treatment and disposal of hazardous waste. As of October 1, 2022, the Company had been named in a lawsuit and several administrative orders alleging certain of its current and former sites contributed to groundwater contamination. One such order demands that the Company and other alleged defendants remediate groundwater contamination at four landfills located in Northern California to which the Company may have sent wastewater in the past. The Company is participating in a working group of other alleged defendants to better understand its potential exposure in this action and has reserved its estimated exposure for this matter as of October 1, 2022. However, there can be no assurance that the Company’s reserve will ultimately be sufficient. In June 2008, the Company was named by the Orange County Water District in a suit alleging that a predecessor company’s actions at a plant the Company sold in 1998 contributed to polluted groundwater managed by the plaintiff. The complaint seeks recovery of compensatory and other damages, as well as declaratory relief, for the payment of costs necessary to investigate, monitor, remediate, abate and contain contamination of groundwater. In April 2013, all claims against the Company were dismissed. The plaintiff appealed this dismissal and the Court of Appeal reversed the judgment in August 2017, remanding the case back to the Superior Court of California for trial. The first phase of a multi-phase trial against the Company and several other defendants commenced in April 2021 and the submission of evidence concluded in May 2022. On June 28, 2022, the Court issued a tentative ruling finding Sanmina and the other defendants liable for certain past investigation costs incurred by the plaintiff. A final statement of decision in this phase of the trial is expected on or about the middle of calendar year 2023. Based upon the Court’s tentative ruling, the Company believes a loss in this matter is probable and has recorded an estimated loss. Subsequent trial phases to assess the Company’s and certain other defendants’ liability for the plaintiff’s future remediation and other costs, and the allocation of damages among the liable defendants, are anticipated to occur in 2024 and beyond. It is probable that the Company will record additional losses in connection with this matter, and it is reasonably possible that the amount of such additional losses will be material. However, at the current time, the Company is unable to estimate the amount of such additional losses or a range of losses. The Company intends to continue defending the case vigorously and to seek appellate review of any adverse liability rulings or judgment at the appropriate time. Other Matters In October 2018, a contractor who had been retained by the Company through a third party temporary staffing agency filed a lawsuit against the Company in the Santa Clara County Superior Court on behalf of himself and all other similarly situated Company contractors and employees in California, alleging violations of California Labor Code provisions governing overtime, meal and rest periods, wages, wage statements and reimbursement of business expenses. The complaint sought certification of a class of all non-exempt employees. Although the Company continued to deny any wrongdoing, on November 19, 2020, the Company reached an agreement to resolve all claims, including claims under California’s Private Attorneys General Act of 2004 (the “Settlement”), which also resulted in the dismissal of a suit alleging substantially similar claims filed in the Santa Clara County Superior Court in June 2021. The final amount of the judicially approved Settlement was approximately $4 million, and was paid during the first quarter of fiscal 2022. In December 2019, the Company sued a former customer, Dialight plc (“Dialight”), in the United States District Court for the Southern District of New York to collect approximately $10 million in unpaid accounts receivable and net obsolete inventory obligations. Later the same day, Dialight commenced its own action in the same court. Dialight’s complaint, which asserts claims for fraudulent inducement, breach of contract, and gross negligence/willful misconduct, alleges that the Company fraudulently misrepresented its capabilities to induce Dialight to enter into a Manufacturing Services Agreement (the “Dialight MSA”), and then breached its obligations contained in the Dialight MSA relating to quality, on-time delivery and supply chain management. Dialight seeks compensatory and punitive damages that it contends exceed $200 million, but which the Company believes are vastly overstated and are subject to a contractual limitation of liability that limits any Dialight recovery to less than $2 million. The Company continues to vigorously prosecute its claims against Dialight. Further, the Company strongly disagrees with Dialight’s allegations and is defending against them vigorously. No trial date has been set in this matter. For each of the pending matters noted above, the Company is unable to reasonably estimate a range of possible loss at this time.

Restructuring

Restructuring	12 Months Ended
Restructuring	Oct. 01, 2022
Restructuring
Restructuring	Note 12. Restructuring Restructuring costs were $11 million, $15 million, and $27 million in 2022, 2021, and 2020, respectively. The following table is a summary of restructuring costs: Year Ended October 1, October 2, October 3, 2022 2021 2020 (In thousands) Severance costs $ 319 $ 9,405 $ 17,919 Other exit costs (recognized as incurred) 1,500 1,834 71 Total - Q1 FY20 Plan 1,819 11,239 17,990 Costs incurred for other plans 9,606 3,818 8,793 Total - all plans $ 11,425 $ 15,057 $ 26,783 Q1 FY20 Plan On October 28, 2019, the Company adopted a Company-wide restructuring plan (“Q1 FY20 Plan”) under which the Company has incurred restructuring costs of approximately $31 million as of October 1, 2022. These charges consist primarily of severance. Substantially all cash payments have occurred and actions under this plan are complete. Other plans Other plans include a number of plans for which costs are not expected to be material individually or in the aggregate. All Plans The Company’s Integrated Manufacturing Solutions (“IMS”) segment incurred costs of $1 million and $9 million for the years ended October 1, 2022 and October 2, 2021, respectively. The Company’s CPS segment incurred costs of $10 million and $5 million for the years ended October 1, 2022 and October 2, 2021, respectively. In addition, the Company incurred costs of $1 million for the year ended October 2, 2021 for Corporate headcount reductions that were not allocated to the Company’s IMS and CPS segments. The Company had accrued liabilities of $6 million as of October 1, 2022 and October 2, 2021, for restructuring costs (exclusive of long-term environmental remediation liabilities). The Company expects to incur restructuring costs, which could be material, in future periods primarily relating to vacant facilities and former sites for which the Company is or may be responsible for environmental remediation.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Oct. 01, 2022
Income Taxes
Income Taxes	Domestic and foreign components of income before income taxes were as follows: Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands) Domestic $ 145,671 $ 174,936 $ 88,450 Foreign 156,649 106,705 103,765 Total $ 302,320 $ 281,641 $ 192,215 The provision for income taxes consists of the following: Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands) Federal: Current $ 1,070 $ 705 $ (917) Deferred 25,399 28,809 7,666 State: Current 1,711 3,677 1,500 Deferred 3,081 (302) 2,579 Foreign: Current 31,241 (906) 46,376 Deferred (566) 112 1,842 Total provision for income taxes $ 61,936 $ 32,095 $ 59,046 The Company’s provision for income taxes for 2022, 2021 and 2020 was $62 million (20% of income before taxes), $32 million (11% of income before taxes) and $59 million (31% of income before taxes), respectively. The effective tax rates for 2022 and 2021 were lower than the expected U.S. statutory rate of 21% primarily due to a $16 million and $43 million tax benefit, respectively, resulting from the release of a foreign tax reserves due to lapse of time and expiration of statutes of limitations. The effective tax rate for 2020 is higher than the expected U.S. statutory rate of 21% primarily due to foreign operations that are taxed at rates higher than the U.S. statutory rate. The tax effects of temporary differences that give rise to significant portions of deferred tax assets and liabilities are as follows: As of October 1, October 2, 2022 2021 (Restated) (In thousands) Deferred tax assets: U.S. net operating loss carryforwards $ 92,882 $ 134,385 Foreign net operating loss carryforwards 109,416 112,516 Intangibles 25,099 24,219 Accruals not currently deductible 44,963 43,932 Property, plant and equipment 27,514 25,494 Tax credit carryforwards 18,465 17,250 Reserves not currently deductible 14,939 11,534 Stock compensation expense 6,365 7,677 Federal benefit of foreign operations 21,312 18,336 Derivatives and other impacts of OCI 838 7,637 Lease deferred tax asset 15,018 11,563 Other 1,915 — Valuation allowance (118,210) (115,258) Total deferred tax assets 260,516 299,285 Deferred tax liabilities on undistributed earnings (14,775) (14,775) Deferred tax liabilities on branch operations (24,182) (30,000) Revenue recognition (1,572) (1,702) Lease deferred tax liability (14,808) (11,349) Other — (2,495) Net deferred tax assets $ 205,179 $ 238,964 Recorded as: Deferred tax assets $ 209,554 $ 242,261 Deferred tax liabilities (4,375) (3,297) Net deferred tax assets $ 205,179 $ 238,964 A valuation allowance is established or maintained when, based on currently available information and other factors, it is more likely than not that all or a portion of the deferred tax assets will not be realized. The Company regularly assesses its valuation allowance against deferred tax assets on a jurisdiction by jurisdiction basis. The Company considers all available positive and negative evidence, including future reversals of temporary differences, projected future taxable income, tax planning strategies and recent financial results. Significant judgment is required in assessing the Company’s ability to generate revenue, gross profit, operating income and jurisdictional taxable income in future periods. The Company’s valuation allowance as of October 1, 2022 relates primarily to foreign net operating losses, with the exception of $14 million related to U.S. state net operating losses. The Company provides deferred tax liabilities for the tax consequences associated with the undistributed earnings that are expected to be repatriated to subsidiaries’ parent unless the subsidiaries’ earnings are considered indefinitely reinvested. As of October 1, 2022, income taxes and foreign withholding taxes have not been provided for approximately $439 million of cumulative undistributed earnings of several non-U.S. subsidiaries. The Company intends to reinvest these earnings indefinitely in operations outside of the U.S. Determination of the amount of unrecognized deferred tax liabilities on these undistributed earnings is not practicable. As of October 1, 2022, the Company has cumulative net operating loss carryforwards for federal, state and foreign tax purposes of $344 million, $357 million and $465 million, respectively. The federal and state net operating loss carryforwards begin expiring in fiscal years 2028 and 2023, respectively, and expire at various dates through September 29, 2035. Certain foreign net operating losses start expiring in 2023. However, the majority of foreign net operating losses carryforward indefinitely. As of October 1, 2022, the Company has federal tax credits of $21 million that expire between 2031 and 2042. There are certain restrictions on the utilization of net operating loss and tax credit carryforwards in the event of an “ownership change” as defined in the Internal Revenue Code. The utilization of certain net operating losses may be restricted due to changes in ownership and business operations. Following is a reconciliation of the statutory federal tax rate to the Company’s effective tax rate: Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) Federal tax at statutory tax rate 21.00 % 21.00 % 21.00 % Effect of foreign operations 3.52 7.99 13.60 Permanent items 0.08 (2.03) (0.62) Federal credits (0.73) (0.54) (1.37) Other 0.59 (0.20) (0.06) State income taxes, net of federal benefit 1.60 0.91 1.94 Release of foreign tax reserves (5.57) (15.73) (3.77) Effective tax rate 20.49 % 11.40 % 30.72 % A reconciliation of the beginning and ending amount of total liabilities for unrecognized tax benefits, excluding accrued penalties and interest, is as follows: Year Ended October 1, October 2, October 3, 2022 2021 2020 (In thousands) Balance, beginning of year $ 67,781 $ 74,612 $ 66,677 Increase (decrease) related to prior year tax positions (4,456) 6,063 1,327 Increase related to current year tax positions 7,154 7,349 9,907 Settlements (7,596) — — Decrease related to lapse of time and expiration of statutes of limitations (9,331) (20,243) (3,299) Balance, end of year $ 53,552 $ 67,781 $ 74,612 The Company had reserves of $11 million and $17 million as of October 1, 2022 and October 2, 2021, respectively, for the payment of interest and penalties relating to unrecognized tax benefits. During 2022, the Company recognized an income tax benefit for interest and penalties of $3 million due to lapse of time and expiration of statutes of limitations compared to an income tax benefit of $23 million in 2021. The Company recognizes interest and penalties related to liabilities for unrecognized tax benefits as a component of income tax expense. Should the Company be able to ultimately recognize all of these uncertain tax positions, it would result in a benefit to net income of $44 million in 2022. The Company conducts business globally and, as a result, files income tax returns in the United States federal jurisdiction and various state and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world. The Company is currently being audited by the Internal Revenue Service for tax years 2008 through 2010. To the extent the final tax liabilities are different from the amounts accrued, this would result in an increase or decrease in net operating loss carryforwards which could materially impact tax expense. Additionally, the Company is being audited by various state tax agencies and certain foreign countries. To the extent the final tax liabilities are different from the amounts accrued, the increases or decreases would be recorded as income tax expense or benefit in the consolidated statements of income. Although the Company believes that the resolution of these audits will not have a material adverse impact on the Company’s results of operations, the outcome is subject to uncertainty. In general, the Company is no longer subject to United States federal or state income tax examinations for years before 2003, and to foreign examinations for years prior to 2006 in its major foreign jurisdictions. It is reasonably possible that the balance of gross unrecognized tax benefits could decrease in the next 12 months by approximately $9 million related to payments, the resolution of audits and expiration of statutes of limitations. In addition, there could be a corresponding decrease in accrued interest and penalties of approximately $4 million.

Earnings Per Share

Earnings Per Share	12 Months Ended
Earnings Per Share	Oct. 01, 2022
Earnings Per Share
Earnings Per Share	Note 14. Earnings Per Share Basic and diluted earnings per share amounts are calculated by dividing net income by the weighted average number of shares of common stock outstanding during the period, as follows: Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands, except per share amounts) Numerator: Net income $ 240,384 $ 249,546 $ 133,169 Denominator: Weighted average common shares outstanding 61,310 65,318 69,041 Effect of dilutive stock options and restricted stock units 1,807 1,766 1,752 Denominator for diluted earnings per share 63,117 67,084 70,793 Net income per share: Basic $ 3.92 $ 3.82 1.93 Diluted $ 3.81 $ 3.72 1.88 Weighted-average dilutive securities that were excluded from the above calculation because their inclusion would have had an anti-dilutive effect under ASC Topic 260, Earnings per Share

Stockholders' Equity

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Oct. 01, 2022
Stockholders' Equity
Stockholders' Equity	Note 15. Stockholders’ Equity The Company’s 2009 Stock Plan (“2009 Plan”) expired as to future grants on January 26, 2019. Although the 2009 Plan expired, it will continue to govern all awards granted under it prior to its expiration date. On March 11, 2019, the Company’s stockholders approved the Company’s 2019 Equity Incentive Plan (“2019 Plan”) and the reservation of 4 million shares of common stock for issuance thereunder, plus any shares subject to stock options or similar awards granted under the 2009 Plan that expire or otherwise terminate without having been exercised in full and shares issued pursuant to awards granted that are forfeited by the Company. As of October 1, 2022, an aggregate of 7 million shares were authorized for future issuance under the Company’s stock plans, of which 4 million of such shares were issuable upon exercise of outstanding options and delivery of shares upon vesting of restricted stock units and 3 million shares of common stock were available for future grant. Awards other than stock options reduce common stock available for grant by 1.36 shares for every share of common stock subject to such an award. Awards under the 2019 Plan and 2009 Plan that expire or are cancelled without delivery of shares generally become available for issuance under the 2019 Plan. The 2019 Plan will expire as to future grants in December 2028. Stock Repurchase Program During 2022, 2021 and 2020, the Company repurchased 8.0 million shares, 1.5 million shares and 6.4 million shares of its common stock for $317 million, $54 million and $166 million (including commissions), respectively, under stock repurchase programs authorized by the Board of Directors. These programs have no expiration dates and the timing of repurchases will depend upon capital needs to support the growth of the Company’s business, market conditions and other factors. Although stock repurchases are intended to increase stockholder value, purchases of shares reduce the Company’s liquidity. As of October 1, 2022, an aggregate of $164 million remains available under these programs. In addition to the repurchases discussed above, the Company repurchased 369,000, 286,000 and 398,000 shares of its common stock during 2022, 2021, and 2020, respectively, in settlement of employee tax withholding obligations due upon the vesting of restricted stock units. The Company paid $14 million, $10 million and $13 million, respectively, to applicable tax authorities in connection with these repurchases. Accumulated Other Comprehensive Income Accumulated other comprehensive income, net of tax as applicable, consisted of the following: As of October 1, October 2, 2022 2021 (In thousands) Foreign currency translation adjustments $ 63,929 $ 76,120 Unrealized holding gain (loss) on derivative financial instruments 4,112 (14,305) Unrecognized net actuarial loss and unrecognized transition cost for benefit plans (11,716) (21,125) Total $ 56,325 $ 40,690 During the third quarter of 2021, a foreign entity of the Company was substantially liquidated and the Company reclassified $8 million of cumulative translation adjustments associated with this entity from accumulated other comprehensive income to other income (expense), net in the consolidated statements of income. During the fourth quarter of 2022, the Company reclassified $2 million of unrecognized pension losses from accumulated other comprehensive income to other income (expense), net in the consolidated statements of income. There were no other significant reclassifications from accumulated other comprehensive income to the consolidated statements of income for any period presented. Unrealized holding gain (loss) on derivative financial instruments includes losses from interest rate swap agreements with independent counterparties to partially hedge the variability in cash flows due to changes in the benchmark interest rate (SOFR) associated with anticipated variable rate borrowings. These swaps are accounted for as cash flow hedges under ASC Topic 815, Derivatives and Hedging. Interest rate swaps with an aggregate notional amount of $350 million were outstanding as of October 1, 2022 and October 2, 2021. The aggregate effective interest rate of these swaps as of October 1, 2022 was approximately 4.1% and was approximately 4.3% as of October 2, 2021. These interest rate swaps had a negative value of $19 million as of October 2, 2021, of which $9 million is included in accrued liabilities and the remaining amount is included in other long-term liabilities on the consolidated balance sheets. Given the recent rise in interest rates and the likelihood of additional rate increases, these interest rate swaps had a positive value of $6 million as of October 1, 2022, of which the majority is included in prepaid expenses and other current assets and the remaining amount is included in other assets on the consolidated balance sheets.

Business Segment, Geographic an

Business Segment, Geographic and Customer Information	12 Months Ended
Business Segment, Geographic and Customer Information	Oct. 01, 2022
Business Segment, Geographic and Customer Information
Business Segment, Geographic and Customer Information	Note 16. Business Segment, Geographic and Customer Information ASC Topic 280, Segment Reporting The Company’s operations are managed as two businesses: 1) Integrated Manufacturing Solutions (IMS). IMS is a reportable segment consisting of printed circuit board assembly and test, high-level assembly and test and direct order fulfillment. 2) Components, Products and Services (CPS). Components include printed circuit boards, backplanes and backplane assemblies, cable assemblies fabricated metal parts, precision machined parts, and plastic injected molded parts. Products include memory solutions from our Viking Technology division; high-performance storage platforms for hyperscale and enterprise solutions from our Viking Enterprise Solutions (VES) division; optical, radio frequency (RF) and microelectronics (microE) design and manufacturing services from Advanced Microsystems Technologies; defense and aerospace products from SCI Technology; and cloud-based manufacturing execution software from the Company’s 42Q division. Services include design, engineering and logistics and repair. The Company determined that it has only one reportable segment - IMS, which generated approximately 80% of the Company’s total revenue in 2022. CPS consists of multiple operating segments which do not meet the quantitative threshold for being presented individually as reportable segments. Therefore, financial information for these operating segments is combined and presented in a single category entitled “Components, Products and Services”. The accounting policies for each segment are the same as those disclosed by the Company for its consolidated financial statements. Intersegment sales consist primarily of sales of components from CPS to IMS. The Company’s chief operating decision making group is the Chief Executive Officer who allocates resources and assesses performance of operating segments based on a measure of revenue and gross profit that excludes items not directly related to the Company’s ongoing business operations. These items are typically either non-recurring or non-cash in nature. Segment information is as follows: Year Ended October 1, 2022 October 2, 2021 October 3, 2020 (In thousands) Gross sales (As restated): IMS $ 6,413,606 $ 5,485,612 $ 5,719,180 CPS 1,655,183 1,379,455 1,369,550 Intersegment revenue (149,167) (126,711) (138,522) Net Sales $ 7,919,622 $ 6,738,356 $ 6,950,208 Gross Profit (As restated): IMS $ 462,606 $ 391,339 $ 381,638 CPS 175,509 151,884 148,301 Total 638,115 543,223 529,939 Unallocated items (1) (15,909) (16,782) (12,775) Total $ 622,206 $ 526,441 $ 517,164 Depreciation and amortization: IMS $ 73,914 $ 77,076 $ 81,169 CPS 30,061 27,770 26,718 Total 103,975 104,846 107,887 Unallocated corporate items (2) 4,808 4,810 6,331 Total $ 108,783 $ 109,656 $ 114,218 Capital expenditures (receipt basis): IMS $ 94,636 $ 44,672 $ 23,933 CPS 55,993 33,839 23,915 Total 150,629 78,511 47,848 Unallocated corporate items (2) 5,650 3,343 3,227 Total $ 156,279 $ 81,854 $ 51,075 (1) For purposes of evaluating segment performance, management excludes certain items from its measures of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets, charges or credits resulting from distressed customers and litigation settlements. (2) Primarily related to selling, general and administration functions. Segment assets, consisting of accounts receivable, inventories and fixed assets, are substantially proportional to segment sales. Net sales by geographic segment, determined based on the country in which a product is manufactured were as follows: Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands) Net sales: Americas (1) $ 3,748,643 $ 3,164,562 $ 3,440,365 APAC 3,007,904 2,517,963 2,514,005 EMEA 1,163,075 1,055,831 995,838 Total $ 7,919,622 $ 6,738,356 $ 6,950,208 (1) Mexico represents approximately 60% of the Americas revenue and the U.S. represents approximately 35% . Percentage of net sales represented by ten largest customers 48.7 % 52.7 % 55.5 % Number of customers representing 10% or more of net sales 2 1 1 As of October 1, October 2, 2022 2021 (In thousands) Property, plant and equipment, net: Americas $ 367,172 $ 322,545 APAC 151,254 143,111 EMEA 56,744 67,329 Total $ 575,170 $ 532,985

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
Stock-Based Compensation	Oct. 01, 2022
Stock-Based Compensation.
Stock-Based Compensation	Note 17. Stock-Based Compensation Stock-based compensation expense was recognized as follows: Year Ended October 1, October 2, October 3, 2022 2021 2020 (In thousands) Cost of sales $ 14,065 $ 14,472 $ 10,099 Selling, general and administrative 25,037 20,118 15,897 Research and development 506 386 239 Total $ 39,608 $ 34,976 $ 26,235 The Company grants restricted stock units and restricted stock units with performance conditions (“PSUs”) to executive officers, directors and certain other employees. These units vest over periods ranging from one year to four years and/or upon achievement of specified performance criteria, with associated compensation expense recognized ratably over the vesting period. The Company grants shares for which vesting is contingent on cumulative non-GAAP earnings per share measured over three fiscal years. If a minimum threshold is not achieved during the measurement period, the shares will be cancelled. If a minimum threshold is achieved or exceeded, the number of shares of common stock that will be issued will range from 80% to 120% of the number of PSUs granted, depending on the extent of performance. Additionally, the number of shares that vest may be adjusted up or down by up to 15% based on the Company’s total shareholder return relative to that of its peer group over this same period. Activity with respect to the Company’s restricted stock units and PSUs was as follows: Weighted Average Weighted-Average Grant-Date Remaining Aggregate Number of Fair Value Contractual Term Intrinsic Value Shares ($) (Years) ($) (In thousands) (In thousands) Outstanding as of September 28, 2019 3,153 27.82 1.30 102,720 Granted 1,340 32.51 Vested/Forfeited/Cancelled (1,925) 28.62 Outstanding as of October 3, 2020 2,568 29.67 1.23 71,571 Granted 1,529 34.26 Vested/Forfeited/Cancelled (1,143) 29.27 Outstanding as of October 2, 2021 2,954 32.21 1.23 113,591 Granted 1,644 40.54 Vested/Forfeited/Cancelled (1,318) 30.42 Outstanding as of October 1, 2022 3,280 37.11 1.35 155,049 Expected to vest as of October 1, 2022 2,909 36.93 1.28 137,524 The fair value of restricted stock units that vested during the year was $44 million for 2022, $32 million for 2021 and $43 million for 2020. As of October 1, 2022, unrecognized compensation expense of $68 million is expected to be recognized over a weighted average period of 1.3 years.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Oct. 01, 2022
Employee Benefit Plans
Employee Benefit Plans	Note 18. Employee Benefit Plans The Company has various defined contribution retirement plans that cover the majority of its domestic employees. These retirement plans permit participants to elect to have contributions made to the retirement plans in the form of salary deferrals. Under these retirement plans, the Company may match a portion of employee contributions. Amounts contributed by the Company were not material for any period presented herein. The Company sponsors a deferred compensation plan for eligible employees that allows participants to defer payment of all or part of their compensation. Deferrals under this plan were immaterial. Assets associated with these plans were $37 million and $46 million as of October 1, 2022 and October 2, 2021, respectively. Liabilities associated with these plans were $37 million and $46 million as of October 1, 2022 and October 2, 2021, respectively. These amounts are recorded in other non-current assets and other long-term liabilities on the consolidated balance sheets. Defined benefit plans covering certain employees in the United States and Canada were frozen in 2001. Employees who had not yet vested will continue to be credited with service until vesting occurs, but no additional benefits will accrue. During the third quarter of 2022, the Board of Directors approved the termination of the Company’s frozen U.S. defined benefit plan (the “Plan”) effective July 3, 2022. In connection with this termination, the Company purchased a group annuity contract for $6 million during the fourth quarter of 2022 that provides for the administration of future payments to eligible plan participants. In addition, the Company recorded a pension settlement charge of $2 million during the fourth quarter of 2022, which includes the reclassification of unrecognized pension losses from accumulated other comprehensive income to other income (expense), net on the consolidated statements of income. The Company also provides defined benefit pension plans in certain other countries. The assumptions used for calculating the pension benefit obligations for non-U.S. plans depend on the local economic environment and regulations. The measurement date for the Company’s defined benefit plans is October 1, 2022. The funded status and plan assets for the defined benefit plans and amount reported on the consolidated balance sheets were as follows: As of October 1, 2022 October 2, 2021 October 3, 2020 Non-U.S. U.S. Non-U.S. U.S. Non-U.S. (In thousands) Plan Assets $ 17,290 $ 16,435 $ 23,575 $ 15,430 $ 23,575 Projected Benefit Obligation 50,871 22,943 63,217 25,704 64,453 Underfunded Status $ 33,581 $ 6,508 $ 39,642 $ 10,274 $ 40,878 Current Liabilities $ 3,038 $ — $ 2,674 $ — $ 2,054 Non-current liabilities 30,543 6,508 36,968 10,274 38,824 Total liabilities $ 33,581 $ 6,508 $ 39,642 $ 10,274 $ 40,878 The Company’s investment strategy is designed to help ensure that sufficient pension assets are available to pay benefits as they become due. Plan assets are invested in mutual funds that are valued using the NAV that is quoted in active markets (Level 1 input). These plans are managed consistent with regulations or market practices of the country in which the assets are invested. As of October 1, 2022 there were no significant concentrations of credit risk related to pension plan assets. All other amounts and assumptions were not material for any period presented herein.

Strategic Transactions

Strategic Transactions	12 Months Ended
Strategic Transactions	Oct. 01, 2022
Strategic Transactions
Business Combination Disclosure	Note 19. Strategic Transactions India Joint Venture On October 3, 2022, subsequent to the end of the fourth quarter of 2022, the Company completed a joint venture transaction in which the Company entered into a Share Subscription and Purchase Agreement (the “SSPA”) and a Joint Venture and Shareholders’ Agreement (the “Shareholders’ Agreement”) with Reliance Strategic Business Ventures Limited (“RSBVL”), a wholly owned subsidiary of Reliance Industries Limited. Pursuant to the SSPA and the Shareholder’ Agreement, the parties established Sanmina SCI India Private Limited (“SIPL”), the Company’s existing Indian manufacturing entity, as a joint venture to engage in manufacturing in India of telecommunications equipment, data center and internet equipment, medical equipment, clean technology equipment and other high-tech equipment. As a result of the transaction, RSBVL acquired shares of SIPL for approximately $215 million of cash such that immediately after the closing of the transaction, RSBVL holds 50.1% of the outstanding shares of SIPL and Sanmina holds the remaining 49.9% of the outstanding shares of SIPL. The amount received from RSBVL was based on preliminary calculations and is subject to adjustment based on final calculations. Given the terms of the agreements entered into by the parties concerning management of the joint venture, the Company expects to continue to consolidate SIPL in future periods. Acquisition On April 6, 2021, the Company purchased all of the outstanding stock of a European subsidiary of a multinational company in the industrial end market. This acquisition increased the Company’s IMS capabilities in Europe. The Company also entered into a master supply agreement with the seller in connection with this acquisition. Total consideration paid in this acquisition was $38 million of cash, of which $29 million was paid upon closing and $9 million is due in April 2023. The acquiree had $8 million of cash as of the acquisition date, resulting in a net cash outlay upon closing of $21 million. The pro-forma effect of the acquisition, as if it had occurred at the beginning of the year, was not material to the consolidated financial statements. The acquisition is reported in the Company’s IMS reportable segment. The Company’s allocation of the purchase price was based on management’s estimate of the acquisition-date fair values of the tangible and identifiable intangible assets acquired and liabilities assumed. The following represents the allocation of the purchase price to the acquired assets and liabilities assumed. (In thousands) Current assets, including cash acquired of $8.1 million $ 18,696 Noncurrent assets, including identifiable intangible assets of $4.4 million and goodwill of $8.5 million 30,711 Current liabilities (10,671) Noncurrent liabilities (152) Total net assets acquired $ 38,584 Goodwill reflects the expectation that the acquisition enables the Company to increase its IMS capabilities in Europe. Goodwill and identifiable intangible assets are recorded in other non-current assets on the consolidated balance sheets. Identifiable intangible assets are being amortized over four years.

Quarterly Financial Data - Unau

Quarterly Financial Data - Unaudited	12 Months Ended
Quarterly Financial Data - Unaudited	Oct. 01, 2022
Quarterly Financial Data - Unaudited
Quarterly Financial Data - Unaudited	Note 20. Quarterly Financial Data – Unaudited The following tables set forth selected unaudited quarterly financial information for the years ended October 1, 2022 and October 2, 2021. As described in Note 2, the Company has restated its unaudited quarterly financial information for each of the interim periods in the years ended October 1, 2022 and October 2, 2021. This information has been prepared on the same basis as the unaudited consolidated financial statements. The adjustments to the unaudited quarterly financial information below are the same as the Investigation Adjustments and Other Adjustments discussed in Note 2. As Restated Year ended October 1, 2022 First Quarter Second Quarter Third Quarter Fourth Quarter (In thousands, except per share data) Net sales $ 1,756,326 $ 1,915,070 $ 2,023,361 $ 2,224,865 Gross profit $ 141,297 $ 146,495 $ 162,185 $ 172,229 Gross margin 8.0 % 7.6 % 8.0 % 7.7 % Operating income $ 78,241 $ 76,274 $ 91,614 $ 103,350 Operating margin 4.5 % 4.0 % 4.5 % 4.6 % Net income $ 56,177 $ 48,621 $ 77,222 $ 58,364 Basic net income per share $ 0.87 $ 0.77 $ 1.29 $ 1.01 Diluted net income per share $ 0.85 $ 0.76 $ 1.25 $ 0.98 As Restated Year ended October 2, 2021 First Quarter Second Quarter Third Quarter Fourth Quarter (In thousands, except per share data) Net sales $ 1,755,984 $ 1,678,497 $ 1,653,266 $ 1,650,609 Gross profit $ 140,351 $ 120,985 $ 135,066 $ 130,039 Gross margin 8.0 % 7.2 % 8.2 % 7.9 % Operating income $ 74,675 $ 42,610 $ 72,741 $ 65,910 Operating margin 4.3 % 2.5 % 4.4 % 4.0 % Net income $ 49,558 $ 27,868 $ 116,195 $ 55,925 Basic net income per share $ 0.76 $ 0.43 $ 1.78 $ 0.86 Diluted net income per share $ 0.74 $ 0.42 $ 1.73 $ 0.83 Consolidated Balance Sheets The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Balance Sheets as of January 1, 2022, April 2, 2022 and July 2, 2022. As of January 1, 2022 April 2, 2022 July 2, 2022 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) ASSETS Current assets: Cash and cash equivalents $ 627,717 $ — $ — $ 627,717 $ 559,893 $ — $ — $ 559,893 $ 493,305 $ — $ — $ 493,305 Accounts receivable, net of allowances 1,298,327 — 687 1,299,014 1,270,494 — 606 1,271,100 1,228,435 — 1,429 1,229,864 Contract assets 364,407 (31,772) 14,948 347,583 417,286 (33,512) 15,508 399,282 459,306 (34,918) 20,408 444,796 Inventories 1,242,440 (2,373) 13,630 1,253,697 1,437,955 (6,913) 12,579 1,443,621 1,591,111 (8,829) 7,841 1,590,123 Prepaid expenses and other current assets 59,188 — — 59,188 61,525 — — 61,525 63,827 — — 63,827 Total current assets 3,592,079 (34,145) 29,265 3,587,199 3,747,153 (40,425) 28,693 3,735,421 3,835,984 (43,747) 29,678 3,821,915 Property, plant and equipment, net 525,159 — — 525,159 525,362 — — 525,362 545,673 — — 545,673 Deferred tax assets 227,239 7,792 — 235,031 220,532 9,042 — 229,574 212,407 9,673 — 222,080 Other 157,533 — — 157,533 156,867 — — 156,867 149,608 — — 149,608 Total assets $ 4,502,010 $ (26,353) $ 29,265 $ 4,504,922 $ 4,649,914 $ (31,383) $ 28,693 $ 4,647,224 $ 4,743,672 $ (34,074) $ 29,678 $ 4,739,276 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 1,694,592 $ — $ 13,630 $ 1,708,222 $ 1,817,465 $ — $ 12,579 $ 1,830,044 $ 1,976,533 $ — $ 7,841 $ 1,984,374 Accrued liabilities 236,227 2,100 15,635 253,962 314,648 1,669 16,114 332,431 303,076 1,299 21,837 326,212 Accrued payroll and related benefits 115,738 — — 115,738 116,794 — — 116,794 133,319 — — 133,319 Short-term debt, including current portion of long-term debt 18,750 — — 18,750 18,750 — — 18,750 18,750 — — 18,750 Total current liabilities 2,065,307 2,100 29,265 2,096,672 2,267,657 1,669 28,693 2,298,019 2,431,678 1,299 29,678 2,462,655 Long-term liabilities: Long-term debt 307,160 — — 307,160 302,751 — — 302,751 298,345 — — 298,345 Other 248,326 — — 248,326 241,416 — — 241,416 209,716 — — 209,716 Total long-term liabilities 555,486 — — 555,486 544,167 — — 544,167 508,061 — — 508,061 Contingencies (Note 11) Stockholders’ equity 1,881,217 (28,453) — 1,852,764 1,838,090 (33,052) — 1,805,038 1,803,933 (35,373) — 1,768,560 Total liabilities and stockholders’ equity $ 4,502,010 $ (26,353) $ 29,265 $ 4,504,922 $ 4,649,914 $ (31,383) $ 28,693 $ 4,647,224 $ 4,743,672 $ (34,074) $ 29,678 $ 4,739,276 Consolidated Statements of Income The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Income for the three months ended January 1, 2022, April 2, 2022 and July 2, 2022. Three Months Ended January 1, 2022 April 2, 2022 July 2, 2022 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) Net sales $ 1,757,325 $ (999) $ — $ 1,756,326 $ 1,911,530 $ 3,540 $ — $ 1,915,070 $ 2,019,059 $ 4,302 $ — $ 2,023,361 Cost of sales 1,612,836 2,193 — 1,615,029 1,759,083 9,492 — 1,768,575 1,853,870 7,306 — 1,861,176 Gross profit 144,489 (3,192) — 141,297 152,447 (5,952) — 146,495 165,189 (3,004) — 162,185 Operating expenses: Selling, general and administrative 61,475 — — 61,475 61,817 — — 61,817 61,506 — — 61,506 Research and development 4,777 — — 4,777 5,472 — — 5,472 5,071 — — 5,071 Restructuring and other 1,414 — — 1,414 2,932 — — 2,932 3,994 — — 3,994 Gain on sale of long-lived assets (4,610) — — (4,610) — — — — — — Total operating expenses 63,056 — — 63,056 70,221 — — 70,221 70,571 — — 70,571 Operating income 81,433 (3,192) — 78,241 82,226 (5,952) — 76,274 94,618 (3,004) — 91,614 — Interest income 309 — — 309 349 — — 349 540 — — 540 Interest expense (4,877) — — (4,877) (4,870) — — (4,870) (5,615) — — (5,615) Other income (expense), net 2,072 — — 2,072 (1,408) — — (1,408) (7,774) — — (7,774) Interest and other, net (2,496) — — (2,496) (5,929) — — (5,929) (12,849) — — (12,849) Income before income taxes 78,937 (3,192) — 75,745 76,297 (5,952) — 70,345 81,769 (3,004) — 78,765 Provision for income taxes 20,303 (735) — 19,568 23,077 (1,353) — 21,724 2,226 (683) — 1,543 Net income $ 58,634 $ (2,457) $ — $ 56,177 $ 53,220 $ (4,599) $ — $ 48,621 $ 79,543 $ (2,321) $ — $ 77,222 Net income per share: Basic $ 0.91 $ (0.04) $ — $ 0.87 $ 0.85 $ (0.08) $ — $ 0.77 $ 1.33 $ (0.04) $ — $ 1.29 Diluted $ 0.89 $ (0.04) $ — $ 0.85 $ 0.83 $ (0.07) $ — $ 0.76 $ 1.29 $ (0.04) $ — $ 1.25 The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Income for the six and nine months ended April 2, 2022 and July 2, 2022, respectively. Six Months Ended Nine Months Ended April 2, 2022 July 2, 2022 Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) Net sales $ 3,668,855 $ 2,541 $ — $ 3,671,396 $ 5,687,914 $ 6,843 $ — $ 5,694,757 Cost of sales 3,371,919 11,685 — 3,383,604 5,225,789 18,991 — 5,244,780 Gross profit 296,936 (9,144) — 287,792 462,125 (12,148) — 449,977 Operating expenses: Selling, general and administrative 123,292 — — 123,292 184,798 — — 184,798 Research and development 10,249 — — 10,249 15,320 — — 15,320 Restructuring and other 4,346 — — 4,346 8,340 — — 8,340 Gain on sale of long-lived assets (4,610) — — (4,610) (4,610) — — (4,610) Total operating expenses 133,277 — — 133,277 203,848 — — 203,848 Operating income 163,659 (9,144) — 154,515 258,277 (12,148) — 246,129 Interest income 658 — — 658 1,198 — — 1,198 Interest expense (9,747) — — (9,747) (15,362) — — (15,362) Other income (expense), net 664 — — 664 (7,110) — — (7,110) Interest and other, net (8,425) — — (8,425) (21,274) — — (21,274) Income before income taxes 155,234 (9,144) — 146,090 237,003 (12,148) — 224,855 Provision for income taxes 43,380 (2,088) — 41,292 45,606 (2,771) — 42,835 Net income $ 111,854 $ (7,056) $ — $ 104,798 $ 191,397 $ (9,377) $ — $ 182,020 Net income per share: Basic $ 1.76 $ (0.11) $ — $ 1.65 $ 3.07 $ (0.15) $ — $ 2.92 Diluted $ 1.71 $ (0.11) $ — $ 1.60 $ 2.98 $ (0.15) $ — $ 2.83 Consolidated Statements of Cash Flows The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Cash Flows for the periods indicated below. Three Months Ended Six Months Ended Nine Months Ended January 1, 2022 April 2, 2022 July 2, 2022 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 58,634 $ (2,457) $ — $ 56,177 $ 111,854 $ (7,056) $ — $ 104,798 $ 191,397 $ (9,377) $ — $ 182,020 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 27,465 — — 27,465 55,032 — — 55,032 82,097 — — 82,097 Stock-based compensation expense 9,032 — — 9,032 18,362 — — 18,362 29,045 — — 29,045 Deferred income taxes 6,707 (648) — 6,059 11,071 (1,898) — 9,173 18,522 (2,529) — 15,993 Impairment of goodwill and other assets — — — — — — — — 1,848 — — 1,848 Loss on sale of intellectual property Other, net (3,638) — — (3,638) (1,903) — — (1,903) (3,146) — — (3,146) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable (106,972) — 316 (106,656) (79,705) — 397 (79,308) (39,850) — (426) (40,276) Contract assets (15,666) 3,064 (2,791) (15,393) (68,545) 4,804 (3,351) (67,092) (110,565) 6,210 (8,251) (112,606) Inventories (207,300) 88 (6,066) (213,278) (403,396) 4,628 (5,015) (403,783) (559,118) 6,544 (277) (552,851) Prepaid expenses and other assets (2,939) — — (2,939) (11,334) — — (11,334) (13,269) — — (13,269) Accounts payable 234,525 — 6,066 240,591 357,176 — 5,015 362,191 507,632 — 277 507,909 Accrued liabilities 68,452 (47) 2,475 70,880 158,661 (478) 2,954 161,137 144,363 (848) 8,677 152,192 Cash provided by operating activities $ 68,300 $ — $ — $ 68,300 $ 147,273 $ — $ — $ 147,273 $ 248,956 $ — $ — $ 248,956 Consolidated Balance Sheets The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Balance Sheets as of January 2, 2021, April 3, 2021 and July 3, 2021. As of January 2, 2021 April 3, 2021 July 3, 2021 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) ASSETS Current assets: Cash and cash equivalents $ 516,030 $ — $ — $ 516,030 $ 575,176 $ — $ 575,176 $ 623,844 $ — $ — $ 623,844 Accounts receivable, net of allowances 1,108,472 - 4,453 1,112,925 1,122,962 - 1,876 1,124,838 1,153,813 — 1,440 1,155,253 Contract assets 350,049 (9,427) 17,367 357,989 334,957 (27,204) 14,194 321,947 345,096 (29,357) 17,699 333,438 Inventories 819,474 — — 819,474 785,406 — 785,406 892,633 — — 892,633 Prepaid expenses and other current assets 48,851 — — 48,851 38,584 — 38,584 50,446 — — 50,446 Total current assets 2,842,876 (9,427) 21,820 2,855,269 2,857,085 (27,204) 16,070 2,845,951 3,065,832 (29,357) 19,139 3,055,614 Property, plant and equipment, net 541,188 - (14,543) 526,645 529,651 - (14,448) 515,203 550,038 — (14,353) 535,685 Deferred tax assets 269,803 2,074 (690) 271,187 259,943 6,649 — 266,592 241,069 6,991 — 248,060 Other 125,867 - 14,543 140,410 123,550 - 14,448 137,998 145,651 — 14,353 160,004 Total assets $ 3,779,734 $ (7,353) $ 21,130 $ 3,793,511 $ 3,770,229 $ (20,555) $ 16,070 $ 3,765,744 $ 4,002,590 $ (22,366) $ 19,139 $ 3,999,363 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 1,143,431 $ — $ — $ 1,143,431 $ 1,108,994 $ — $ — $ 1,108,994 $ 1,296,005 $ — $ — $ 1,296,005 Accrued liabilities 190,797 (136) 18,920 209,581 176,148 3,621 16,070 195,839 149,236 2,990 19,139 171,365 Accrued payroll and related benefits 120,469 — — 120,469 114,704 — — 114,704 123,365 — — 123,365 Short-term debt, including current portion of long-term debt 18,750 — — 18,750 18,750 — — 18,750 18,750 — — 18,750 Total current liabilities 1,473,447 (136) 18,920 1,492,231 1,418,596 3,621 16,070 1,438,287 1,587,356 2,990 19,139 1,609,485 Long-term liabilities: Long-term debt 324,825 — — 324,825 320,405 — — 320,405 315,987 — — 315,987 Other 303,514 — — 303,514 296,121 — — 296,121 260,132 — — 260,132 Total long-term liabilities 628,339 — — 628,339 616,526 — — 616,526 576,119 — — 576,119 Contingencies (Note 11) Stockholders’ equity 1,677,948 (7,217) 2,210 1,672,941 1,735,107 (24,176) — 1,710,931 1,839,115 (25,356) — 1,813,759 Total liabilities and stockholders’ equity $ 3,779,734 $ (7,353) $ 21,130 $ 3,793,511 $ 3,770,229 $ (20,555) $ 16,070 $ 3,765,744 $ 4,002,590 $ (22,366) $ 19,139 $ 3,999,363 Consolidated Statements of Income The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Income for the periods indicated below. January 2, 2021 April 3, 2021 July 3, 2021 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) Net sales $ 1,755,249 $ 735 $ — $ 1,755,984 $ 1,699,677 $ (21,180) $ — $ 1,678,497 $ 1,657,741 $ (4,475) $ — $ 1,653,266 Cost of sales 1,614,014 1,619 — 1,615,633 1,556,579 933 — 1,557,512 1,521,151 (2,951) — 1,518,200 Gross profit 141,235 (884) — 140,351 143,098 (22,113) — 120,985 136,590 (1,524) — 135,066 Operating expenses: Selling, general and administrative 58,967 — — 58,967 61,142 — — 61,142 57,438 — — 57,438 Research and development 4,805 — — 4,805 5,353 — — 5,353 5,269 — — 5,269 Restructuring and other 1,904 — — 1,904 11,880 — — 11,880 (382) — — (382) Total operating expenses 65,676 — — 65,676 78,375 — — 78,375 62,325 — — 62,325 Operating income 75,559 (884) — 74,675 64,723 (22,113) — 42,610 74,265 (1,524) — 72,741 Interest income 230 — — 230 244 — — 244 217 — — 217 Interest expense (4,954) — — (4,954) (4,880) — — (4,880) (4,823) — — (4,823) Other income (expense), net 1,867 — 2,900 4,767 6,143 — (2,900) 3,243 29,258 — — 29,258 Interest and other, net (2,857) — 2,900 43 1,507 — (2,900) (1,393) 24,652 — — 24,652 Income before income taxes 72,702 (884) 2,900 74,718 66,230 (22,113) (2,900) 41,217 98,917 (1,524) — 97,393 Provision for income taxes 24,681 (211) 690 25,160 19,193 (5,154) (690) 13,349 (18,458) (344) — (18,802) Net income $ 48,021 $ (673) $ 2,210 $ 49,558 $ 47,037 $ (16,959) $ (2,210) $ 27,868 $ 117,375 $ (1,180) $ — $ 116,195 Net income per share: Basic $ 0.74 $ (0.01) $ 0.03 $ 0.76 $ 0.72 $ (0.26) $ (0.03) $ 0.43 $ 1.79 $ (0.01) $ — $ 1.78 Diluted $ 0.72 $ (0.01) $ 0.03 $ 0.74 $ 0.70 $ (0.26) $ (0.03) $ 0.42 $ 1.74 $ (0.01) $ — $ 1.73 Six Months Ended Nine Months Ended April 3, 2021 July 3, 2021 Previously Investigation Other As Previously Investigation Other As Reported Adjustments Adjustments Restated Reported Adjustments Adjustments Restated (Unaudited) (In thousands) Net sales $ 3,454,926 $ (20,445) $ — $ 3,434,481 $ 5,112,667 $ (24,920) $ — $ 5,087,747 Cost of sales 3,170,593 2,552 — 3,173,145 4,691,744 (399) — 4,691,345 Gross profit 284,333 (22,997) — 261,336 420,923 (24,521) — 396,402 Operating expenses: Selling, general and administrative 120,109 — — 120,109 177,547 — — 177,547 Research and development 10,158 — — 10,158 15,427 — — 15,427 Restructuring and other 13,784 — — 13,784 13,402 — — 13,402 Total operating expenses 144,051 — — 144,051 206,376 — — 206,376 Operating income 140,282 (22,997) — 117,285 214,547 (24,521) — 190,026 Interest income 474 — — 474 691 — — 691 Interest expense (9,834) — — (9,834) (14,657) — — (14,657) Other income (expense), net 8,010 — — 8,010 37,268 — — 37,268 Interest and other, net (1,350) — — (1,350) 23,302 — — 23,302 Income before income taxes 138,932 (22,997) — 115,935 237,849 (24,521) — 213,328 Provision for income taxes 43,874 (5,365) — 38,509 25,416 (5,709) — 19,707 Net income $ 95,058 $ (17,632) $ — $ 77,426 $ 212,433 $ (18,812) $ — $ 193,621 Net income per share: Basic $ 1.46 $ (0.27) $ — $ 1.19 $ 3.25 $ (0.29) $ — $ 2.96 Diluted $ 1.42 $ (0.26) $ — $ 1.16 $ 3.17 $ (0.28) $ — $ 2.89 Consolidated Statements of Cash Flows The following table presents the impact of the financial statement adjustments on the Company’s previously reported Consolidated Statements of Cash Flows for the periods indicated below. Three Months Ended Six Months Ended Nine Months Ended January 2, 2021 April 3, 2021 July 3, 2021 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 48,021 $ (673) $ 2,210 $ 49,558 $ 95,058 $ (17,632) $ — $ 77,426 $ 212,433 $ (18,812) $ — $ 193,621 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 27,635 — — 27,635 54,831 — — 54,831 82,204 — — 82,204 Stock-based compensation expense 8,208 — — 8,208 17,432 — — 17,432 26,147 — — 26,147 Deferred income taxes 3,447 (279) 690 3,858 13,641 (4,854) — 8,787 32,142 (5,196) — 26,946 Gain on sale of intellectual property — — — — — — — — (15,000) — — (15,000) Gain on liquidation of foreign entity — — — — — — — — (8,263) — — (8,263) Impairment of goodwill and other asset — — — — — — — — — — — — Other, net (99) — — (99) (19) — — (19) (633) — — (633) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable (64,217) — (2,744) (66,961) (79,166) — (167) (79,333) (108,277) — 269 (108,008) Contract assets 46,534 (15,009) (2,845) 28,680 61,626 2,768 328 64,722 51,487 4,921 (3,177) 53,231 Inventories 42,282 15,187 — 57,469 75,303 15,187 — 90,490 (22,606) 15,187 — (7,419) Prepaid expenses and other assets (9,400) 706 — (8,694) 1,359 706 — 2,065 (3,574) 706 — (2,868) Accounts payable (66,657) — — (66,657) (99,525) — — (99,525) 61,524 — — 61,524 Accrued liabilities 26,057 68 2,689 28,814 2,360 3,825 (161) 6,024 (60,963) 3,194 2,908 (54,861) Cash provided by operating activities $ 61,811 $ — $ — $ 61,811 $ 142,900 $ — $ — $ 142,900 $ 246,621 $ — $ — $ 246,621

SCHEDULE II-VALUATION AND QUALI

SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS	Oct. 01, 2022
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS	The financial statement Schedule II-VALUATION AND QUALIFYING ACCOUNTS is filed as part of this Form 10-K. SANMINA CORPORATION SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS Balance at Balance at Beginning of Charged to Charges End of Period Operations Utilized Period (In thousands) Allowances for Doubtful Accounts, Product Returns and Other Net Sales Adjustments Fiscal year ended October 3, 2020 $ 12,481 $ (3,911) $ — $ 8,570 Fiscal year ended October 2, 2021 $ 8,570 $ (1,635) $ — $ 6,935 Fiscal year ended October 1, 2022 $ 6,935 $ 7,978 $ — $ 14,913

Organization of Sanmina (Polici

Organization of Sanmina (Policies)	12 Months Ended
Organization of Sanmina (Policies)	Oct. 01, 2022
Organization of Sanmina
Fiscal Period, Policy [Policy Text Block]	Fiscal Year.
Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]	Principles of Consolidation.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Oct. 01, 2022
Significant Accounting Policies
Management Estimates and Uncertainties	Management Estimates and Uncertainties.
Financial Instruments and Concentration of Credit Risk	Financial Instruments and Concentration of Credit Risk.
Cash and Cash Equivalents	Cash and Cash Equivalents.
Accounts Receivable and Other Related Allowances	Accounts Receivable and Other Related Allowances.
Accounts Receivable Sales	Accounts Receivable Sales. In addition to the RPA, the Company has the option to participate in trade receivables sales programs that have been implemented by certain of the Company’s customers, as in effect from time to time. The Company does not service trade receivables sold under these other programs. Under each of the programs noted above, the Company sells its entire interest in a trade receivable for 100% of face value, less a discount. Accounts receivable balances sold are removed from the consolidated balance sheets and the related proceeds are reported as cash provided by operating activities in the consolidated statements of cash flows.
Inventories	Inventories. Provisions are made to reduce excess and obsolete inventories to their estimated net realizable values. The ultimate realization of inventory carrying amounts is primarily affected by changes in customer demand. Inventory provisions are established based on forecasted demand, past experience with specific customers, the age and nature of the inventory, the ability to redistribute inventory to other programs or back to suppliers, and whether customers are contractually obligated and have the ability to pay for the related inventory. Certain payments received from customers for inventory held by the Company are recorded as a reduction of inventory.
Long-lived Assets	Long-lived Assets. buildings and 3 to 15 years for machinery, equipment, furniture and fixtures. Leasehold improvements are amortized on a straight-line basis over the shorter of the lease term or useful life of the asset. The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. An asset group is the unit of accounting which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets. An asset or asset group is considered impaired if its carrying amount exceeds the undiscounted future net cash flows the asset or asset group is expected to generate. If an asset or asset group is considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset or asset group exceeds its fair value. For asset groups for which the primary asset is a building, the Company estimates fair value based on data provided by commercial real estate brokers. For other asset groups, the Company estimates fair value based on projected discounted future net cash flows.
Foreign Currency Translation	Foreign Currency Translation.
Derivative Instruments and Hedging Activities	Derivative Instruments and Hedging Activities. The Company accounts for derivative instruments and hedging activities in accordance with ASC Topic 815, Derivatives and Hedging, which requires each derivative instrument to be recorded on the consolidated balance sheets at its fair value as either an asset or a liability. If a derivative is designated as a cash flow hedge, the Company excludes time value from its assessment of hedge effectiveness and recognizes the amount of time value in earnings over the life of the derivative. Gains or losses on the derivative not caused by changes in time value are recorded in Accumulated Other Comprehensive Income (“AOCI”), a component of equity, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is designated as a fair value hedge, changes in the fair value of the derivative and of the item being hedged are recognized in earnings in the current period. Derivative instruments are entered into for periods of time consistent with the related underlying exposures and are not entered into for speculative purposes. At the inception of a hedge, the Company documents all relationships between derivative instruments and related hedged items, as well as its risk-management objectives and strategies for the hedging transaction. The Company’s foreign currency forward contracts and interest rate swaps potentially expose the Company to credit risk to the extent the counterparties may be unable to meet the terms of the agreement. The Company minimizes such risk by seeking high quality counterparties.
Leases	Leases. The Company’s lease liability and ROU assets represent the present value of future lease payments which are a combination of lease components and non-lease components such as maintenance and utilities. Operating lease expense is recognized on a straight line basis over the term of the lease. Certain of the Company’s lease payments are variable because such payments adjust periodically based on changes in consumer price and other indexes. Variable payments are expensed as incurred and not included in the measurement of lease liabilities and ROU assets. Since the Company’s leases generally do not provide an implicit rate, the Company uses an incremental borrowing rate based on information available at the lease commencement date for purposes of determining the present value of lease payments. The Company’s incremental borrowing rate is based on the term of the lease, the economic environment of the lease and the effect of collateralization, if any.
Revenue Recognition	Revenue Recognition. For purposes of determining when to recognize revenue, and in what amount, the Company applies a 5-step model: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the Company satisfies a performance obligation. Each of these steps may involve the use of significant judgments. The Company recognizes revenue for the majority of its contracts on an over time basis. This is due to the fact that 1) the Company does not have an alternative use for the end products it manufactures for its customers and has an enforceable right to payment, including a reasonable profit, for work-in-progress upon a customer’s cancellation of a contract for convenience or 2) the Company’s customer simultaneously receives and consumes the benefits provided by the Company’s services. For these contracts, revenue is recognized on an over time basis using the cost-to-cost method (ratio of costs incurred to date to total estimated costs at completion) which the Company believes best depicts the transfer of control to the customer. Revenue streams for which revenue is recognized on an over time basis include sales of vertically integrated manufacturing solutions (integrated manufacturing solutions and components); global services (logistics and repair); design, development and engineering services; and defense and aerospace programs. Application of the cost-to-cost method for government contracts in the Company’s Defense and Aerospace division requires the use of significant judgments with respect to estimated materials, labor and subcontractor costs included in the total estimated costs at completion. Additionally, the Company evaluates whether contract modifications for claims have been approved and, if so, estimates the amount, if any, of variable consideration that can be included in the transaction price of the contract. This division is an operating segment whose results are combined with eleven other operating segments and reported under Components, Products and Services (“CPS”) for segment reporting purposes. In 2022, CPS revenue and gross profit were $1.5 billion and $176 million, respectively. Estimates of materials, labor and subcontractor costs expected to be incurred to satisfy a performance obligation are updated on a quarterly basis. These estimates consider costs incurred to date and estimated costs to be incurred over the remaining expected period of performance to satisfy a performance obligation. Such estimates are reviewed each quarter by a group of employees that includes representatives from numerous functions such as engineering, materials, contracts, manufacturing, program management, finance and senior management. If a change in estimate is deemed necessary, the impact of the change is recognized in the period of change. Additionally, contract modifications for claims are assessed each quarter to determine whether the claims have been approved. If it is determined that a claim has been approved, the amount of the claim, if any, that can be included in transaction price is estimated considering a number of factors such as the length of time expected to lapse until uncertainty about the claim has been resolved and the extent to which our experience with claims for similar contracts has predictive value. For contracts for which revenue is required to be recognized at a point-in-time, the Company recognizes revenue when it has transferred control of the related goods, which generally occurs upon shipment or delivery of the goods to the customer. Revenue streams for which revenue is recognized at a point-in-time include Company-proprietary products and sales of raw materials. Refer to Note 5 for further discussion.
Income taxes	Income taxes. . The Company’s tax rate is dependent upon the geographic distribution of its worldwide income or losses, the tax regulations and tax holidays in each geographic region, the availability of tax credits and carryforwards, including net operating losses, and the effectiveness of its tax planning strategies. The Company makes an assessment of whether each income tax position is “more likely than not” of being sustained on audit, including resolution of related appeals or litigation, if any. For each income tax position that meets the “more likely than not” recognition threshold, the Company then assesses the largest amount of tax benefit that is greater than 50% likely of being realized upon effective settlement with the tax authority. Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense.
Recent Accounting Pronouncement Adopted	Recent Accounting Pronouncement Adopted In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848)”, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform. The amendments are effective for all entities as of March 12, 2020 through December 31, 2022. The Company adopted this ASU during the fourth quarter of 2022. The impact of adoption was not material.

Restatement of Consolidated F_2

Restatement of Consolidated Financial Statements (Tables)	12 Months Ended
Restatement of Consolidated Financial Statements (Tables)	Oct. 01, 2022
Restatement of Consolidated Financial Statements
Schedule of error corrections and prior period adjustments	As of As of October 1, 2022 October 2, 2021 Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 529,857 $ — $ — $ 529,857 $ 650,026 $ — $ — $ 650,026 Accounts receivable, net of allowances 1,138,894 — — 1,138,894 1,192,434 — 1,003 1,193,437 Contract assets 503,674 (27,953) — 475,721 348,741 (28,708) 12,157 332,190 Inventories 1,691,081 (21,705) 14,723 1,684,099 1,036,511 (2,285) 7,564 1,041,790 Prepaid expenses and other current assets 62,044 — — 62,044 53,952 — — 53,952 Total current assets 3,925,550 (49,658) 14,723 3,890,615 3,281,664 (30,993) 20,724 3,271,395 Property, plant and equipment, net 575,170 — — 575,170 532,985 — — 532,985 Deferred tax assets 198,588 10,966 — 209,554 235,117 7,144 — 242,261 Other 160,192 — — 160,192 156,953 — — 156,953 Total assets $ 4,859,500 (38,692) 14,723 $ 4,835,531 $ 4,206,719 $ (23,849) $ 20,724 $ 4,203,594 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 2,029,534 $ — $ 11,900 $ 2,041,434 $ 1,464,693 $ — $ 7,564 $ 1,472,257 Accrued liabilities 275,735 1,441 4,423 281,599 161,896 2,147 13,160 177,203 Accrued payroll and related benefits 130,892 — — 130,892 117,648 — — 117,648 Short-term debt, including current portion of long-term debt 17,500 — — 17,500 18,750 — — 18,750 Total current liabilities 2,453,661 1,441 16,323 2,471,425 1,762,987 2,147 20,724 1,785,858 Long-term liabilities: Long-term debt 329,237 — — 329,237 311,572 — — 311,572 Other 215,333 — — 215,333 253,532 — — 253,532 Total long-term liabilities $ 544,570 $ — $ — $ 544,570 $ 565,104 $ — $ — $ 565,104 Commitments and Contingencies (Note 11) Stockholders' equity: Preferred stock, $0.01 par value, authorized 5,000 shares, none issued and outstanding — — — — — — — — Common stock, $0.01 par value, authorized 166,667 shares; 110,160 and 108,734 shares issued and 57,394 and 64,307 shares outstanding as of October 1, 2022 and October 2, 2021, respectively 574 — — 574 643 — — 643 Treasury stock, 52,766 and 44,427 shares as of October 1, 2022 and October 2, 2021, respectively, at cost (1,378,159) — — (1,378,159) (1,047,202) — — (1,047,202) Additional paid-in capital 6,380,774 — — 6,380,774 6,338,863 — — 6,338,863 Accumulated other comprehensive income 56,325 — — 56,325 40,690 — — 40,690 Accumulated deficit (3,198,245) (40,133) (1,600) (3,239,978) (3,454,366) (25,996) — (3,480,362) Total stockholders’ equity 1,861,269 (40,133) (1,600) 1,819,536 1,878,628 (25,996) — 1,852,632 Total liabilities and stockholders’ equity $ 4,859,500 $ (38,692) $ 14,723 $ 4,835,531 $ 4,206,719 $ (23,849) $ 20,724 $ 4,203,594 Year Ended Year Ended October 1, 2022 October 2, 2021 Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (In thousands, except per share amounts) Net sales $ 7,890,475 $ 23,265 $ 5,882 $ 7,919,622 $ 6,756,643 $ (18,287) $ — $ 6,738,356 Cost of sales 7,249,961 41,573 5,882 7,297,416 6,204,838 7,077 — 6,211,915 Gross profit 640,514 (18,308) — 622,206 551,805 (25,364) — 526,441 Operating expenses: Selling, general and administrative 244,569 — — 244,569 234,537 — — 234,537 Research and development 21,343 — — 21,343 20,911 — — 20,911 Restructuring and other 11,425 — — 11,425 15,057 — — 15,057 Gain on sale of long-lived assets (4,610) — — (4,610) — — — — Total operating expenses 272,727 — — 272,727 270,505 — — 270,505 Operating income 367,787 (18,308) — 349,479 281,300 (25,364) — 255,936 Interest income 1,628 — — 1,628 925 — — 925 Interest expense (22,473) — — (22,473) (19,551) — — (19,551) Other income (expense), net (26,314) — — (26,314) 44,331 — — 44,331 Interest and other, net (47,159) — — (47,159) 25,705 — — 25,705 Income before income taxes 320,628 (18,308) — 302,320 307,005 (25,364) — 281,641 Provision for income taxes 64,507 (4,171) 1,600 61,936 38,007 (5,912) — 32,095 Net income $ 256,121 $ (14,137) $ (1,600) $ 240,384 $ 268,998 $ (19,452) $ — $ 249,546 Net income per share: Basic $ 4.18 $ (0.23) $ (0.03) $ 3.92 $ 4.12 $ (0.30) $ — $ 3.82 Diluted $ 4.06 $ (0.23) $ (0.03) $ 3.81 $ 4.01 $ (0.29) $ — $ 3.72 Weighted-average shares used in computing per share amounts: Basic 61,310 — — 61,310 65,318 — — 65,318 Diluted 63,117 — — 63,117 67,084 — — 67,084 Year Ended October 3, 2020 Previously Investigation Reported Adjustments Other Adjustments As Restated (In thousands, except per share amounts) Net sales $ 6,960,370 $ (10,162) $ — $ 6,950,208 Cost of sales 6,434,663 (1,619) — 6,433,044 Gross profit 525,707 (8,543) — 517,164 Operating expenses: Selling, general and administrative 240,931 — — 240,931 Research and development 22,564 — — 22,564 Restructuring and other 27,916 — — 27,916 Goodwill impairment 6,609 — — 6,609 Total operating expenses 298,020 — — 298,020 Operating income 227,687 (8,543) — 219,144 Interest income 2,322 — — 2,322 Interest expense (28,903) — — (28,903) Other expense, net (348) — — (348) Interest and other, net (26,929) — — (26,929) Income before income taxes 200,758 (8,543) — 192,215 Provision for income taxes 61,045 (1,999) 59,046 Net income $ 139,713 $ (6,544) $ — $ 133,169 Net income per share: Basic $ 2.02 $ (0.09) $ — $ 1.93 Diluted $ 1.97 $ (0.09) $ — $ 1.88 Weighted-average shares used in computing per share amounts: Basic 69,041 — — 69,041 Diluted 70,793 — — 70,793 Year Ended Year Ended October 1, 2022 October 2, 2021 Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (In thousands) CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 256,121 $ (14,137) $ (1,600) $ 240,384 $ 268,998 $ (19,452) $ — $ 249,546 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 108,783 — — 108,783 109,656 — — 109,656 Stock-based compensation expense 39,608 — — 39,608 34,976 — — 34,976 Deferred income taxes 31,733 (3,823) — 27,910 33,724 (5,349) — 28,375 Gain on sale of intellectual property — — — — (15,000) — — (15,000) Gain on liquidation of foreign entity — — — — (8,263) — — (8,263) Impairment of goodwill and other assets 1,848 — — 1,848 — — — — Loss on sale of intellectual property 7,000 — — 7,000 — — — — Other, net 1,260 — — 1,260 (1,371) — — (1,371) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable 46,480 — 1,003 47,483 (146,516) — 706 (145,810) Contract assets (154,933) (755) 12,157 (143,531) 47,842 4,272 2,365 54,479 Inventories (663,379) 19,420 (7,159) (651,118) (167,186) 17,472 (7,564) (157,278) Prepaid expenses and other assets (31,700) — — (31,700) (6,486) 706 — (5,780) Accounts payable 554,492 — 4,336 558,828 236,270 — 7,564 243,834 Accrued liabilities 133,541 (705) (8,737) 124,099 (48,302) 2,351 (3,071) (49,022) Cash provided by operating activities $ 330,854 $ — $ — $ 330,854 $ 338,342 $ — $ — $ 338,342 Year Ended October 3, 2020 Previously Investigation Other Reported Adjustments Adjustments As Restated (In thousands) CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 139,713 $ (6,544) $ — $ 133,169 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 114,218 — — 114,218 Stock-based compensation expense 26,235 — — 26,235 Deferred income taxes 13,567 (1,795) — 11,772 Gain on sale of intellectual property — — — — Gain on liquidation of foreign entity — — — — Impairment of goodwill and other assets 8,409 — — 8,409 Loss on sale of intellectual property — — — — Other, net (239) — — (239) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable 83,623 — (1,709) 81,914 Contract assets (283) 24,436 (14,522) 9,631 Inventories 39,564 (15,187) — 24,377 Prepaid expenses and other assets 17,798 (706) — 17,092 Accounts payable (106,640) — — (106,640) Accrued liabilities (35,410) (204) 16,231 (19,383) Cash provided by operating activities $ 300,555 $ — $ — $ 300,555

Balance Sheet and Income Stat_2

Balance Sheet and Income Statement Details (Tables)	12 Months Ended
Balance Sheet and Income Statement Details (Tables)	Oct. 01, 2022
Balance Sheet and Income Statement Details
Balance Sheet and Income Statement Details	As of October 1, October 2, 2022 2021 (In thousands) Machinery and equipment $ 1,523,598 $ 1,491,156 Land and buildings 656,839 645,639 Leasehold improvements 42,793 44,899 Furniture and fixtures 24,805 25,394 Construction in progress 91,928 40,524 2,339,963 2,247,612 Less: Accumulated depreciation and amortization (1,764,793) (1,714,627) Property, plant and equipment, net $ 575,170 $ 532,985

Revenue Recognition (Tables)

Revenue Recognition (Tables)	12 Months Ended
Revenue Recognition (Tables)	Oct. 01, 2022
Revenue Recognition
Revenue Recognition	Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands) Segments: IMS $ 6,378,324 $ 5,454,269 $ 5,685,751 CPS 1,541,298 1,284,087 1,264,457 Total $ 7,919,622 $ 6,738,356 $ 6,950,208 End Markets: Communications Networks and Cloud Infrastructure $ 3,175,534 $ 2,866,602 $ 2,832,650 Industrial, Defense, Medical and Automotive 4,744,088 3,871,754 4,117,558 Total $ 7,919,622 $ 6,738,356 $ 6,950,208 Geography: Americas (1) $ 3,748,643 $ 3,164,562 $ 3,440,365 APAC 3,007,904 2,517,963 2,514,005 EMEA 1,163,075 1,055,831 995,838 Total $ 7,919,622 $ 6,738,356 $ 6,950,208 (1) Mexico represents approximately 60% of the Americas revenue and the U.S. represents approximately 35% .

Financial Instruments (Tables)

Financial Instruments (Tables)	12 Months Ended
Financial Instruments (Tables)	Oct. 01, 2022
Financial Instruments [Abstract]
Schedule of hedge foreign currency exposures	As of October 1, October 2, 2022 2021 Derivatives Designated as Accounting Hedges: Notional amount (in thousands) $ 123,172 $ 110,098 Number of contracts 50 48 Derivatives Not Designated as Accounting Hedges: Notional amount (in thousands) $ 531,558 $ 353,108 Number of contracts 43 46

Debt (Tables)

Debt (Tables)	12 Months Ended
Debt (Tables)	Oct. 01, 2022
Debt
Schedule of Long-term Debt Instruments [Table Text Block]	As of October 1, October 2, 2022 2021 (In thousands) Term loan due 2023, net of issuance costs $ — $ 330,322 Term loan due 2027, net of issuance costs 346,737 — Less: Current portion of long-term debt 17,500 18,750 Long-term debt $ 329,237 $ 311,572
Schedule of Maturities of Long-term Debt [Table Text Block]	(In Thousands) 2023 $ 17,500 2024 13,125 2025 17,500 2026 21,875 2027 280,000 $ 350,000

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Oct. 01, 2022
Leases
Schedule of asset and liabilities, lessee	As of October 1, October 2, 2022 2021 (In thousands) Other assets $ 79,495 $ 68,012 Accrued liabilities $ 16,695 $ 17,219 Other long-term liabilities 48,566 38,587 Total lease liabilities $ 65,261 $ 55,806 Weighted average remaining lease term (in years) 15.74 14.46 Weighted average discount rate 2.4 % 2.72 %
Schedule of lease, cost	Year Ended October 1, October 2, October 3, 2022 2021 2020 Operating lease expense (1) $ 23,978 $ 21,455 $ 20,670 As of October 1, October 2, 2022 2021 (In thousands) Cash paid for operating lease liabilities $ 19,249 $ 19,531 (1) Includes immaterial amounts of short term leases, variable lease costs and sublease income.
Schedule of lessee, operating lease, liability, maturity	Operating Leases (In thousands) 2023 $ 18,109 2024 15,350 2025 12,450 2026 8,907 2027 5,724 Thereafter 10,412 Total lease payments 70,952 Less: imputed interest 5,691 Total $ 65,261

Restructuring (Tables)

Restructuring (Tables)	12 Months Ended
Restructuring (Tables)	Oct. 01, 2022
Restructuring
Schedule of restructuring costs	Year Ended October 1, October 2, October 3, 2022 2021 2020 (In thousands) Severance costs $ 319 $ 9,405 $ 17,919 Other exit costs (recognized as incurred) 1,500 1,834 71 Total - Q1 FY20 Plan 1,819 11,239 17,990 Costs incurred for other plans 9,606 3,818 8,793 Total - all plans $ 11,425 $ 15,057 $ 26,783

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
Income Tax (Tables)	Oct. 01, 2022
Income Taxes
Schedule of Income before income tax, domestic and foreign	Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands) Domestic $ 145,671 $ 174,936 $ 88,450 Foreign 156,649 106,705 103,765 Total $ 302,320 $ 281,641 $ 192,215
Schedule of provision for income taxes	Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands) Federal: Current $ 1,070 $ 705 $ (917) Deferred 25,399 28,809 7,666 State: Current 1,711 3,677 1,500 Deferred 3,081 (302) 2,579 Foreign: Current 31,241 (906) 46,376 Deferred (566) 112 1,842 Total provision for income taxes $ 61,936 $ 32,095 $ 59,046
Schedule of deferred tax assets and liabilities	As of October 1, October 2, 2022 2021 (Restated) (In thousands) Deferred tax assets: U.S. net operating loss carryforwards $ 92,882 $ 134,385 Foreign net operating loss carryforwards 109,416 112,516 Intangibles 25,099 24,219 Accruals not currently deductible 44,963 43,932 Property, plant and equipment 27,514 25,494 Tax credit carryforwards 18,465 17,250 Reserves not currently deductible 14,939 11,534 Stock compensation expense 6,365 7,677 Federal benefit of foreign operations 21,312 18,336 Derivatives and other impacts of OCI 838 7,637 Lease deferred tax asset 15,018 11,563 Other 1,915 — Valuation allowance (118,210) (115,258) Total deferred tax assets 260,516 299,285 Deferred tax liabilities on undistributed earnings (14,775) (14,775) Deferred tax liabilities on branch operations (24,182) (30,000) Revenue recognition (1,572) (1,702) Lease deferred tax liability (14,808) (11,349) Other — (2,495) Net deferred tax assets $ 205,179 $ 238,964 Recorded as: Deferred tax assets $ 209,554 $ 242,261 Deferred tax liabilities (4,375) (3,297) Net deferred tax assets $ 205,179 $ 238,964
Schedule of effective income tax rate reconciliation	Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) Federal tax at statutory tax rate 21.00 % 21.00 % 21.00 % Effect of foreign operations 3.52 7.99 13.60 Permanent items 0.08 (2.03) (0.62) Federal credits (0.73) (0.54) (1.37) Other 0.59 (0.20) (0.06) State income taxes, net of federal benefit 1.60 0.91 1.94 Release of foreign tax reserves (5.57) (15.73) (3.77) Effective tax rate 20.49 % 11.40 % 30.72 %
Schedule of total liabilities for unrecognized tax benefits	Year Ended October 1, October 2, October 3, 2022 2021 2020 (In thousands) Balance, beginning of year $ 67,781 $ 74,612 $ 66,677 Increase (decrease) related to prior year tax positions (4,456) 6,063 1,327 Increase related to current year tax positions 7,154 7,349 9,907 Settlements (7,596) — — Decrease related to lapse of time and expiration of statutes of limitations (9,331) (20,243) (3,299) Balance, end of year $ 53,552 $ 67,781 $ 74,612

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
Earnings Per Share (Tables)	Oct. 01, 2022
Earnings Per Share
Schedule of earnings per share, basic and diluted	Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands, except per share amounts) Numerator: Net income $ 240,384 $ 249,546 $ 133,169 Denominator: Weighted average common shares outstanding 61,310 65,318 69,041 Effect of dilutive stock options and restricted stock units 1,807 1,766 1,752 Denominator for diluted earnings per share 63,117 67,084 70,793 Net income per share: Basic $ 3.92 $ 3.82 1.93 Diluted $ 3.81 $ 3.72 1.88

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
Stockholders' Equity (Tables)	Oct. 01, 2022
Stockholders' Equity
Schedule of Accumulated Other Comprehensive Income (Loss)	As of October 1, October 2, 2022 2021 (In thousands) Foreign currency translation adjustments $ 63,929 $ 76,120 Unrealized holding gain (loss) on derivative financial instruments 4,112 (14,305) Unrecognized net actuarial loss and unrecognized transition cost for benefit plans (11,716) (21,125) Total $ 56,325 $ 40,690

Business Segment, Geographic _2

Business Segment, Geographic and Customer Information (Tables)	12 Months Ended
	Oct. 01, 2022
Business Segment, Geographic and Customer Information
Schedule of segment information	Year Ended October 1, 2022 October 2, 2021 October 3, 2020 (In thousands) Gross sales (As restated): IMS $ 6,413,606 $ 5,485,612 $ 5,719,180 CPS 1,655,183 1,379,455 1,369,550 Intersegment revenue (149,167) (126,711) (138,522) Net Sales $ 7,919,622 $ 6,738,356 $ 6,950,208 Gross Profit (As restated): IMS $ 462,606 $ 391,339 $ 381,638 CPS 175,509 151,884 148,301 Total 638,115 543,223 529,939 Unallocated items (1) (15,909) (16,782) (12,775) Total $ 622,206 $ 526,441 $ 517,164 Depreciation and amortization: IMS $ 73,914 $ 77,076 $ 81,169 CPS 30,061 27,770 26,718 Total 103,975 104,846 107,887 Unallocated corporate items (2) 4,808 4,810 6,331 Total $ 108,783 $ 109,656 $ 114,218 Capital expenditures (receipt basis): IMS $ 94,636 $ 44,672 $ 23,933 CPS 55,993 33,839 23,915 Total 150,629 78,511 47,848 Unallocated corporate items (2) 5,650 3,343 3,227 Total $ 156,279 $ 81,854 $ 51,075 (1) For purposes of evaluating segment performance, management excludes certain items from its measures of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets, charges or credits resulting from distressed customers and litigation settlements. (2) Primarily related to selling, general and administration functions.
Schedule of net sales by geographic segment	Year Ended October 1, October 2, October 3, 2022 2021 2020 (Restated) (In thousands) Net sales: Americas (1) $ 3,748,643 $ 3,164,562 $ 3,440,365 APAC 3,007,904 2,517,963 2,514,005 EMEA 1,163,075 1,055,831 995,838 Total $ 7,919,622 $ 6,738,356 $ 6,950,208 (1) Mexico represents approximately 60% of the Americas revenue and the U.S. represents approximately 35% . Percentage of net sales represented by ten largest customers 48.7 % 52.7 % 55.5 % Number of customers representing 10% or more of net sales 2 1 1
Schedule of long-lived assets by geographic areas	As of October 1, October 2, 2022 2021 (In thousands) Property, plant and equipment, net: Americas $ 367,172 $ 322,545 APAC 151,254 143,111 EMEA 56,744 67,329 Total $ 575,170 $ 532,985

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
Stock-Based Compensation (Tables)	Oct. 01, 2022
Stock-Based Compensation.
Schedule of stock-based compensation expense	Year Ended October 1, October 2, October 3, 2022 2021 2020 (In thousands) Cost of sales $ 14,065 $ 14,472 $ 10,099 Selling, general and administrative 25,037 20,118 15,897 Research and development 506 386 239 Total $ 39,608 $ 34,976 $ 26,235
Schedule of activity with respect to the company's restricted stock units and psu	Weighted Average Weighted-Average Grant-Date Remaining Aggregate Number of Fair Value Contractual Term Intrinsic Value Shares ($) (Years) ($) (In thousands) (In thousands) Outstanding as of September 28, 2019 3,153 27.82 1.30 102,720 Granted 1,340 32.51 Vested/Forfeited/Cancelled (1,925) 28.62 Outstanding as of October 3, 2020 2,568 29.67 1.23 71,571 Granted 1,529 34.26 Vested/Forfeited/Cancelled (1,143) 29.27 Outstanding as of October 2, 2021 2,954 32.21 1.23 113,591 Granted 1,644 40.54 Vested/Forfeited/Cancelled (1,318) 30.42 Outstanding as of October 1, 2022 3,280 37.11 1.35 155,049 Expected to vest as of October 1, 2022 2,909 36.93 1.28 137,524

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	12 Months Ended
Employee Benefit Plans (Tables)	Oct. 01, 2022
Employee Benefit Plans
Schedule of defined benefit plans	As of October 1, 2022 October 2, 2021 October 3, 2020 Non-U.S. U.S. Non-U.S. U.S. Non-U.S. (In thousands) Plan Assets $ 17,290 $ 16,435 $ 23,575 $ 15,430 $ 23,575 Projected Benefit Obligation 50,871 22,943 63,217 25,704 64,453 Underfunded Status $ 33,581 $ 6,508 $ 39,642 $ 10,274 $ 40,878 Current Liabilities $ 3,038 $ — $ 2,674 $ — $ 2,054 Non-current liabilities 30,543 6,508 36,968 10,274 38,824 Total liabilities $ 33,581 $ 6,508 $ 39,642 $ 10,274 $ 40,878

Strategic Transactions (Tables)

Strategic Transactions (Tables)	12 Months Ended
Strategic Transactions (Tables)	Oct. 01, 2022
Strategic Transactions
Schedule of allocation of the purchase price to the acquired assets and liabilities assumed	(In thousands) Current assets, including cash acquired of $8.1 million $ 18,696 Noncurrent assets, including identifiable intangible assets of $4.4 million and goodwill of $8.5 million 30,711 Current liabilities (10,671) Noncurrent liabilities (152) Total net assets acquired $ 38,584

Quarterly Financial Data - Un_2

Quarterly Financial Data - Unaudited (Tables)	12 Months Ended
Quarterly Financial Data - Unaudited (Tables)	Oct. 01, 2022
Quarterly Financial Data - Unaudited
Schedule of Financial data	As Restated Year ended October 1, 2022 First Quarter Second Quarter Third Quarter Fourth Quarter (In thousands, except per share data) Net sales $ 1,756,326 $ 1,915,070 $ 2,023,361 $ 2,224,865 Gross profit $ 141,297 $ 146,495 $ 162,185 $ 172,229 Gross margin 8.0 % 7.6 % 8.0 % 7.7 % Operating income $ 78,241 $ 76,274 $ 91,614 $ 103,350 Operating margin 4.5 % 4.0 % 4.5 % 4.6 % Net income $ 56,177 $ 48,621 $ 77,222 $ 58,364 Basic net income per share $ 0.87 $ 0.77 $ 1.29 $ 1.01 Diluted net income per share $ 0.85 $ 0.76 $ 1.25 $ 0.98 As Restated Year ended October 2, 2021 First Quarter Second Quarter Third Quarter Fourth Quarter (In thousands, except per share data) Net sales $ 1,755,984 $ 1,678,497 $ 1,653,266 $ 1,650,609 Gross profit $ 140,351 $ 120,985 $ 135,066 $ 130,039 Gross margin 8.0 % 7.2 % 8.2 % 7.9 % Operating income $ 74,675 $ 42,610 $ 72,741 $ 65,910 Operating margin 4.3 % 2.5 % 4.4 % 4.0 % Net income $ 49,558 $ 27,868 $ 116,195 $ 55,925 Basic net income per share $ 0.76 $ 0.43 $ 1.78 $ 0.86 Diluted net income per share $ 0.74 $ 0.42 $ 1.73 $ 0.83 As of January 1, 2022 April 2, 2022 July 2, 2022 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) ASSETS Current assets: Cash and cash equivalents $ 627,717 $ — $ — $ 627,717 $ 559,893 $ — $ — $ 559,893 $ 493,305 $ — $ — $ 493,305 Accounts receivable, net of allowances 1,298,327 — 687 1,299,014 1,270,494 — 606 1,271,100 1,228,435 — 1,429 1,229,864 Contract assets 364,407 (31,772) 14,948 347,583 417,286 (33,512) 15,508 399,282 459,306 (34,918) 20,408 444,796 Inventories 1,242,440 (2,373) 13,630 1,253,697 1,437,955 (6,913) 12,579 1,443,621 1,591,111 (8,829) 7,841 1,590,123 Prepaid expenses and other current assets 59,188 — — 59,188 61,525 — — 61,525 63,827 — — 63,827 Total current assets 3,592,079 (34,145) 29,265 3,587,199 3,747,153 (40,425) 28,693 3,735,421 3,835,984 (43,747) 29,678 3,821,915 Property, plant and equipment, net 525,159 — — 525,159 525,362 — — 525,362 545,673 — — 545,673 Deferred tax assets 227,239 7,792 — 235,031 220,532 9,042 — 229,574 212,407 9,673 — 222,080 Other 157,533 — — 157,533 156,867 — — 156,867 149,608 — — 149,608 Total assets $ 4,502,010 $ (26,353) $ 29,265 $ 4,504,922 $ 4,649,914 $ (31,383) $ 28,693 $ 4,647,224 $ 4,743,672 $ (34,074) $ 29,678 $ 4,739,276 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 1,694,592 $ — $ 13,630 $ 1,708,222 $ 1,817,465 $ — $ 12,579 $ 1,830,044 $ 1,976,533 $ — $ 7,841 $ 1,984,374 Accrued liabilities 236,227 2,100 15,635 253,962 314,648 1,669 16,114 332,431 303,076 1,299 21,837 326,212 Accrued payroll and related benefits 115,738 — — 115,738 116,794 — — 116,794 133,319 — — 133,319 Short-term debt, including current portion of long-term debt 18,750 — — 18,750 18,750 — — 18,750 18,750 — — 18,750 Total current liabilities 2,065,307 2,100 29,265 2,096,672 2,267,657 1,669 28,693 2,298,019 2,431,678 1,299 29,678 2,462,655 Long-term liabilities: Long-term debt 307,160 — — 307,160 302,751 — — 302,751 298,345 — — 298,345 Other 248,326 — — 248,326 241,416 — — 241,416 209,716 — — 209,716 Total long-term liabilities 555,486 — — 555,486 544,167 — — 544,167 508,061 — — 508,061 Contingencies (Note 11) Stockholders’ equity 1,881,217 (28,453) — 1,852,764 1,838,090 (33,052) — 1,805,038 1,803,933 (35,373) — 1,768,560 Total liabilities and stockholders’ equity $ 4,502,010 $ (26,353) $ 29,265 $ 4,504,922 $ 4,649,914 $ (31,383) $ 28,693 $ 4,647,224 $ 4,743,672 $ (34,074) $ 29,678 $ 4,739,276 Three Months Ended January 1, 2022 April 2, 2022 July 2, 2022 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) Net sales $ 1,757,325 $ (999) $ — $ 1,756,326 $ 1,911,530 $ 3,540 $ — $ 1,915,070 $ 2,019,059 $ 4,302 $ — $ 2,023,361 Cost of sales 1,612,836 2,193 — 1,615,029 1,759,083 9,492 — 1,768,575 1,853,870 7,306 — 1,861,176 Gross profit 144,489 (3,192) — 141,297 152,447 (5,952) — 146,495 165,189 (3,004) — 162,185 Operating expenses: Selling, general and administrative 61,475 — — 61,475 61,817 — — 61,817 61,506 — — 61,506 Research and development 4,777 — — 4,777 5,472 — — 5,472 5,071 — — 5,071 Restructuring and other 1,414 — — 1,414 2,932 — — 2,932 3,994 — — 3,994 Gain on sale of long-lived assets (4,610) — — (4,610) — — — — — — Total operating expenses 63,056 — — 63,056 70,221 — — 70,221 70,571 — — 70,571 Operating income 81,433 (3,192) — 78,241 82,226 (5,952) — 76,274 94,618 (3,004) — 91,614 — Interest income 309 — — 309 349 — — 349 540 — — 540 Interest expense (4,877) — — (4,877) (4,870) — — (4,870) (5,615) — — (5,615) Other income (expense), net 2,072 — — 2,072 (1,408) — — (1,408) (7,774) — — (7,774) Interest and other, net (2,496) — — (2,496) (5,929) — — (5,929) (12,849) — — (12,849) Income before income taxes 78,937 (3,192) — 75,745 76,297 (5,952) — 70,345 81,769 (3,004) — 78,765 Provision for income taxes 20,303 (735) — 19,568 23,077 (1,353) — 21,724 2,226 (683) — 1,543 Net income $ 58,634 $ (2,457) $ — $ 56,177 $ 53,220 $ (4,599) $ — $ 48,621 $ 79,543 $ (2,321) $ — $ 77,222 Net income per share: Basic $ 0.91 $ (0.04) $ — $ 0.87 $ 0.85 $ (0.08) $ — $ 0.77 $ 1.33 $ (0.04) $ — $ 1.29 Diluted $ 0.89 $ (0.04) $ — $ 0.85 $ 0.83 $ (0.07) $ — $ 0.76 $ 1.29 $ (0.04) $ — $ 1.25 Six Months Ended Nine Months Ended April 2, 2022 July 2, 2022 Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) Net sales $ 3,668,855 $ 2,541 $ — $ 3,671,396 $ 5,687,914 $ 6,843 $ — $ 5,694,757 Cost of sales 3,371,919 11,685 — 3,383,604 5,225,789 18,991 — 5,244,780 Gross profit 296,936 (9,144) — 287,792 462,125 (12,148) — 449,977 Operating expenses: Selling, general and administrative 123,292 — — 123,292 184,798 — — 184,798 Research and development 10,249 — — 10,249 15,320 — — 15,320 Restructuring and other 4,346 — — 4,346 8,340 — — 8,340 Gain on sale of long-lived assets (4,610) — — (4,610) (4,610) — — (4,610) Total operating expenses 133,277 — — 133,277 203,848 — — 203,848 Operating income 163,659 (9,144) — 154,515 258,277 (12,148) — 246,129 Interest income 658 — — 658 1,198 — — 1,198 Interest expense (9,747) — — (9,747) (15,362) — — (15,362) Other income (expense), net 664 — — 664 (7,110) — — (7,110) Interest and other, net (8,425) — — (8,425) (21,274) — — (21,274) Income before income taxes 155,234 (9,144) — 146,090 237,003 (12,148) — 224,855 Provision for income taxes 43,380 (2,088) — 41,292 45,606 (2,771) — 42,835 Net income $ 111,854 $ (7,056) $ — $ 104,798 $ 191,397 $ (9,377) $ — $ 182,020 Net income per share: Basic $ 1.76 $ (0.11) $ — $ 1.65 $ 3.07 $ (0.15) $ — $ 2.92 Diluted $ 1.71 $ (0.11) $ — $ 1.60 $ 2.98 $ (0.15) $ — $ 2.83 Three Months Ended Six Months Ended Nine Months Ended January 1, 2022 April 2, 2022 July 2, 2022 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 58,634 $ (2,457) $ — $ 56,177 $ 111,854 $ (7,056) $ — $ 104,798 $ 191,397 $ (9,377) $ — $ 182,020 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 27,465 — — 27,465 55,032 — — 55,032 82,097 — — 82,097 Stock-based compensation expense 9,032 — — 9,032 18,362 — — 18,362 29,045 — — 29,045 Deferred income taxes 6,707 (648) — 6,059 11,071 (1,898) — 9,173 18,522 (2,529) — 15,993 Impairment of goodwill and other assets — — — — — — — — 1,848 — — 1,848 Loss on sale of intellectual property Other, net (3,638) — — (3,638) (1,903) — — (1,903) (3,146) — — (3,146) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable (106,972) — 316 (106,656) (79,705) — 397 (79,308) (39,850) — (426) (40,276) Contract assets (15,666) 3,064 (2,791) (15,393) (68,545) 4,804 (3,351) (67,092) (110,565) 6,210 (8,251) (112,606) Inventories (207,300) 88 (6,066) (213,278) (403,396) 4,628 (5,015) (403,783) (559,118) 6,544 (277) (552,851) Prepaid expenses and other assets (2,939) — — (2,939) (11,334) — — (11,334) (13,269) — — (13,269) Accounts payable 234,525 — 6,066 240,591 357,176 — 5,015 362,191 507,632 — 277 507,909 Accrued liabilities 68,452 (47) 2,475 70,880 158,661 (478) 2,954 161,137 144,363 (848) 8,677 152,192 Cash provided by operating activities $ 68,300 $ — $ — $ 68,300 $ 147,273 $ — $ — $ 147,273 $ 248,956 $ — $ — $ 248,956 As of January 2, 2021 April 3, 2021 July 3, 2021 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) ASSETS Current assets: Cash and cash equivalents $ 516,030 $ — $ — $ 516,030 $ 575,176 $ — $ 575,176 $ 623,844 $ — $ — $ 623,844 Accounts receivable, net of allowances 1,108,472 - 4,453 1,112,925 1,122,962 - 1,876 1,124,838 1,153,813 — 1,440 1,155,253 Contract assets 350,049 (9,427) 17,367 357,989 334,957 (27,204) 14,194 321,947 345,096 (29,357) 17,699 333,438 Inventories 819,474 — — 819,474 785,406 — 785,406 892,633 — — 892,633 Prepaid expenses and other current assets 48,851 — — 48,851 38,584 — 38,584 50,446 — — 50,446 Total current assets 2,842,876 (9,427) 21,820 2,855,269 2,857,085 (27,204) 16,070 2,845,951 3,065,832 (29,357) 19,139 3,055,614 Property, plant and equipment, net 541,188 - (14,543) 526,645 529,651 - (14,448) 515,203 550,038 — (14,353) 535,685 Deferred tax assets 269,803 2,074 (690) 271,187 259,943 6,649 — 266,592 241,069 6,991 — 248,060 Other 125,867 - 14,543 140,410 123,550 - 14,448 137,998 145,651 — 14,353 160,004 Total assets $ 3,779,734 $ (7,353) $ 21,130 $ 3,793,511 $ 3,770,229 $ (20,555) $ 16,070 $ 3,765,744 $ 4,002,590 $ (22,366) $ 19,139 $ 3,999,363 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 1,143,431 $ — $ — $ 1,143,431 $ 1,108,994 $ — $ — $ 1,108,994 $ 1,296,005 $ — $ — $ 1,296,005 Accrued liabilities 190,797 (136) 18,920 209,581 176,148 3,621 16,070 195,839 149,236 2,990 19,139 171,365 Accrued payroll and related benefits 120,469 — — 120,469 114,704 — — 114,704 123,365 — — 123,365 Short-term debt, including current portion of long-term debt 18,750 — — 18,750 18,750 — — 18,750 18,750 — — 18,750 Total current liabilities 1,473,447 (136) 18,920 1,492,231 1,418,596 3,621 16,070 1,438,287 1,587,356 2,990 19,139 1,609,485 Long-term liabilities: Long-term debt 324,825 — — 324,825 320,405 — — 320,405 315,987 — — 315,987 Other 303,514 — — 303,514 296,121 — — 296,121 260,132 — — 260,132 Total long-term liabilities 628,339 — — 628,339 616,526 — — 616,526 576,119 — — 576,119 Contingencies (Note 11) Stockholders’ equity 1,677,948 (7,217) 2,210 1,672,941 1,735,107 (24,176) — 1,710,931 1,839,115 (25,356) — 1,813,759 Total liabilities and stockholders’ equity $ 3,779,734 $ (7,353) $ 21,130 $ 3,793,511 $ 3,770,229 $ (20,555) $ 16,070 $ 3,765,744 $ 4,002,590 $ (22,366) $ 19,139 $ 3,999,363 January 2, 2021 April 3, 2021 July 3, 2021 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) Net sales $ 1,755,249 $ 735 $ — $ 1,755,984 $ 1,699,677 $ (21,180) $ — $ 1,678,497 $ 1,657,741 $ (4,475) $ — $ 1,653,266 Cost of sales 1,614,014 1,619 — 1,615,633 1,556,579 933 — 1,557,512 1,521,151 (2,951) — 1,518,200 Gross profit 141,235 (884) — 140,351 143,098 (22,113) — 120,985 136,590 (1,524) — 135,066 Operating expenses: Selling, general and administrative 58,967 — — 58,967 61,142 — — 61,142 57,438 — — 57,438 Research and development 4,805 — — 4,805 5,353 — — 5,353 5,269 — — 5,269 Restructuring and other 1,904 — — 1,904 11,880 — — 11,880 (382) — — (382) Total operating expenses 65,676 — — 65,676 78,375 — — 78,375 62,325 — — 62,325 Operating income 75,559 (884) — 74,675 64,723 (22,113) — 42,610 74,265 (1,524) — 72,741 Interest income 230 — — 230 244 — — 244 217 — — 217 Interest expense (4,954) — — (4,954) (4,880) — — (4,880) (4,823) — — (4,823) Other income (expense), net 1,867 — 2,900 4,767 6,143 — (2,900) 3,243 29,258 — — 29,258 Interest and other, net (2,857) — 2,900 43 1,507 — (2,900) (1,393) 24,652 — — 24,652 Income before income taxes 72,702 (884) 2,900 74,718 66,230 (22,113) (2,900) 41,217 98,917 (1,524) — 97,393 Provision for income taxes 24,681 (211) 690 25,160 19,193 (5,154) (690) 13,349 (18,458) (344) — (18,802) Net income $ 48,021 $ (673) $ 2,210 $ 49,558 $ 47,037 $ (16,959) $ (2,210) $ 27,868 $ 117,375 $ (1,180) $ — $ 116,195 Net income per share: Basic $ 0.74 $ (0.01) $ 0.03 $ 0.76 $ 0.72 $ (0.26) $ (0.03) $ 0.43 $ 1.79 $ (0.01) $ — $ 1.78 Diluted $ 0.72 $ (0.01) $ 0.03 $ 0.74 $ 0.70 $ (0.26) $ (0.03) $ 0.42 $ 1.74 $ (0.01) $ — $ 1.73 Six Months Ended Nine Months Ended April 3, 2021 July 3, 2021 Previously Investigation Other As Previously Investigation Other As Reported Adjustments Adjustments Restated Reported Adjustments Adjustments Restated (Unaudited) (In thousands) Net sales $ 3,454,926 $ (20,445) $ — $ 3,434,481 $ 5,112,667 $ (24,920) $ — $ 5,087,747 Cost of sales 3,170,593 2,552 — 3,173,145 4,691,744 (399) — 4,691,345 Gross profit 284,333 (22,997) — 261,336 420,923 (24,521) — 396,402 Operating expenses: Selling, general and administrative 120,109 — — 120,109 177,547 — — 177,547 Research and development 10,158 — — 10,158 15,427 — — 15,427 Restructuring and other 13,784 — — 13,784 13,402 — — 13,402 Total operating expenses 144,051 — — 144,051 206,376 — — 206,376 Operating income 140,282 (22,997) — 117,285 214,547 (24,521) — 190,026 Interest income 474 — — 474 691 — — 691 Interest expense (9,834) — — (9,834) (14,657) — — (14,657) Other income (expense), net 8,010 — — 8,010 37,268 — — 37,268 Interest and other, net (1,350) — — (1,350) 23,302 — — 23,302 Income before income taxes 138,932 (22,997) — 115,935 237,849 (24,521) — 213,328 Provision for income taxes 43,874 (5,365) — 38,509 25,416 (5,709) — 19,707 Net income $ 95,058 $ (17,632) $ — $ 77,426 $ 212,433 $ (18,812) $ — $ 193,621 Net income per share: Basic $ 1.46 $ (0.27) $ — $ 1.19 $ 3.25 $ (0.29) $ — $ 2.96 Diluted $ 1.42 $ (0.26) $ — $ 1.16 $ 3.17 $ (0.28) $ — $ 2.89 Three Months Ended Six Months Ended Nine Months Ended January 2, 2021 April 3, 2021 July 3, 2021 Previously Investigation Other Previously Investigation Other Previously Investigation Other Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated Reported Adjustments Adjustments As Restated (Unaudited) (In thousands) CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 48,021 $ (673) $ 2,210 $ 49,558 $ 95,058 $ (17,632) $ — $ 77,426 $ 212,433 $ (18,812) $ — $ 193,621 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 27,635 — — 27,635 54,831 — — 54,831 82,204 — — 82,204 Stock-based compensation expense 8,208 — — 8,208 17,432 — — 17,432 26,147 — — 26,147 Deferred income taxes 3,447 (279) 690 3,858 13,641 (4,854) — 8,787 32,142 (5,196) — 26,946 Gain on sale of intellectual property — — — — — — — — (15,000) — — (15,000) Gain on liquidation of foreign entity — — — — — — — — (8,263) — — (8,263) Impairment of goodwill and other asset — — — — — — — — — — — — Other, net (99) — — (99) (19) — — (19) (633) — — (633) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable (64,217) — (2,744) (66,961) (79,166) — (167) (79,333) (108,277) — 269 (108,008) Contract assets 46,534 (15,009) (2,845) 28,680 61,626 2,768 328 64,722 51,487 4,921 (3,177) 53,231 Inventories 42,282 15,187 — 57,469 75,303 15,187 — 90,490 (22,606) 15,187 — (7,419) Prepaid expenses and other assets (9,400) 706 — (8,694) 1,359 706 — 2,065 (3,574) 706 — (2,868) Accounts payable (66,657) — — (66,657) (99,525) — — (99,525) 61,524 — — 61,524 Accrued liabilities 26,057 68 2,689 28,814 2,360 3,825 (161) 6,024 (60,963) 3,194 2,908 (54,861) Cash provided by operating activities $ 61,811 $ — $ — $ 61,811 $ 142,900 $ — $ — $ 142,900 $ 246,621 $ — $ — $ 246,621

Organization of Sanmina (Detail

Organization of Sanmina (Details)	12 Months Ended
Organization of Sanmina (Details)	Oct. 01, 2022
IMS
Summary of Significant Accounting Policies
Revenue percentage generated by reportable segment	80%

Restatement of Consolidated F_3

Restatement of Consolidated Financial Statements (CONSOLIDATED BALANCE SHEETS) (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Oct. 03, 2020	Sep. 28, 2019
Current assets:
Cash and cash equivalents	$ 529,857	$ 493,305	$ 559,893	$ 627,717	$ 650,026	$ 623,844	$ 575,176	$ 516,030
Accounts receivable, net of allowances	1,138,894	1,229,864	1,271,100	1,299,014	1,193,437	1,155,253	1,124,838	1,112,925
Contract assets	475,721	444,796	399,282	347,583	332,190	333,438	321,947	357,989
Inventories	1,684,099	1,590,123	1,443,621	1,253,697	1,041,790	892,633	785,406	819,474
Prepaid expenses and other current assets	62,044	63,827	61,525	59,188	53,952	50,446	38,584	48,851
Total current assets	3,890,615	3,821,915	3,735,421	3,587,199	3,271,395	3,055,614	2,845,951	2,855,269
Property, plant and equipment, net	575,170	545,673	525,362	525,159	532,985	535,685	515,203	526,645
Deferred tax assets	209,554	222,080	229,574	235,031	242,261	248,060	266,592	271,187
Other	160,192	149,608	156,867	157,533	156,953	160,004	137,998	140,410
Total assets	4,835,531	4,739,276	4,647,224	4,504,922	4,203,594	3,999,363	3,765,744	3,793,511
Current liabilities:
Accounts payable	2,041,434	1,984,374	1,830,044	1,708,222	1,472,257	1,296,005	1,108,994	1,143,431
Accrued liabilities	281,599	326,212	332,431	253,962	177,203	171,365	195,839	209,581
Accrued payroll and related benefits	130,892	133,319	116,794	115,738	117,648	123,365	114,704	120,469
Short-term debt, including current portion of long-term debt	17,500	18,750	18,750	18,750	18,750	18,750	18,750	18,750
Total current liabilities	2,471,425	2,462,655	2,298,019	2,096,672	1,785,858	1,609,485	1,438,287	1,492,231
Long-term debt	329,237	298,345	302,751	307,160	311,572	315,987	320,405	324,825
Other	215,333	209,716	241,416	248,326	253,532	260,132	296,121	303,514
Total long-term liabilities	544,570	508,061	544,167	555,486	565,104	576,119	616,526	628,339
Commitments and Contingencies
Preferred stock, $0.01 par value, authorized 5,000 shares, none issued and outstanding	0				0
Common stock, $0.01 par value, authorized 166,667 shares; 110,160 and 108,734 shares issued and 57,394 and 64,307 shares outstanding as of October 1, 2022 and October 2, 2021, respectively	574				643
Treasury stock, 52,766 and 44,427 shares as of October 1, 2022 and October 2, 2021, respectively, at cost	(1,378,159)				(1,047,202)
Additional paid-in capital	6,380,774				6,338,863
Accumulated other comprehensive income	56,325				40,690
Accumulated deficit	(3,239,978)				(3,480,362)
Total stockholders' equity	1,819,536	1,768,560	1,805,038	1,852,764	1,852,632	1,813,759	1,710,931	1,672,941	$ 1,623,372	$ 1,647,073
Total liabilities and stockholders' equity	4,835,531	4,739,276	4,647,224	4,504,922	4,203,594	3,999,363	3,765,744	3,793,511
Long-term liabilities:
Commitments and Contingencies
Stockholders' equity:
Total liabilities and stockholders' equity	4,835,531	4,739,276	4,647,224	4,504,922	4,203,594	3,999,363	3,765,744	3,793,511
Previously Reported
Current assets:
Cash and cash equivalents	529,857	493,305	559,893	627,717	650,026	623,844	575,176	516,030
Accounts receivable, net of allowances	1,138,894	1,228,435	1,270,494	1,298,327	1,192,434	1,153,813	1,122,962	1,108,472
Contract assets	503,674	459,306	417,286	364,407	348,741	345,096	334,957	350,049
Inventories	1,691,081	1,591,111	1,437,955	1,242,440	1,036,511	892,633	785,406	819,474
Prepaid expenses and other current assets	62,044	63,827	61,525	59,188	53,952	50,446	38,584	48,851
Total current assets	3,925,550	3,835,984	3,747,153	3,592,079	3,281,664	3,065,832	2,857,085	2,842,876
Property, plant and equipment, net	575,170	545,673	525,362	525,159	532,985	550,038	529,651	541,188
Deferred tax assets	198,588	212,407	220,532	227,239	235,117	241,069	259,943	269,803
Other	160,192	149,608	156,867	157,533	156,953	145,651	123,550	125,867
Total assets	4,859,500	4,743,672	4,649,914	4,502,010	4,206,719	4,002,590	3,770,229	3,779,734
Current liabilities:
Accounts payable	2,029,534	1,976,533	1,817,465	1,694,592	1,464,693	1,296,005	1,108,994	1,143,431
Accrued liabilities	275,735	303,076	314,648	236,227	161,896	149,236	176,148	190,797
Accrued payroll and related benefits	130,892	133,319	116,794	115,738	117,648	123,365	114,704	120,469
Short-term debt, including current portion of long-term debt	17,500	18,750	18,750	18,750	18,750	18,750	18,750	18,750
Total current liabilities	2,453,661	2,431,678	2,267,657	2,065,307	1,762,987	1,587,356	1,418,596	1,473,447
Long-term debt	329,237	298,345	302,751	307,160	311,572	315,987	320,405	324,825
Other	215,333	209,716	241,416	248,326	253,532	260,132	296,121	303,514
Total long-term liabilities	544,570	508,061	544,167	555,486	565,104	576,119	616,526	628,339
Commitments and Contingencies
Common stock, $0.01 par value, authorized 166,667 shares; 110,160 and 108,734 shares issued and 57,394 and 64,307 shares outstanding as of October 1, 2022 and October 2, 2021, respectively	574				643
Treasury stock, 52,766 and 44,427 shares as of October 1, 2022 and October 2, 2021, respectively, at cost	(1,378,159)				(1,047,202)
Additional paid-in capital	6,380,774				6,338,863
Accumulated other comprehensive income	56,325				40,690
Accumulated deficit	(3,198,245)				(3,454,366)
Total stockholders' equity	1,861,269	1,803,933	1,838,090	1,881,217	1,878,628	1,839,115	1,735,107	1,677,948
Total liabilities and stockholders' equity	4,859,500	4,743,672	4,649,914	4,502,010	4,206,719	4,002,590	3,770,229	3,779,734
Long-term liabilities:
Commitments and Contingencies
Stockholders' equity:
Total liabilities and stockholders' equity	4,859,500	4,743,672	4,649,914	4,502,010	4,206,719	4,002,590	3,770,229	3,779,734
Investigative Adjustments
Current assets:
Contract assets	(27,953)	(34,918)	(33,512)	(31,772)	(28,708)	(29,357)	(27,204)	(9,427)
Inventories	(21,705)	(8,829)	(6,913)	(2,373)	(2,285)
Total current assets	(49,658)	(43,747)	(40,425)	(34,145)	(30,993)	(29,357)	(27,204)	(9,427)
Deferred tax assets	10,966	9,673	9,042	7,792	7,144	6,991	6,649	2,074
Total assets	(38,692)	(34,074)	(31,383)	(26,353)	(23,849)	(22,366)	(20,555)	(7,353)
Current liabilities:
Accrued liabilities	1,441	1,299	1,669	2,100	2,147	2,990	3,621	(136)
Total current liabilities	1,441	1,299	1,669	2,100	2,147	2,990	3,621	(136)
Commitments and Contingencies
Accumulated deficit	(40,133)				(25,996)
Total stockholders' equity	(40,133)	(35,373)	(33,052)	(28,453)	(25,996)	(25,356)	(24,176)	(7,217)
Total liabilities and stockholders' equity	(38,692)	(34,074)	(31,383)	(26,353)	(23,849)	(22,366)	(20,555)	(7,353)
Long-term liabilities:
Commitments and Contingencies
Stockholders' equity:
Total liabilities and stockholders' equity	(38,692)	$ (34,074)	$ (31,383)	$ (26,353)	(23,849)	$ (22,366)	$ (20,555)	$ (7,353)
Other Adjustments
Current assets:
Accounts receivable, net of allowances					1,003
Contract assets					12,157
Inventories	14,723				7,564
Total current assets	14,723				20,724
Total assets	14,723				20,724
Current liabilities:
Accounts payable	11,900				7,564
Accrued liabilities	4,423				13,160
Total current liabilities	16,323				20,724
Accumulated deficit	(1,600)
Total stockholders' equity	(1,600)
Total liabilities and stockholders' equity	14,723				20,724
Stockholders' equity:
Total liabilities and stockholders' equity	$ 14,723				$ 20,724

Restatement of Consolidated F_4

Restatement of Consolidated Financial Statements (Parenthetical) (Details) - $ / shares	Oct. 01, 2022	Oct. 02, 2021
Restatement of Consolidated Financial Statements
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	166,667,000	166,667,000
Common Stock, Shares, Issued	110,160,000	108,734,000
Common Stock, Shares, Outstanding	57,394,000	64,307,000
Treasury Stock, Shares	52,766,000	44,427,000

Restatement of Consolidated F_5

Restatement of Consolidated Financial Statements (CONSOLIDATED STATEMENTS OF INCOME) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Restatement of Consolidated Financial Statements
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396		$ 5,694,757		$ 7,919,622	$ 6,738,356	$ 6,950,208
Cost of sales		1,861,176	1,768,575	1,615,029					3,383,604		5,244,780		7,297,416	6,211,915	6,433,044
Gross profit	172,229	162,185	146,495	141,297	130,039	135,066	120,985	140,351	287,792		449,977		622,206	526,441	517,164
Operating expenses:
Selling, general and administrative		61,506	61,817	61,475					123,292		184,798		244,569	234,537	240,931
Research and development		5,071	5,472	4,777					10,249		15,320		21,343	20,911	22,564
Restructuring and other		3,994	2,932	1,414					4,346		8,340		11,425	15,057	27,916
Goodwill impairment															6,609
Gain on sale of long-lived assets				(4,610)					(4,610)		(4,610)		(4,610)
Total operating expenses		70,571	70,221	63,056					133,277		203,848		272,727	270,505	298,020
Operating income	103,350	91,614	76,274	78,241	65,910	72,741	42,610	74,675	154,515		246,129		349,479	255,936	219,144
Interest income		540	349	309					658		1,198		1,628	925	2,322
Interest expense		(5,615)	(4,870)	(4,877)					(9,747)		(15,362)		(22,473)	(19,551)	(28,903)
Other income (expense), net		(7,774)	(1,408)	2,072					664		(7,110)		(26,314)	44,331	(348)
Interest and other, net		(12,849)	(5,929)	(2,496)					(8,425)		(21,274)		(47,159)	25,705	(26,929)
Income before income taxes		78,765	70,345	75,745					146,090		224,855		302,320	281,641	192,215
Provision for income taxes		1,543	21,724	19,568					41,292		42,835		61,936	32,095	59,046
Net income	$ 58,364	$ 77,222	$ 48,621	$ 56,177	$ 55,925	$ 116,195	$ 27,868	$ 49,558	$ 104,798	$ 77,426	$ 182,020	$ 193,621	$ 240,384	$ 249,546	$ 133,169
Net income per share:
Basic	$ 1.01	$ 1.29	$ 0.77	$ 0.87	$ 0.86	$ 1.78	$ 0.43	$ 0.76	$ 1.65		$ 2.92		$ 3.92	$ 3.82	$ 1.93
Diluted	$ 0.98	$ 1.25	$ 0.76	$ 0.85	$ 0.83	$ 1.73	$ 0.42	$ 0.74	$ 1.60		$ 2.83		$ 3.81	$ 3.72	$ 1.88
Weighted-average shares used in computing per share amounts:
Basic													61,310	65,318	69,041
Diluted													63,117	67,084	70,793
Previously Reported
Restatement of Consolidated Financial Statements
Net sales		$ 2,019,059	$ 1,911,530	$ 1,757,325		$ 1,657,741	$ 1,699,677	$ 1,755,249	$ 3,668,855	3,454,926	$ 5,687,914	5,112,667	$ 7,890,475	$ 6,756,643	$ 6,960,370
Cost of sales		1,853,870	1,759,083	1,612,836		1,521,151	1,556,579	1,614,014	3,371,919	3,170,593	5,225,789	4,691,744	7,249,961	6,204,838	6,434,663
Gross profit		165,189	152,447	144,489		136,590	143,098	141,235	296,936	284,333	462,125	420,923	640,514	551,805	525,707
Operating expenses:
Selling, general and administrative		61,506	61,817	61,475		57,438	61,142	58,967	123,292	120,109	184,798	177,547	244,569	234,537	240,931
Research and development		5,071	5,472	4,777		5,269	5,353	4,805	10,249	10,158	15,320	15,427	21,343	20,911	22,564
Restructuring and other		3,994	2,932	1,414		(382)	11,880	1,904	4,346	13,784	8,340	13,402	11,425	15,057	27,916
Goodwill impairment															6,609
Gain on sale of long-lived assets				(4,610)					(4,610)		(4,610)		(4,610)
Total operating expenses		70,571	70,221	63,056		62,325	78,375	65,676	133,277	144,051	203,848	206,376	272,727	270,505	298,020
Operating income		94,618	82,226	81,433		74,265	64,723	75,559	163,659	140,282	258,277	214,547	367,787	281,300	227,687
Interest income		540	349	309		217	244	230	658	474	1,198	691	1,628	925	2,322
Interest expense		(5,615)	(4,870)	(4,877)		(4,823)	(4,880)	(4,954)	(9,747)	(9,834)	(15,362)	(14,657)	(22,473)	(19,551)	(28,903)
Other income (expense), net		(7,774)	(1,408)	2,072		29,258	6,143	1,867	664	8,010	(7,110)	37,268	(26,314)	44,331	(348)
Interest and other, net		(12,849)	(5,929)	(2,496)		24,652	1,507	(2,857)	(8,425)	(1,350)	(21,274)	23,302	(47,159)	25,705	(26,929)
Income before income taxes		81,769	76,297	78,937		98,917	66,230	72,702	155,234	138,932	237,003	237,849	320,628	307,005	200,758
Provision for income taxes		2,226	23,077	20,303		$ (18,458)	$ 19,193	24,681	43,380	43,874	45,606	25,416	64,507	38,007	61,045
Net income		$ 79,543	$ 53,220	$ 58,634				$ 48,021	$ 111,854	$ 95,058	$ 191,397	$ 212,433	$ 256,121	$ 268,998	$ 139,713
Net income per share:
Basic		$ 1.33	$ 0.85	$ 0.91		$ 1.79	$ 0.72	$ 0.74	$ 1.76	$ 1.46	$ 3.07	$ 3.25	$ 4.18	$ 4.12	$ 2.02
Diluted		$ 1.29	$ 0.83	$ 0.89		$ 1.74	$ 0.70	$ 0.72	$ 1.71	$ 1.42	$ 2.98	$ 3.17	$ 4.06	$ 4.01	$ 1.97
Weighted-average shares used in computing per share amounts:
Basic													61,310	65,318	69,041
Diluted													63,117	67,084	70,793
Investigative Adjustments
Restatement of Consolidated Financial Statements
Net sales		$ 4,302	$ 3,540	$ (999)		$ (4,475)	$ (21,180)	$ 735	$ 2,541	$ (20,445)	$ 6,843	$ (24,920)	$ 23,265	$ (18,287)	$ (10,162)
Cost of sales		7,306	9,492	2,193		(2,951)	933	1,619	11,685	2,552	18,991	(399)	41,573	7,077	(1,619)
Gross profit		(3,004)	(5,952)	(3,192)		(1,524)	(22,113)	(884)	(9,144)	(22,997)	(12,148)	(24,521)	(18,308)	(25,364)	(8,543)
Operating expenses:
Operating income		(3,004)	(5,952)	(3,192)		(1,524)	(22,113)	(884)	(9,144)	(22,997)	(12,148)	(24,521)	(18,308)	(25,364)	(8,543)
Income before income taxes		(3,004)	(5,952)	(3,192)		(1,524)	(22,113)	(884)	(9,144)	(22,997)	(12,148)	(24,521)	(18,308)	(25,364)	(8,543)
Provision for income taxes		(683)	(1,353)	(735)		(344)	$ (5,154)	(211)	(2,088)	(5,365)	(2,771)	$ (5,709)	(4,171)	(5,912)	(1,999)
Net income		$ (2,321)	$ (4,599)	$ (2,457)		$ (18,812)		$ (673)	$ (7,056)	$ (17,632)	$ (9,377)		$ (14,137)	$ (19,452)	$ (6,544)
Net income per share:
Basic		$ (0.04)	$ (0.08)	$ (0.04)		$ (0.01)	$ (0.26)	$ (0.01)	$ (0.11)	$ (0.27)	$ (0.15)	$ (0.29)	$ (0.23)	$ (0.30)	$ (0.09)
Diluted		$ (0.04)	$ (0.07)	$ (0.04)		$ (0.01)	$ (0.26)	$ (0.01)	$ (0.11)	$ (0.26)	$ (0.15)	$ (0.28)	$ (0.23)	$ (0.29)	$ (0.09)
Other Adjustments
Restatement of Consolidated Financial Statements
Net sales													$ 5,882
Cost of sales													5,882
Operating expenses:
Provision for income taxes													1,600
Net income													$ (1,600)
Net income per share:
Basic													$ (0.03)
Diluted													$ (0.03)

Restatement of Consolidated F_6

Restatement of Consolidated Financial Statements (CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME) (Details) - USD ($) $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Restatement of Consolidated Financial Statements
Net income	$ 58,364	$ 77,222	$ 48,621	$ 56,177	$ 55,925	$ 116,195	$ 27,868	$ 49,558	$ 104,798	$ 77,426	$ 182,020	$ 193,621	$ 240,384	$ 249,546	$ 133,169
Other comprehensive income (loss), net of tax:
Change in foreign currency translation adjustments													(12,191)	(9,223)	(925)
Derivative financial instruments:
Change in net unrealized amount													8,414	3,034	(8,146)
Amount reclassified into net income													10,003	4,863	1,332
Defined benefit plans:
Changes in unrecognized net actuarial losses and unrecognized transition cost													5,884	4,713	(6,240)
Amortization of actuarial losses and transition cost													3,525	2,417	2,106
Total other comprehensive income (loss)													15,635	5,804	(11,873)
Comprehensive income													256,019	255,350	121,296
Previously Reported
Restatement of Consolidated Financial Statements
Net income		79,543	53,220	58,634				48,021	111,854	95,058	191,397	$ 212,433	256,121	268,998	139,713
Investigative Adjustments
Restatement of Consolidated Financial Statements
Net income		$ (2,321)	$ (4,599)	$ (2,457)		$ (18,812)		$ (673)	$ (7,056)	$ (17,632)	$ (9,377)		(14,137)	$ (19,452)	$ (6,544)
Other Adjustments
Restatement of Consolidated Financial Statements
Net income													$ (1,600)

Restatement of Consolidated F_7

Restatement of Consolidated Financial Statements (CONSOLIDATED STATEMENTS OF CASH FLOWS) (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended		9 Months Ended		12 Months Ended
	Jan. 01, 2022	Jul. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income										$ 133,169
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	$ 27,465		$ 27,635	$ 55,032	$ 54,831	$ 82,097	$ 82,204	$ 108,783	$ 109,656	114,218
Stock-based compensation expense	9,032		8,208	18,362	17,432	29,045	26,147	39,608	34,976	26,235
Deferred income taxes	6,059		3,858	9,173	8,787	15,993	26,946	27,910	28,375	11,772
Gain on sale of intellectual property									(15,000)
Gain on liquidation of foreign entity							(8,263)		(8,263)
Impairment of goodwill and other assets						1,848		1,848		8,409
Loss on sale of intellectual property								7,000
Other, net	(3,638)		(99)	(1,903)	(19)	(3,146)	(633)	1,260	(1,371)	(239)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable	(106,656)		(66,961)	(79,308)	(79,333)	(40,276)	(108,008)	47,483	(145,810)	81,914
Contract assets	(15,393)		28,680	(67,092)	64,722	(112,606)	53,231	(143,531)	54,479	9,631
Inventories	(213,278)		57,469	(403,783)	90,490	(552,851)	(7,419)	(651,118)	(157,278)	24,377
Prepaid expenses and other assets	(2,939)		(8,694)	(11,334)	2,065	(13,269)	(2,868)	(31,700)	(5,780)	17,092
Accounts payable	240,591		(66,657)	362,191	(99,525)	507,909	61,524	558,828	243,834	(106,640)
Accrued liabilities	70,880		28,814	161,137	6,024	152,192	(54,861)	124,099	(49,022)	(19,383)
Cash provided by operating activities	68,300		61,811	147,273	142,900	248,956	246,621	330,854	338,342	300,555
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES:
Purchases of property, plant and equipment								(138,639)	(73,296)	(65,982)
Proceeds from sales of property, plant and equipment								8,425	1,084	1,573
Purchases of investments								(2,000)	(2,705)	(30,000)
Sale of investments										30,000
Cash paid for business acquisition, net of cash acquired									(21,408)
Proceeds from sale of intellectual property									5,000
Cash used in investing activities								(132,214)	(91,325)	(64,409)
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES:
Proceeds from revolving credit facility borrowings								1,874,000	399,600	1,909,000
Repayments of revolving credit facility borrowings								(1,874,000)	(399,600)	(1,909,000)
Repayments of long-term debt								(332,814)	(18,752)	(39,048)
Proceeds from issuance of long-term debt								350,000
Debt issuance costs								(3,263)
Net proceeds from stock issuances								2,379	2,993	7,793
Repurchases of common stock								(331,101)	(64,059)	(179,025)
Proceeds from collection of notes receivable								500	2,500
Cash used in financing activities								(314,299)	(77,318)	(210,280)
Effect of exchange rate changes								(4,510)	(199)	(81)
Increase (decrease) in cash and cash equivalents								(120,169)	169,500	25,785
Cash and cash equivalents at beginning of year	650,026		480,526	650,026	480,526	650,026	480,526	650,026	480,526	454,741
Cash and cash equivalents at end of year								529,857	650,026	480,526
Previously Reported
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income										139,713
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	27,465		27,635	55,032	54,831	82,097	82,204	108,783	109,656	114,218
Stock-based compensation expense	9,032		8,208	18,362	17,432	29,045	26,147	39,608	34,976	26,235
Deferred income taxes	6,707		3,447	11,071	13,641	18,522	32,142	31,733	33,724	13,567
Gain on sale of intellectual property									(15,000)
Gain on liquidation of foreign entity							(8,263)		(8,263)
Impairment of goodwill and other assets						1,848		1,848		8,409
Loss on sale of intellectual property								7,000
Other, net	(3,638)		(99)	(1,903)	(19)	(3,146)	(633)	1,260	(1,371)	(239)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable	(106,972)		(64,217)	(79,705)	(79,166)	(39,850)	(108,277)	46,480	(146,516)	83,623
Contract assets	(15,666)		46,534	(68,545)	61,626	(110,565)	51,487	(154,933)	47,842	(283)
Inventories	(207,300)		42,282	(403,396)	75,303	(559,118)	(22,606)	(663,379)	(167,186)	39,564
Prepaid expenses and other assets	(2,939)		(9,400)	(11,334)	1,359	(13,269)	(3,574)	(31,700)	(6,486)	17,798
Accounts payable	234,525		(66,657)	357,176	(99,525)	507,632	61,524	554,492	236,270	(106,640)
Accrued liabilities	68,452		26,057	158,661	2,360	144,363	(60,963)	133,541	(48,302)	(35,410)
Cash provided by operating activities	68,300		61,811	147,273	142,900	248,956	$ 246,621	330,854	338,342	300,555
Investigative Adjustments
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income										(6,544)
Adjustments to reconcile net income to cash provided by operating activities:
Deferred income taxes	(648)	$ (5,196)	(279)	(1,898)	(4,854)	(2,529)		(3,823)	(5,349)	(1,795)
Changes in operating assets and liabilities, net of amounts acquired:
Contract assets	3,064	4,921	(15,009)	4,804	2,768	6,210		(755)	4,272	24,436
Inventories	88	15,187	15,187	4,628	15,187	6,544		19,420	17,472	(15,187)
Prepaid expenses and other assets		706	706		706				706	(706)
Accrued liabilities	$ (47)	$ 3,194	$ 68	$ (478)	$ 3,825	$ (848)		(705)	2,351	(204)
Other Adjustments
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable								1,003	706	(1,709)
Contract assets								12,157	2,365	(14,522)
Inventories								(7,159)	(7,564)
Accounts payable								4,336	7,564
Accrued liabilities								$ (8,737)	$ (3,071)	$ 16,231

Restatement of Consolidated F_8

Restatement of Consolidated Financial Statements - Previously reported revenue disaggregated by segment, geography and market sector (Details) - USD ($) $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396		$ 5,694,757		$ 7,919,622	$ 6,738,356	$ 6,950,208
Gross profit	$ 172,229	162,185	146,495	141,297	$ 130,039	135,066	120,985	140,351	287,792		449,977		622,206	526,441	517,164
Operating segments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Gross profit													638,115	543,223	529,939
Segment reconciling items
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Gross profit													(15,909)	(16,782)	(12,775)
Intersegment eliminations
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													(149,167)	(126,711)	(138,522)
Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		2,019,059	1,911,530	1,757,325		1,657,741	1,699,677	1,755,249	3,668,855	$ 3,454,926	5,687,914	$ 5,112,667	7,890,475	6,756,643	6,960,370
Gross profit		165,189	152,447	144,489		136,590	143,098	141,235	296,936	284,333	462,125	420,923	640,514	551,805	525,707
Investigative Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		4,302	3,540	(999)		(4,475)	(21,180)	735	2,541	(20,445)	6,843	(24,920)	23,265	(18,287)	(10,162)
Gross profit		$ (3,004)	$ (5,952)	$ (3,192)		$ (1,524)	$ (22,113)	$ (884)	$ (9,144)	$ (22,997)	$ (12,148)	$ (24,521)	(18,308)	(25,364)	(8,543)
Other Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													5,882
IMS \| Operating segments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													6,413,606	5,485,612	5,719,180
Gross profit													462,606	391,339	381,638
Other Segments \| Operating segments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													1,655,183	1,379,455	1,369,550
Gross profit													$ 175,509	$ 151,884	$ 148,301

Restatement of Consolidated F_9

Restatement of Consolidated Financial Statements - Net sales by geographic segment, determined based on the country (Details) - USD ($) $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396		$ 5,694,757		$ 7,919,622	$ 6,738,356	$ 6,950,208
Industrial, Defense, Medical and Automotive
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													4,744,088	3,871,754	4,117,558
Communications Networks and Cloud Infrastructure
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													3,175,534	2,866,602	2,832,650
Americas
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													3,748,643	3,164,562	3,440,365
APAC
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													3,007,904	2,517,963	2,514,005
EMEA
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													1,163,075	1,055,831	995,838
Intersegment eliminations
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													(149,167)	(126,711)	(138,522)
Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		2,019,059	1,911,530	1,757,325		1,657,741	1,699,677	1,755,249	3,668,855	$ 3,454,926	5,687,914	$ 5,112,667	7,890,475	6,756,643	6,960,370
Investigative Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		$ 4,302	$ 3,540	$ (999)		$ (4,475)	$ (21,180)	$ 735	$ 2,541	$ (20,445)	$ 6,843	$ (24,920)	23,265	$ (18,287)	$ (10,162)
Other Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales													$ 5,882

Restatement of Consolidated _10

Restatement of Consolidated Financial Statements - Previously reported domestic and foreign components of income before income taxes (Details) - USD ($) $ in Thousands	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Income Taxes
Domestic											$ 145,671	$ 174,936	$ 88,450
Foreign											156,649	106,705	103,765
Income before income taxes	$ 78,765	$ 70,345	$ 75,745				$ 146,090		$ 224,855		302,320	281,641	192,215
Federal:
Current											1,070	705	(917)
Deferred											25,399	28,809	7,666
State:
Current											1,711	3,677	1,500
Deferred											3,081	(302)	2,579
Foreign:
Current											31,241	(906)	46,376
Deferred											(566)	112	1,842
Total provision for income taxes	1,543	21,724	19,568				41,292		42,835		61,936	32,095	59,046
Previously Reported
Income Taxes
Income before income taxes	81,769	76,297	78,937	$ 98,917	$ 66,230	$ 72,702	155,234	$ 138,932	237,003	$ 237,849	320,628	307,005	200,758
Foreign:
Total provision for income taxes	2,226	23,077	20,303	(18,458)	19,193	24,681	43,380	43,874	45,606	25,416	64,507	38,007	61,045
Investigative Adjustments
Income Taxes
Income before income taxes	(3,004)	(5,952)	(3,192)	(1,524)	(22,113)	(884)	(9,144)	(22,997)	(12,148)	(24,521)	(18,308)	(25,364)	(8,543)
Foreign:
Total provision for income taxes	$ (683)	$ (1,353)	$ (735)	$ (344)	$ (5,154)	$ (211)	$ (2,088)	$ (5,365)	$ (2,771)	$ (5,709)	(4,171)	$ (5,912)	$ (1,999)
Other Adjustments
Foreign:
Total provision for income taxes											$ 1,600

Restatement of Consolidated _11

Restatement of Consolidated Financial Statements - Previously reported tax effects of temporary differences that give rise to significant portions of deferred tax assets and liabilities (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021
Deferred tax assets:
U.S. net operating loss carryforwards	$ 92,882				$ 134,385
Foreign net operating loss carryforwards	109,416				112,516
Intangibles	25,099				24,219
Accruals not currently deductible	44,963				43,932
Property, plant and equipment	27,514				25,494
Tax credit carryforwards	18,465				17,250
Reserves not currently deductible	14,939				11,534
Stock compensation expense	6,365				7,677
Federal benefit of foreign operations	21,312				18,336
Derivatives and other impacts of OCI	838				7,637
Lease deferred tax asset	15,018				11,563
Other	1,915
Valuation allowance	(118,210)				(115,258)
Total deferred tax assets	260,516				299,285
Deferred tax liabilities on undistributed earnings	(14,775)				(14,775)
Deferred tax liabilities on branch operations	(24,182)				(30,000)
Revenue recognition	(1,572)				(1,702)
Lease deferred tax liability	(14,808)				(11,349)
Other					(2,495)
Net deferred tax assets	205,179				238,964
Recorded as:
Deferred income tax assets, net	209,554	$ 222,080	$ 229,574	$ 235,031	242,261	$ 248,060	$ 266,592	$ 271,187
Deferred tax liabilities	(4,375)				(3,297)
Net deferred tax assets	205,179				238,964
Previously Reported
Recorded as:
Deferred income tax assets, net	198,588	212,407	220,532	227,239	235,117	241,069	259,943	269,803
Investigative Adjustments
Recorded as:
Deferred income tax assets, net	$ 10,966	$ 9,673	$ 9,042	$ 7,792	$ 7,144	$ 6,991	$ 6,649	$ 2,074

Restatement of Consolidated _12

Restatement of Consolidated Financial Statements - Previously reported reconciliation of the statutory federal tax rate to the company effective tax rate (Details)	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Income Taxes
Federal tax at statutory tax rate	21%	21%	21%
Effect of foreign operations	3.52%	7.99%	13.60%
Permanent items	0.08%	(2.03%)	(0.62%)
Federal credits	(0.73%)	(0.54%)	(1.37%)
Other	0.59%	(0.20%)	(0.06%)
State income taxes, net of federal benefit	1.60%	0.91%	1.94%
Release of foreign tax reserves	(5.57%)	(15.73%)	(3.77%)
Effective tax rate	20.49%	11.40%	30.72%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Accounts Receivable and Other Related Allowances) (Details) - USD ($) $ in Millions	Oct. 01, 2022	Oct. 02, 2021
Significant Accounting Policies
Accounts receivable allowances	$ 8	$ 7

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Accounts Receivable Sales) (Details)	12 Months Ended
	Oct. 01, 2022
Summary of Significant Accounting Policies
Percentage of face value of receivable sold	100%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Long-lived Assets) (Details)	12 Months Ended
	Oct. 01, 2022
Leasehold improvements
Summary of Significant Accounting Policies
Property, plant and equipment, depreciation methods	straight-line basis over the shorter of the lease term or useful life of the asset
Minimum \| Building
Summary of Significant Accounting Policies
Useful life In years	20 years
Minimum \| Machinery, Equipment, Furniture and Fixtures
Summary of Significant Accounting Policies
Property, plant and equipment, depreciation methods	P3Y
Maximum \| Building
Summary of Significant Accounting Policies
Useful life In years	40 years
Maximum \| Machinery, Equipment, Furniture and Fixtures
Summary of Significant Accounting Policies
Property, plant and equipment, depreciation methods	P15Y

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Leases) (Details)	Oct. 01, 2022
Maximum
Summary of Significant Accounting Policies
Term of contracts	44 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Revenue Recognition) (Details) $ in Thousands	3 Months Ended								6 Months Ended	9 Months Ended	12 Months Ended
	Oct. 01, 2022 USD ($)	Jul. 02, 2022 USD ($)	Apr. 02, 2022 USD ($)	Jan. 01, 2022 USD ($)	Oct. 02, 2021 USD ($)	Jul. 03, 2021 USD ($)	Apr. 03, 2021 USD ($)	Jan. 02, 2021 USD ($)	Apr. 02, 2022 USD ($)	Jul. 02, 2022 USD ($)	Oct. 01, 2022 USD ($) segment	Oct. 02, 2021 USD ($)	Oct. 03, 2020 USD ($)
Summary of Significant Accounting Policies
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396	$ 5,694,757	$ 7,919,622	$ 6,738,356	$ 6,950,208
Gross profit	$ 172,229	$ 162,185	$ 146,495	$ 141,297	$ 130,039	$ 135,066	$ 120,985	$ 140,351	$ 287,792	$ 449,977	$ 622,206	526,441	517,164
Number of other operating segment excluding DAS \| segment											11
Operating segments
Summary of Significant Accounting Policies
Gross profit											$ 638,115	543,223	529,939
CPS
Summary of Significant Accounting Policies
Net sales											1,541,298	1,284,087	1,264,457
Gross profit											176,000
CPS \| Operating segments
Summary of Significant Accounting Policies
Net sales											1,500,000
Gross profit											176,000
Other Segments \| Operating segments
Summary of Significant Accounting Policies
Net sales											1,655,183	1,379,455	1,369,550
Gross profit											$ 175,509	$ 151,884	$ 148,301

Balance Sheet and Income Stat_3

Balance Sheet and Income Statement Details (Property, Plant and Equipment, net) (Details) - USD ($) $ in Thousands	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021
Summary of Significant Accounting Policies
Property, plant and equipment, gross	$ 2,339,963	$ 2,247,612
Less: Accumulated depreciation and amortization	(1,764,793)	(1,714,627)
Property, plant and equipment, net	575,170	532,985		$ 545,673	$ 525,362	$ 525,159	$ 535,685	$ 515,203	$ 526,645
Depreciation expense	108,000	109,000	$ 113,000
Machinery and equipment
Summary of Significant Accounting Policies
Property, plant and equipment, gross	1,523,598	1,491,156
Land and buildings
Summary of Significant Accounting Policies
Property, plant and equipment, gross	656,839	645,639
Leasehold improvements
Summary of Significant Accounting Policies
Property, plant and equipment, gross	42,793	44,899
Furniture and fixtures
Summary of Significant Accounting Policies
Property, plant and equipment, gross	24,805	25,394
Construction in progress
Summary of Significant Accounting Policies
Property, plant and equipment, gross	$ 91,928	$ 40,524

Balance Sheet and Income Stat_4

Balance Sheet and Income Statement Details (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Oct. 01, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021
Balance Sheet and Income Statement Details
Pension expense (Income) for defined benefit plan termination	$ 2,000
Proceeds from sale of intellectual property				$ 5,000
Foreign currency translation reclassification adjustment from AOCI, realized upon sale or liquidation, before tax		$ 8,000		8,000
Litigation settlement, amount awarded from other party				16,000
Fourth amended and restated credit agreement
Balance Sheet and Income Statement Details
Gain (Loss) on Extinguishment of Debt	1,000		$ 1,000
Intellectual property
Balance Sheet and Income Statement Details
Other nonoperating income				15,000
Proceeds from sale of intellectual property				$ 8,000
Intellectual property \| Notes receivable
Balance Sheet and Income Statement Details
Nontrade receivables, current	7,000		7,000
Allowance for credit loss, receivable, other, current	$ 7,000		$ 7,000

Revenue Recognition (Details)

Revenue Recognition (Details) $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
Revenue Recognition (Details) $ in Thousands	Oct. 01, 2022 USD ($)	Jul. 02, 2022 USD ($)	Apr. 02, 2022 USD ($)	Jan. 01, 2022 USD ($)	Oct. 02, 2021 USD ($)	Jul. 03, 2021 USD ($)	Apr. 03, 2021 USD ($)	Jan. 02, 2021 USD ($)	Apr. 02, 2022 USD ($)	Apr. 03, 2021 USD ($)	Jul. 02, 2022 USD ($)	Jul. 03, 2021 USD ($)	Oct. 01, 2022 USD ($) segment	Oct. 02, 2021 USD ($)	Oct. 03, 2020 USD ($)
Revenue Recognition
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396		$ 5,694,757		$ 7,919,622	$ 6,738,356	$ 6,950,208
Percent of Net Sales Transferred Over Time													95%
Raw Materials as a percentage of total Inventory	99%												99%
Gross profit	$ 172,229	162,185	146,495	141,297	$ 130,039	135,066	120,985	140,351	287,792		449,977		$ 622,206	526,441	517,164
Number of other operating segment excluding DAS \| segment													11
Operating segments
Revenue Recognition
Gross profit													$ 638,115	543,223	529,939
Americas
Revenue Recognition
Net sales													3,748,643	3,164,562	3,440,365
APAC
Revenue Recognition
Net sales													3,007,904	2,517,963	2,514,005
EMEA
Revenue Recognition
Net sales													$ 1,163,075	1,055,831	995,838
Mexico
Revenue Recognition
Percentage of Net Sales to Americas Net Sales	60%												60%
U.S.
Revenue Recognition
Percentage of Net Sales to Americas Net Sales	35%												35%
Previously Reported
Revenue Recognition
Net sales		2,019,059	1,911,530	1,757,325		1,657,741	1,699,677	1,755,249	3,668,855	$ 3,454,926	5,687,914	$ 5,112,667	$ 7,890,475	6,756,643	6,960,370
Gross profit		165,189	152,447	144,489		136,590	143,098	141,235	296,936	284,333	462,125	420,923	640,514	551,805	525,707
Investigative Adjustments
Revenue Recognition
Net sales		4,302	3,540	(999)		(4,475)	(21,180)	735	2,541	(20,445)	6,843	(24,920)	23,265	(18,287)	(10,162)
Gross profit		$ (3,004)	$ (5,952)	$ (3,192)		$ (1,524)	$ (22,113)	$ (884)	$ (9,144)	$ (22,997)	$ (12,148)	$ (24,521)	(18,308)	(25,364)	(8,543)
Other Adjustments
Revenue Recognition
Net sales													5,882
Communications Networks and Cloud Infrastructure
Revenue Recognition
Net sales													3,175,534	2,866,602	2,832,650
Industrial, Defense, Medical and Automotive
Revenue Recognition
Net sales													4,744,088	3,871,754	4,117,558
IMS
Revenue Recognition
Net sales													6,378,324	5,454,269	5,685,751
CPS
Revenue Recognition
Net sales													1,541,298	1,284,087	1,264,457
Gross profit													176,000
CPS \| Operating segments
Revenue Recognition
Net sales													1,500,000
Gross profit													176,000
Other Segments \| Operating segments
Revenue Recognition
Net sales													1,655,183	1,379,455	1,369,550
Gross profit													$ 175,509	$ 151,884	$ 148,301

Financial Instruments (Details)

Financial Instruments (Details) $ in Thousands	12 Months Ended
Financial Instruments (Details) $ in Thousands	Oct. 01, 2022 USD ($)	Oct. 03, 2020 USD ($)	Oct. 02, 2021 USD ($)
Derivative [Line Items]
Cash Equivalents	10%
Goodwill impairment		$ 6,609
Impairment of Long-Lived Assets to be Disposed of	$ 2,000
Fair value Inputs Level 1 \| Fair Value, Recurring [Member]
Derivative [Line Items]
Deferred compensation plan assets	37,000		$ 46,000
Defined benefit plan assets	17,000		40,000
Foreign Currency Forward \| Derivatives Designated as Accounting Hedges:
Derivative [Line Items]
Derivative, Notional Amount	$ 123,172		$ 110,098
Number of Contracts	50		48
Maximum Length of Time Hedged	12 months
Foreign Currency Forward \| Derivatives Not Designated as Accounting Hedges:
Derivative [Line Items]
Derivative, Notional Amount	$ 531,558		$ 353,108
Number of Contracts	43		46
Maximum Remaining Maturity	2 months
Interest Rate Swap \| Derivatives Designated as Accounting Hedges:
Derivative [Line Items]
Derivative, Notional Amount	$ 350,000		$ 350,000
Effective Interest Rate	4.10%		4.30%
Maturity Date	Dec. 01, 2023
Interest Rate Swap \| Derivatives Designated as Accounting Hedges: \| Level 2 \| Fair Value, Recurring [Member]
Derivative [Line Items]
Interest Rate Cash Flow Hedge Liability at Fair Value			$ 19,000
Interest Rate Cash Flow Hedge Asset at Fair Value	$ 6,000

Financial Instruments and Con_2

Financial Instruments and Concentration of Credit Risk (Details)	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Revenue Benchmark [Member] \| Nokia [Member]
Concentration Risk [Line Items]
Concentration of Sales or Receivables		10%	10%
Revenue Benchmark [Member] \| Motorola [Member]
Concentration Risk [Line Items]
Concentration of Sales or Receivables	10%
Accounts Receivable [Member] \| Nokia [Member]
Concentration Risk [Line Items]
Concentration of Sales or Receivables		10%
Accounts Receivable [Member] \| Motorola [Member]
Concentration Risk [Line Items]
Concentration of Sales or Receivables	10%

Debt - Long term debt (Details)

Debt - Long term debt (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021
Debt Instrument [Line Items]
Long-term debt	$ 329,237	$ 298,345	$ 302,751	$ 307,160	$ 311,572	$ 315,987	$ 320,405	$ 324,825
Term Loan Due 2027
Debt Instrument [Line Items]
Loans Payable to Bank	346,737
Less: Current portion of long-term debt	$ 17,500				18,750
Term Loan Due 2023
Debt Instrument [Line Items]
Loans Payable to Bank					$ 330,322

Debt - Additional information (

Debt - Additional information (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Oct. 01, 2022	Oct. 01, 2022	Sep. 27, 2022	Oct. 02, 2021
Fifth Amended and Restated Credit Agreement [Member]
Line of Credit Facility [Line Items]
Maximum Borrowing Capacity			$ 800,000
Additional Credit Line			200,000
Line of Credit Facility, Initiation Date		Sep. 27, 2022
Facility Expiration Date		Sep. 27, 2027
Amount Outstanding	$ 0	$ 0		$ 0
Letters of Credit Outstanding, Amount	9,000	9,000
Line of Credit Facility, Remaining Borrowing Capacity	791,000	791,000
Term Loan			$ 350,000
Debt Issuance Costs, Gross	3,000	3,000
Foreign Line of Credit
Line of Credit Facility [Line Items]
Maximum Borrowing Capacity	70,000	70,000
Amount Outstanding	0	$ 0
Line of Credit Expiration Date		the second quarter of 2024
Fourth amended and restated credit agreement
Line of Credit Facility [Line Items]
Gain (Loss) on Extinguishment of Debt	$ 1,000	$ 1,000
Term Loan Due 2027
Line of Credit Facility [Line Items]
Quarterly Principal Repayment Percentage for Long-term Debt	1.25%	1.25%
Long Term Debt, Gross	$ 350,000	$ 350,000
Long-term Debt, Fiscal Year Maturity [Abstract]
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months	17,500	17,500
Long-term Debt, Maturities, Repayments of Principal in Year Two	13,125	13,125
Long-term Debt, Maturities, Repayments of Principal in Year Three	17,500	17,500
Long-term Debt, Maturities, Repayments of Principal in Year Four	21,875	21,875
Long-term Debt, Maturities, Repayments of Principal in Year Five	$ 280,000	$ 280,000

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Oct. 02, 2021
Leases
Other assets	$ 79,495	$ 68,012
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other
Accrued liabilities	$ 16,695	17,219
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities
Other long-term liabilities	$ 48,566	38,587
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other
Total lease liabilities	$ 65,261	$ 55,806
Weighted average remaining lease term	15 years 8 months 26 days	14 years 5 months 15 days
Weighted average discount rate	2.40%	2.72%

Leases - Lease cost (Details)

Leases - Lease cost (Details) - USD ($) $ in Thousands	12 Months Ended
Leases - Lease cost (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Leases
Operating lease expense	$ 23,978	$ 21,455	$ 20,670
Cash paid for operating lease liabilities	$ 19,249	$ 19,531

Leases - Future lease liability

Leases - Future lease liability (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Oct. 02, 2021
Leases
2023	$ 18,109
2024	15,350
2025	12,450
2026	8,907
2027	5,724
Thereafter	10,412
Total lease payments	70,952
Less: imputed interest	5,691
Total	$ 65,261	$ 55,806

Accounts Receivable Sale Prog_2

Accounts Receivable Sale Program (Details) - USD ($) $ in Millions	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021
Accounts Receivable Sale Program
Percentage of face value of receivable sold	100%
Accounts receivable sold during the period	$ 1,900	$ 500
RPA
Accounts Receivable Sale Program
Accounts receivable sold and outstanding	194	7
Amount collected but not remitted to financial institutions	$ 49	$ 18

Contingencies (Details)

Contingencies (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
Contingencies (Details) - USD ($) $ in Millions	Dec. 31, 2019	Jan. 01, 2022	Oct. 01, 2022	Oct. 02, 2021
Contingencies
Loss contingency accrual			$ 38	$ 37
Collectability of Receivable and Excess and Obsolete Inventory [Member]
Contingencies
Loss contingency, damages sought, value	$ 10
Performance Of Manufacturing Service Agreement
Contingencies
Loss contingency, damages sought, value	200
Performance Of Manufacturing Service Agreement \| Maximum
Contingencies
Loss contingency, estimate of possible loss	$ 2
Violation of Labor Code
Contingencies
Loss contingency, damages awarded, value		$ 4

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Thousands	12 Months Ended
Restructuring (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Restructuring
Restructuring costs	$ 11,425	$ 15,057	$ 26,783
Restructuring reserve, current	6,000	6,000
Unallocated corporate items
Restructuring
Restructuring costs		1,000
IMS
Restructuring
Restructuring costs	1,000	9,000
CPS
Restructuring
Restructuring costs	10,000	5,000
Costs incurred for other plans
Restructuring
Restructuring costs	9,606	3,818	8,793
Q1 FY20 Plan
Restructuring
Restructuring costs	1,819	11,239	17,990
Restructuring and related cost, cost incurred to date	31,000
Q1 FY20 Plan \| Severance costs
Restructuring
Restructuring costs	319	9,405	17,919
Q1 FY20 Plan \| Other exit costs
Restructuring
Restructuring costs	$ 1,500	$ 1,834	$ 71

Income Taxes - Domestic and For

Income Taxes - Domestic and Foreign Components of Income Before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Income Taxes
Domestic											$ 145,671	$ 174,936	$ 88,450
Foreign											156,649	106,705	103,765
Income before income taxes	$ 78,765	$ 70,345	$ 75,745				$ 146,090		$ 224,855		302,320	281,641	192,215
Federal:
Current											1,070	705	(917)
Deferred											25,399	28,809	7,666
State:
Current											1,711	3,677	1,500
Deferred											3,081	(302)	2,579
Foreign:
Current											31,241	(906)	46,376
Deferred											(566)	112	1,842
Total provision for income taxes											61,936	32,095	59,046
Previously Reported
Income Taxes
Income before income taxes	81,769	76,297	78,937	$ 98,917	$ 66,230	$ 72,702	155,234	$ 138,932	237,003	$ 237,849	320,628	307,005	200,758
Investigative Adjustments
Income Taxes
Income before income taxes	$ (3,004)	$ (5,952)	$ (3,192)	$ (1,524)	(22,113)	(884)	$ (9,144)	$ (22,997)	$ (12,148)	$ (24,521)	$ (18,308)	$ (25,364)	$ (8,543)
Other Adjustments
Income Taxes
Income before income taxes					$ (2,900)	$ 2,900

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Apr. 02, 2022	Jul. 02, 2022	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Income Taxes
Provision for income taxes	$ 1,543	$ 21,724	$ 19,568	$ 41,292	$ 42,835	$ 61,936	$ 32,095	$ 59,046
Effective Income Tax Rate Reconciliation, Percent						20.49%	11.40%	30.72%
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations						$ 9,331	$ 20,243	$ 3,299
Federal tax at statutory tax rate						21%	21%	21%
Foreign
Income Taxes
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations						$ 16,000	$ 43,000
Foreign \| Maximum
Income Taxes
Federal tax at statutory tax rate								21%
Foreign \| Minimum
Income Taxes
Federal tax at statutory tax rate						21%	21%

Income Taxes - Tax Effects of T

Income Taxes - Tax Effects of Temporary Differences (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Oct. 02, 2021
Deferred tax assets:
U.S. net operating loss carryforwards	$ 92,882	$ 134,385
Foreign net operating loss carryforwards	109,416	112,516
Intangibles	25,099	24,219
Accruals not currently deductible	44,963	43,932
Property, plant and equipment	27,514	25,494
Tax credit carryforwards	18,465	17,250
Reserves not currently deductible	14,939	11,534
Stock compensation expense	6,365	7,677
Federal benefit of foreign operations	21,312	18,336
Derivatives and other impacts of OCI	838	7,637
Lease deferred tax asset	15,018	11,563
Other	1,915
Valuation allowance	(118,210)	(115,258)
Total deferred tax assets	260,516	299,285
Deferred tax liabilities on undistributed earnings	(14,775)	(14,775)
Deferred tax liabilities on branch operations	(24,182)	(30,000)
Revenue recognition	(1,572)	(1,702)
Lease deferred tax liability	(14,808)	(11,349)
Other		(2,495)
Net deferred tax assets	205,179	238,964
Recorded as:
Deferred tax assets	209,554	242,261
Deferred tax liabilities	(4,375)	(3,297)
Net deferred tax assets	$ 205,179	$ 238,964

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) $ in Millions	12 Months Ended
	Oct. 01, 2022 USD ($)
Income Taxes
Undistributed earnings of foreign subsidiaries	$ 439
Federal
Income Taxes
Net operating loss carryforwards	344
Tax credit, other	21
State
Income Taxes
Foreign net operating losses	14
Net operating loss carryforwards	357
Foreign
Income Taxes
Net operating loss carryforwards	$ 465
Domestic Tax Authority
Income Taxes
Operating loss carryforwards, expiration date	Sep. 29, 2035

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of The Statutory Federal Tax (Details)	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Income Taxes
Federal tax at statutory tax rate	21%	21%	21%
Effect of foreign operations	3.52%	7.99%	13.60%
Permanent items	0.08%	(2.03%)	(0.62%)
Federal credits	(0.73%)	(0.54%)	(1.37%)
Other	0.59%	(0.20%)	(0.06%)
State income taxes, net of federal benefit	1.60%	0.91%	1.94%
Release of foreign tax reserves	(5.57%)	(15.73%)	(3.77%)
Effective tax rate	20.49%	11.40%	30.72%

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Income Taxes
Balance, beginning of year	$ 67,781	$ 74,612	$ 66,677
Increase (decrease) related to prior year tax positions	4,456	6,063	1,327
Increase related to current year tax positions	7,154	7,349	9,907
Settlements	(7,596)
Decrease related to lapse of time and expiration of statutes of limitations	(9,331)	(20,243)	(3,299)
Balance, end of year	53,552	67,781	$ 74,612
Unrecognized tax benefits, reserve for penalties and interest	11,000	17,000
Unrecognized tax benefits, penalties and interest accrued during the year	3,000	$ 23,000
Unrecognized tax benefits that would impact effective tax rate	44,000
Resolution of Audits and Expiration of Statutes
Income Taxes
Decrease in unrecognized tax benefits is reasonably possible	9,000
Interest and Penalties
Income Taxes
Decrease in unrecognized tax benefits is reasonably possible	$ 4,000

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Weighted average shares used in computing per share amount:
Net income	$ 58,364	$ 77,222	$ 48,621	$ 56,177	$ 55,925	$ 116,195	$ 27,868	$ 49,558	$ 104,798	$ 77,426	$ 182,020	$ 193,621	$ 240,384	$ 249,546	$ 133,169
Weighted average common shares outstanding													61,310	65,318	69,041
Effect of dilutive stock options and restricted stock units													1,807	1,766	1,752
Denominator for diluted earnings per share													63,117	67,084	70,793
Net income per share:
Basic	$ 1.01	$ 1.29	$ 0.77	$ 0.87	$ 0.86	$ 1.78	$ 0.43	$ 0.76	$ 1.65		$ 2.92		$ 3.92	$ 3.82	$ 1.93
Net income per share:
Diluted	$ 0.98	$ 1.25	$ 0.76	$ 0.85	$ 0.83	$ 1.73	$ 0.42	$ 0.74	$ 1.60		$ 2.83		$ 3.81	$ 3.72	$ 1.88

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ in Millions	12 Months Ended
Stockholders' Equity (Details) - USD ($) $ in Millions	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020	Mar. 11, 2019
Stock-Based Compensation
Common Stock, Capital Shares Reserved for Future Issuance	7,000,000
Stock options and unvested restricted stock units outstanding	4,000,000
Number of Shares Available for Future Grant	3,000,000
Stock Repurchased During Period, Shares	8,000,000	1,500,000	6,400,000
Stock Repurchased During Period, Value	$ 317	$ 54	$ 166
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 164
Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation	369,000	286,000	398,000
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	$ 14	$ 10	$ 13
2019 Stock Plan [Member]
Stock-Based Compensation
Common Stock, Capital Shares Reserved for Future Issuance				4,000,000
Stock Plan Expiration Date	December 2028

Stockholders, Equity - Accumula

Stockholders, Equity - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Oct. 01, 2022	Jul. 03, 2021	Oct. 02, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustments	$ 63,929		$ 76,120
Unrealized holding gain (loss) on derivative financial instruments	4,112		(14,305)
Unrecognized net actuarial loss and unrecognized transition cost for benefit plans	(11,716)		(21,125)
Total	56,325		40,690
Foreign currency translation reclassification adjustment from AOCI, realized upon sale or liquidation, before tax		$ 8,000	$ 8,000
Pension expense (Income) for defined benefit plan termination	$ 2,000

Stockholders' Equity - Derivati

Stockholders' Equity - Derivatives (Details) - Interest Rate Swap - Designated as Hedging Instrument [Member] - USD ($) $ in Millions	Oct. 01, 2022	Oct. 02, 2021
Derivative [Line Items]
Derivative, Notional Amount	$ 350	$ 350
Effective Interest Rate	4.10%	4.30%
Other Current Liabilities [Member]
Derivative [Line Items]
Interest Rate Cash Flow Hedge Liability at Fair Value		$ 9
Level 2 \| Fair Value, Recurring [Member]
Derivative [Line Items]
Interest Rate Cash Flow Hedge Liability at Fair Value		$ 19
Interest Rate Cash Flow Hedge Asset at Fair Value	$ 6

Business Segment, Geographic _3

Business Segment, Geographic and Customer Information (Details) $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022 USD ($)	Jul. 02, 2022 USD ($)	Apr. 02, 2022 USD ($)	Jan. 01, 2022 USD ($)	Oct. 02, 2021 USD ($)	Jul. 03, 2021 USD ($)	Apr. 03, 2021 USD ($)	Jan. 02, 2021 USD ($)	Apr. 02, 2022 USD ($)	Apr. 03, 2021 USD ($)	Jul. 02, 2022 USD ($)	Jul. 03, 2021 USD ($)	Oct. 01, 2022 USD ($) segment	Oct. 02, 2021 USD ($)	Oct. 03, 2020 USD ($)
Business Segment, Geographic and Customer Information
Number of reportable segments \| segment													1
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396		$ 5,694,757		$ 7,919,622	$ 6,738,356	$ 6,950,208
Gross profit	$ 172,229	$ 162,185	$ 146,495	141,297	$ 130,039	$ 135,066	$ 120,985	140,351	287,792		449,977		622,206	526,441	517,164
Depreciation and amortization				$ 27,465				$ 27,635	$ 55,032	$ 54,831	$ 82,097	$ 82,204	108,783	109,656	114,218
Capital expenditures													$ 156,279	81,854	51,075
IMS
Business Segment, Geographic and Customer Information
Revenue percentage generated by reportable segment													80%
Operating segments
Business Segment, Geographic and Customer Information
Gross profit													$ 638,115	543,223	529,939
Depreciation and amortization													103,975	104,846	107,887
Capital expenditures													150,629	78,511	47,848
Operating segments \| IMS
Business Segment, Geographic and Customer Information
Net sales													6,413,606	5,485,612	5,719,180
Gross profit													462,606	391,339	381,638
Depreciation and amortization													73,914	77,076	81,169
Capital expenditures													94,636	44,672	23,933
Operating segments \| Other Segments
Business Segment, Geographic and Customer Information
Net sales													1,655,183	1,379,455	1,369,550
Gross profit													175,509	151,884	148,301
Depreciation and amortization													30,061	27,770	26,718
Capital expenditures													55,993	33,839	23,915
Segment reconciling items
Business Segment, Geographic and Customer Information
Gross profit													(15,909)	(16,782)	(12,775)
Unallocated corporate items
Business Segment, Geographic and Customer Information
Depreciation and amortization													4,808	4,810	6,331
Capital expenditures													5,650	3,343	3,227
Intersegment eliminations
Business Segment, Geographic and Customer Information
Net sales													$ (149,167)	$ (126,711)	$ (138,522)

Business Segment, Geographic _4

Business Segment, Geographic and Customer Information - Net sales by geographic segment (Details) $ in Thousands	3 Months Ended								6 Months Ended	9 Months Ended	12 Months Ended
	Oct. 01, 2022 USD ($)	Jul. 02, 2022 USD ($)	Apr. 02, 2022 USD ($)	Jan. 01, 2022 USD ($)	Oct. 02, 2021 USD ($)	Jul. 03, 2021 USD ($)	Apr. 03, 2021 USD ($)	Jan. 02, 2021 USD ($)	Apr. 02, 2022 USD ($)	Jul. 02, 2022 USD ($)	Oct. 01, 2022 USD ($) customer	Oct. 02, 2021 USD ($) customer	Oct. 03, 2020 USD ($) customer
Business Segment, Geographic and Customer Information
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396	$ 5,694,757	$ 7,919,622	$ 6,738,356	$ 6,950,208
Percentage of net sales represented by ten largest customers											48.70%	52.70%	55.50%
Number of customers representing 10% or more of net sales \| customer											2	1	1
Americas
Business Segment, Geographic and Customer Information
Net sales											$ 3,748,643	$ 3,164,562	$ 3,440,365
APAC
Business Segment, Geographic and Customer Information
Net sales											3,007,904	2,517,963	2,514,005
EMEA
Business Segment, Geographic and Customer Information
Net sales											$ 1,163,075	$ 1,055,831	$ 995,838
Mexico
Business Segment, Geographic and Customer Information
Percentage of Net Sales to Americas Net Sales	60%										60%
U.S.
Business Segment, Geographic and Customer Information
Percentage of Net Sales to Americas Net Sales	35%										35%

Business Segment, Geographic _5

Business Segment, Geographic and Customer Information - Long lived assets (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021
Business Segment, Geographic and Customer Information
Property, plant and equipment, net	$ 575,170	$ 545,673	$ 525,362	$ 525,159	$ 532,985	$ 535,685	$ 515,203	$ 526,645
Americas
Business Segment, Geographic and Customer Information
Property, plant and equipment, net	367,172				322,545
APAC
Business Segment, Geographic and Customer Information
Property, plant and equipment, net	151,254				143,111
EMEA
Business Segment, Geographic and Customer Information
Property, plant and equipment, net	$ 56,744				$ 67,329

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		9 Months Ended		12 Months Ended
Stock-Based Compensation (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Stock-Based Compensation
Share-based Payment Arrangement, Noncash Expense	$ 9,032	$ 8,208	$ 18,362	$ 17,432	$ 29,045	$ 26,147	$ 39,608	$ 34,976	$ 26,235
Cost of sales
Stock-Based Compensation
Share-based payment arrangement, expense							14,065	14,472	10,099
Selling, general and administrative
Stock-Based Compensation
Share-based payment arrangement, expense							25,037	20,118	15,897
Research and development
Stock-Based Compensation
Share-based payment arrangement, expense							$ 506	$ 386	$ 239

Stock-Based Compensation - Acti

Stock-Based Compensation - Activity with respect to the Company's restricted stock units and PSUs (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020	Sep. 28, 2019
Number of Shares
Beginning outstanding	2,954	2,568	3,153
Granted	1,644	1,529	1,340
Vested/Forfeited/Cancelled	(1,318)	(1,143)	(1,925)
Ending outstanding	3,280	2,954	2,568	3,153
Expected to vest	2,909
Weighted Average Grant Date Fair Value
Beginning outstanding	$ 32.21	$ 29.67	$ 27.82
Granted	40.54	34.26	32.51
Vested/Forfeited/Cancelled	30.42	29.27	28.62
Ending outstanding	37.11	$ 32.21	$ 29.67	$ 27.82
Expected to vest	$ 36.93
Weighted Average Remaining Contractual Term
Outstanding	1 year 4 months 6 days	1 year 2 months 23 days	1 year 2 months 23 days	1 year 3 months 18 days
Expected to vest	1 year 3 months 10 days
Aggregate Intrinsic Value
Outstanding	$ 155,049	$ 113,591	$ 71,571	$ 102,720
Expected to vest	$ 137,524

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Stock-Based Compensation
RSU vested in period, fair value	$ 44	$ 32	$ 43
Minimum
Stock-Based Compensation
Vesting period	1 year
Maximum
Stock-Based Compensation
Vesting period	4 years
Performance Shares With TSR
Stock-Based Compensation
Potential adjustments to PSUs	15%
Performance Shares With TSR \| Minimum
Stock-Based Compensation
Potential payout percentage	80%
Performance Shares With TSR \| Maximum
Stock-Based Compensation
Potential payout percentage	120%
Restricted stock units
Stock-Based Compensation
Unrecognized compensation expense	$ 68
Weighted average period of recognition (Years)	1 year 3 months 18 days

Employee Benefit Plans (Details

Employee Benefit Plans (Details) - USD ($) $ in Thousands	3 Months Ended
Employee Benefit Plans (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Employee Benefit Plans
Defined benefit plan, benefit obligation, payment for settlement	$ 6,000
Pension expense (Income) for defined benefit plan termination	2,000
Non-U.S.
Employee Benefit Plans
Projected Benefit Obligation	50,871	$ 63,217	$ 64,453
Underfunded status	33,581	39,642	40,878
Current Liabilities	3,038	2,674	2,054
Non-current liabilities	30,543	36,968	38,824
Total liabilities	33,581	39,642	40,878
U.S.
Employee Benefit Plans
Projected Benefit Obligation	22,943	25,704
Underfunded status	6,508	10,274
Non-current liabilities	6,508	10,274
Total liabilities	6,508	10,274
Fair value Inputs Level 1 \| Non-U.S.
Employee Benefit Plans
Plan Assets	17,290	23,575	$ 23,575
Fair value Inputs Level 1 \| U.S.
Employee Benefit Plans
Plan Assets	16,435	15,430
Fair value Inputs Level 1 \| Fair Value, Measurements, Recurring
Defined contribution plan
Deferred compensation plan assets	37,000	46,000
Deferred compensation liability	$ 37,000	$ 46,000

Strategic Transactions (Details

Strategic Transactions (Details) - USD ($) $ in Thousands			3 Months Ended	12 Months Ended
Strategic Transactions (Details) - USD ($) $ in Thousands	Oct. 03, 2023	Oct. 03, 2022	Jul. 02, 2022	Oct. 01, 2022	Oct. 02, 2021	Apr. 06, 2021
Strategic Transactions
Cash paid for business acquisition, net of cash acquired					$ 21,408
FY21 Acquisition
Strategic Transactions
Effective Date of Acquisition			Apr. 06, 2021
Consideration transferred			$ 38,000
Payments to acquire businesses			29,000
Business combination, consideration transferred liabilities incurred			9,000
Due date for liability incurred				April 2023
Cash paid for business acquisition, net of cash acquired			$ 21,000
Current assets						$ 18,696
Noncurrent assets						30,711
Cash						8,100
Finite-lived intangibles						4,400
Goodwill						8,500
Current liabilities						(10,671)
Noncurrent liabilities						(152)
Total net assets acquired						$ 38,584
Finite-lived Identifiable intangible assets				4 years
Joint Venture with Reliance \| Subsequent event
Strategic Transactions
Proceeds from RSBVL to Acquire Interest in Joint Venture	$ 215,000
Subsequent event date		Oct. 03, 2022
Joint Venture with Reliance \| RSBVL \| Subsequent event
Strategic Transactions
Business acquisition, percentage of voting interests acquired	50.10%
Joint Venture with Reliance \| Sanmina \| Subsequent event
Strategic Transactions
Business acquisition, percentage of voting interests acquired	49.90%

Quarterly Financial Data (Detai

Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
CONSOLIDATED STATEMENTS OF INCOME
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396		$ 5,694,757		$ 7,919,622	$ 6,738,356	$ 6,950,208
Gross profit	$ 172,229	$ 162,185	$ 146,495	$ 141,297	$ 130,039	$ 135,066	$ 120,985	$ 140,351	287,792		449,977		622,206	526,441	517,164
Gross margin	7.70%	8%	7.60%	8%	7.90%	8.20%	7.20%	8%
Operating income	$ 103,350	$ 91,614	$ 76,274	$ 78,241	$ 65,910	$ 72,741	$ 42,610	$ 74,675	154,515		246,129		349,479	255,936	219,144
Operating margin	4.60%	4.50%	4%	4.50%	4%	4.40%	2.50%	4.30%
Net income	$ 58,364	$ 77,222	$ 48,621	$ 56,177	$ 55,925	$ 116,195	$ 27,868	$ 49,558	$ 104,798	$ 77,426	$ 182,020	$ 193,621	$ 240,384	$ 249,546	$ 133,169
Basic net income per share	$ 1.01	$ 1.29	$ 0.77	$ 0.87	$ 0.86	$ 1.78	$ 0.43	$ 0.76	$ 1.65		$ 2.92		$ 3.92	$ 3.82	$ 1.93
Diluted net income per share	$ 0.98	$ 1.25	$ 0.76	$ 0.85	$ 0.83	$ 1.73	$ 0.42	$ 0.74	$ 1.60		$ 2.83		$ 3.81	$ 3.72	$ 1.88

Quarterly Financial Data - Un_3

Quarterly Financial Data - Unaudited (Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Oct. 03, 2020	Sep. 28, 2019
Current assets:
Cash and cash equivalents	$ 529,857	$ 493,305	$ 559,893	$ 627,717	$ 650,026	$ 623,844	$ 575,176	$ 516,030
Accounts receivable, net of allowances	1,138,894	1,229,864	1,271,100	1,299,014	1,193,437	1,155,253	1,124,838	1,112,925
Contract assets	475,721	444,796	399,282	347,583	332,190	333,438	321,947	357,989
Inventories	1,684,099	1,590,123	1,443,621	1,253,697	1,041,790	892,633	785,406	819,474
Prepaid expenses and other current assets	62,044	63,827	61,525	59,188	53,952	50,446	38,584	48,851
Total current assets	3,890,615	3,821,915	3,735,421	3,587,199	3,271,395	3,055,614	2,845,951	2,855,269
Property, plant and equipment, net	575,170	545,673	525,362	525,159	532,985	535,685	515,203	526,645
Deferred income tax assets, net	209,554	222,080	229,574	235,031	242,261	248,060	266,592	271,187
Other	160,192	149,608	156,867	157,533	156,953	160,004	137,998	140,410
Total assets	4,835,531	4,739,276	4,647,224	4,504,922	4,203,594	3,999,363	3,765,744	3,793,511
Current liabilities:
Accounts payable	2,041,434	1,984,374	1,830,044	1,708,222	1,472,257	1,296,005	1,108,994	1,143,431
Accrued liabilities	281,599	326,212	332,431	253,962	177,203	171,365	195,839	209,581
Accrued payroll and related benefits	130,892	133,319	116,794	115,738	117,648	123,365	114,704	120,469
Short-term debt, including current portion of long-term debt	17,500	18,750	18,750	18,750	18,750	18,750	18,750	18,750
Total current liabilities	2,471,425	2,462,655	2,298,019	2,096,672	1,785,858	1,609,485	1,438,287	1,492,231
Long-term liabilities:
Long-term debt	329,237	298,345	302,751	307,160	311,572	315,987	320,405	324,825
Other	215,333	209,716	241,416	248,326	253,532	260,132	296,121	303,514
Total long-term liabilities	544,570	508,061	544,167	555,486	565,104	576,119	616,526	628,339
Contingencies
Stockholders' equity	1,819,536	1,768,560	1,805,038	1,852,764	1,852,632	1,813,759	1,710,931	1,672,941	$ 1,623,372	$ 1,647,073
Total liabilities and stockholders' equity	4,835,531	4,739,276	4,647,224	4,504,922	4,203,594	3,999,363	3,765,744	3,793,511
Previously Reported
Current assets:
Cash and cash equivalents	529,857	493,305	559,893	627,717	650,026	623,844	575,176	516,030
Accounts receivable, net of allowances	1,138,894	1,228,435	1,270,494	1,298,327	1,192,434	1,153,813	1,122,962	1,108,472
Contract assets	503,674	459,306	417,286	364,407	348,741	345,096	334,957	350,049
Inventories	1,691,081	1,591,111	1,437,955	1,242,440	1,036,511	892,633	785,406	819,474
Prepaid expenses and other current assets	62,044	63,827	61,525	59,188	53,952	50,446	38,584	48,851
Total current assets	3,925,550	3,835,984	3,747,153	3,592,079	3,281,664	3,065,832	2,857,085	2,842,876
Property, plant and equipment, net	575,170	545,673	525,362	525,159	532,985	550,038	529,651	541,188
Deferred income tax assets, net	198,588	212,407	220,532	227,239	235,117	241,069	259,943	269,803
Other	160,192	149,608	156,867	157,533	156,953	145,651	123,550	125,867
Total assets	4,859,500	4,743,672	4,649,914	4,502,010	4,206,719	4,002,590	3,770,229	3,779,734
Current liabilities:
Accounts payable	2,029,534	1,976,533	1,817,465	1,694,592	1,464,693	1,296,005	1,108,994	1,143,431
Accrued liabilities	275,735	303,076	314,648	236,227	161,896	149,236	176,148	190,797
Accrued payroll and related benefits	130,892	133,319	116,794	115,738	117,648	123,365	114,704	120,469
Short-term debt, including current portion of long-term debt	17,500	18,750	18,750	18,750	18,750	18,750	18,750	18,750
Total current liabilities	2,453,661	2,431,678	2,267,657	2,065,307	1,762,987	1,587,356	1,418,596	1,473,447
Long-term liabilities:
Long-term debt	329,237	298,345	302,751	307,160	311,572	315,987	320,405	324,825
Other	215,333	209,716	241,416	248,326	253,532	260,132	296,121	303,514
Total long-term liabilities	544,570	508,061	544,167	555,486	565,104	576,119	616,526	628,339
Contingencies
Stockholders' equity	1,861,269	1,803,933	1,838,090	1,881,217	1,878,628	1,839,115	1,735,107	1,677,948
Total liabilities and stockholders' equity	4,859,500	4,743,672	4,649,914	4,502,010	4,206,719	4,002,590	3,770,229	3,779,734
Investigation Adjustments
Current assets:
Contract assets	(27,953)	(34,918)	(33,512)	(31,772)	(28,708)	(29,357)	(27,204)	(9,427)
Inventories	(21,705)	(8,829)	(6,913)	(2,373)	(2,285)
Total current assets	(49,658)	(43,747)	(40,425)	(34,145)	(30,993)	(29,357)	(27,204)	(9,427)
Deferred income tax assets, net	10,966	9,673	9,042	7,792	7,144	6,991	6,649	2,074
Total assets	(38,692)	(34,074)	(31,383)	(26,353)	(23,849)	(22,366)	(20,555)	(7,353)
Current liabilities:
Accrued liabilities	1,441	1,299	1,669	2,100	2,147	2,990	3,621	(136)
Total current liabilities	1,441	1,299	1,669	2,100	2,147	2,990	3,621	(136)
Long-term liabilities:
Contingencies
Stockholders' equity	(40,133)	(35,373)	(33,052)	(28,453)	(25,996)	(25,356)	(24,176)	(7,217)
Total liabilities and stockholders' equity	$ (38,692)	(34,074)	(31,383)	(26,353)	$ (23,849)	(22,366)	(20,555)	(7,353)
Other Adjustments
Current assets:
Accounts receivable, net of allowances		1,429	606	687		1,440	1,876	4,453
Contract assets		20,408	15,508	14,948		17,699	14,194	17,367
Inventories		7,841	12,579	13,630
Total current assets		29,678	28,693	29,265		19,139	16,070	21,820
Property, plant and equipment, net						(14,353)	(14,448)	(14,543)
Deferred income tax assets, net								(690)
Other						14,353	14,448	14,543
Total assets		29,678	28,693	29,265		19,139	16,070	21,130
Current liabilities:
Accounts payable		7,841	12,579	13,630
Accrued liabilities		21,837	16,114	15,635		19,139	16,070	18,920
Total current liabilities		29,678	28,693	29,265		19,139	16,070	18,920
Long-term liabilities:
Contingencies
Stockholders' equity								2,210
Total liabilities and stockholders' equity		$ 29,678	$ 28,693	$ 29,265		$ 19,139	$ 16,070	$ 21,130

Quarterly Financial Data - Un_4

Quarterly Financial Data - Unaudited (Consolidated Statements of Income) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Net sales	$ 2,224,865	$ 2,023,361	$ 1,915,070	$ 1,756,326	$ 1,650,609	$ 1,653,266	$ 1,678,497	$ 1,755,984	$ 3,671,396		$ 5,694,757		$ 7,919,622	$ 6,738,356	$ 6,950,208
Cost of sales		1,861,176	1,768,575	1,615,029					3,383,604		5,244,780		7,297,416	6,211,915	6,433,044
Gross profit	172,229	162,185	146,495	141,297	130,039	135,066	120,985	140,351	287,792		449,977		622,206	526,441	517,164
Operating expenses:
Selling, general and administrative		61,506	61,817	61,475					123,292		184,798		244,569	234,537	240,931
Research and development		5,071	5,472	4,777					10,249		15,320		21,343	20,911	22,564
Restructuring and other		3,994	2,932	1,414					4,346		8,340		11,425	15,057	27,916
Gain on sale of long-lived assets				(4,610)					(4,610)		(4,610)		(4,610)
Total operating expenses		70,571	70,221	63,056					133,277		203,848		272,727	270,505	298,020
Operating income	$ 103,350	91,614	76,274	78,241	$ 65,910	$ 72,741	$ 42,610	$ 74,675	154,515		246,129		349,479	255,936	219,144
Interest income		540	349	309					658		1,198		1,628	925	2,322
Interest expense		(5,615)	(4,870)	(4,877)					(9,747)		(15,362)		(22,473)	(19,551)	(28,903)
Other income (expense), net		(7,774)	(1,408)	2,072					664		(7,110)		(26,314)	44,331	(348)
Interest and other, net		(12,849)	(5,929)	(2,496)					(8,425)		(21,274)		(47,159)	25,705	(26,929)
Income before income taxes		78,765	70,345	75,745					146,090		224,855		302,320	281,641	192,215
Provision for income taxes		$ 1,543	$ 21,724	$ 19,568					41,292		42,835		$ 61,936	$ 32,095	$ 59,046
Net income									$ 104,798		$ 182,020
Net income per share:
Basic	$ 1.01	$ 1.29	$ 0.77	$ 0.87	$ 0.86	$ 1.78	$ 0.43	$ 0.76	$ 1.65		$ 2.92		$ 3.92	$ 3.82	$ 1.93
Diluted	$ 0.98	$ 1.25	$ 0.76	$ 0.85	$ 0.83	$ 1.73	$ 0.42	$ 0.74	$ 1.60		$ 2.83		$ 3.81	$ 3.72	$ 1.88
Previously Reported
Net sales		$ 2,019,059	$ 1,911,530	$ 1,757,325		$ 1,657,741	$ 1,699,677	$ 1,755,249	$ 3,668,855	$ 3,454,926	$ 5,687,914	$ 5,112,667	$ 7,890,475	$ 6,756,643	$ 6,960,370
Cost of sales		1,853,870	1,759,083	1,612,836		1,521,151	1,556,579	1,614,014	3,371,919	3,170,593	5,225,789	4,691,744	7,249,961	6,204,838	6,434,663
Gross profit		165,189	152,447	144,489		136,590	143,098	141,235	296,936	284,333	462,125	420,923	640,514	551,805	525,707
Operating expenses:
Selling, general and administrative		61,506	61,817	61,475		57,438	61,142	58,967	123,292	120,109	184,798	177,547	244,569	234,537	240,931
Research and development		5,071	5,472	4,777		5,269	5,353	4,805	10,249	10,158	15,320	15,427	21,343	20,911	22,564
Restructuring and other		3,994	2,932	1,414		(382)	11,880	1,904	4,346	13,784	8,340	13,402	11,425	15,057	27,916
Gain on sale of long-lived assets				(4,610)					(4,610)		(4,610)		(4,610)
Total operating expenses		70,571	70,221	63,056		62,325	78,375	65,676	133,277	144,051	203,848	206,376	272,727	270,505	298,020
Operating income		94,618	82,226	81,433		74,265	64,723	75,559	163,659	140,282	258,277	214,547	367,787	281,300	227,687
Interest income		540	349	309		217	244	230	658	474	1,198	691	1,628	925	2,322
Interest expense		(5,615)	(4,870)	(4,877)		(4,823)	(4,880)	(4,954)	(9,747)	(9,834)	(15,362)	(14,657)	(22,473)	(19,551)	(28,903)
Other income (expense), net		(7,774)	(1,408)	2,072		29,258	6,143	1,867	664	8,010	(7,110)	37,268	(26,314)	44,331	(348)
Interest and other, net		(12,849)	(5,929)	(2,496)		24,652	1,507	(2,857)	(8,425)	(1,350)	(21,274)	23,302	(47,159)	25,705	(26,929)
Income before income taxes		81,769	76,297	78,937		98,917	66,230	72,702	155,234	138,932	237,003	237,849	320,628	307,005	200,758
Provision for income taxes		$ 2,226	$ 23,077	$ 20,303		(18,458)	19,193	24,681	43,380	43,874	45,606	25,416	$ 64,507	$ 38,007	$ 61,045
Net income						$ 117,375	$ 47,037	$ 48,021	$ 111,854	$ 95,058	$ 191,397	$ 212,433
Net income per share:
Basic		$ 1.33	$ 0.85	$ 0.91		$ 1.79	$ 0.72	$ 0.74	$ 1.76	$ 1.46	$ 3.07	$ 3.25	$ 4.18	$ 4.12	$ 2.02
Diluted		$ 1.29	$ 0.83	$ 0.89		$ 1.74	$ 0.70	$ 0.72	$ 1.71	$ 1.42	$ 2.98	$ 3.17	$ 4.06	$ 4.01	$ 1.97
Investigation Adjustments
Net sales		$ 4,302	$ 3,540	$ (999)		$ (4,475)	$ (21,180)	$ 735	$ 2,541	$ (20,445)	$ 6,843	$ (24,920)	$ 23,265	$ (18,287)	$ (10,162)
Cost of sales		7,306	9,492	2,193		(2,951)	933	1,619	11,685	2,552	18,991	(399)	41,573	7,077	(1,619)
Gross profit		(3,004)	(5,952)	(3,192)		(1,524)	(22,113)	(884)	(9,144)	(22,997)	(12,148)	(24,521)	(18,308)	(25,364)	(8,543)
Operating expenses:
Operating income		(3,004)	(5,952)	(3,192)		(1,524)	(22,113)	(884)	(9,144)	(22,997)	(12,148)	(24,521)	(18,308)	(25,364)	(8,543)
Income before income taxes		(3,004)	(5,952)	(3,192)		(1,524)	(22,113)	(884)	(9,144)	(22,997)	(12,148)	(24,521)	(18,308)	(25,364)	(8,543)
Provision for income taxes		$ (683)	$ (1,353)	$ (735)		(344)	(5,154)	(211)	(2,088)	(5,365)	(2,771)	(5,709)	$ (4,171)	$ (5,912)	$ (1,999)
Net income						$ (1,180)	$ (16,959)	$ (673)	$ (7,056)	$ (17,632)	$ (9,377)	$ (18,812)
Net income per share:
Basic		$ (0.04)	$ (0.08)	$ (0.04)		$ (0.01)	$ (0.26)	$ (0.01)	$ (0.11)	$ (0.27)	$ (0.15)	$ (0.29)	$ (0.23)	$ (0.30)	$ (0.09)
Diluted		$ (0.04)	$ (0.07)	$ (0.04)		$ (0.01)	$ (0.26)	$ (0.01)	$ (0.11)	$ (0.26)	$ (0.15)	$ (0.28)	$ (0.23)	$ (0.29)	$ (0.09)
Other Adjustments
Operating expenses:
Other income (expense), net							$ (2,900)	$ 2,900
Interest and other, net							(2,900)	2,900
Income before income taxes							(2,900)	2,900
Provision for income taxes							(690)	690
Net income							$ (2,210)	$ 2,210
Net income per share:
Basic							$ (0.03)	$ 0.03
Diluted							$ (0.03)	$ 0.03
As Restated
Net sales						$ 1,653,266	$ 1,678,497	$ 1,755,984		$ 3,434,481		$ 5,087,747
Cost of sales						1,518,200	1,557,512	1,615,633		3,173,145		4,691,345
Gross profit						135,066	120,985	140,351		261,336		396,402
Operating expenses:
Selling, general and administrative						57,438	61,142	58,967		120,109		177,547
Research and development						5,269	5,353	4,805		10,158		15,427
Restructuring and other						(382)	11,880	1,904		13,784		13,402
Total operating expenses						62,325	78,375	65,676		144,051		206,376
Operating income						72,741	42,610	74,675		117,285		190,026
Interest income						217	244	230		474		691
Interest expense						(4,823)	(4,880)	(4,954)		(9,834)		(14,657)
Other income (expense), net						29,258	3,243	4,767		8,010		37,268
Interest and other, net						24,652	(1,393)	43		(1,350)		23,302
Income before income taxes						97,393	41,217	74,718		115,935		213,328
Provision for income taxes						(18,802)	13,349	25,160		38,509		19,707
Net income						$ 116,195	$ 27,868	$ 49,558		$ 77,426		$ 193,621
Net income per share:
Basic						$ 1.78	$ 0.43	$ 0.76		$ 1.19		$ 2.96
Diluted						$ 1.73	$ 0.42	$ 0.74		$ 1.16		$ 2.89

Quarterly Financial Data - Un_5

Quarterly Financial Data - Unaudited (Consolidated Statements of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income	$ 58,364	$ 77,222	$ 48,621	$ 56,177	$ 55,925	$ 116,195	$ 27,868	$ 49,558	$ 104,798	$ 77,426	$ 182,020	$ 193,621	$ 240,384	$ 249,546	$ 133,169
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization				27,465				27,635	55,032	54,831	82,097	82,204	108,783	109,656	114,218
Stock-based compensation expense				9,032				8,208	18,362	17,432	29,045	26,147	39,608	34,976	26,235
Deferred income taxes				6,059				3,858	9,173	8,787	15,993	26,946	27,910	28,375	11,772
Impairment of goodwill and other assets											1,848		1,848		8,409
Loss (Gain) on sale of intellectual property												(15,000)	7,000	(15,000)
Gain on liquidation of foreign entity												(8,263)		(8,263)
Other, net				(3,638)				(99)	(1,903)	(19)	(3,146)	(633)	1,260	(1,371)	(239)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable				(106,656)				(66,961)	(79,308)	(79,333)	(40,276)	(108,008)	47,483	(145,810)	81,914
Contract assets				(15,393)				28,680	(67,092)	64,722	(112,606)	53,231	(143,531)	54,479	9,631
Inventories				(213,278)				57,469	(403,783)	90,490	(552,851)	(7,419)	(651,118)	(157,278)	24,377
Prepaid expenses and other assets				(2,939)				(8,694)	(11,334)	2,065	(13,269)	(2,868)	(31,700)	(5,780)	17,092
Accounts payable				240,591				(66,657)	362,191	(99,525)	507,909	61,524	558,828	243,834	(106,640)
Accrued liabilities				70,880				28,814	161,137	6,024	152,192	(54,861)	124,099	(49,022)	(19,383)
Cash provided by operating activities				68,300				61,811	147,273	142,900	248,956	246,621	330,854	338,342	300,555
Previously Reported
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income		79,543	53,220	58,634				48,021	111,854	95,058	191,397	212,433	256,121	268,998	139,713
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization				27,465				27,635	55,032	54,831	82,097	82,204	108,783	109,656	114,218
Stock-based compensation expense				9,032				8,208	18,362	17,432	29,045	26,147	39,608	34,976	26,235
Deferred income taxes				6,707				3,447	11,071	13,641	18,522	32,142	31,733	33,724	13,567
Impairment of goodwill and other assets											1,848		1,848		8,409
Loss (Gain) on sale of intellectual property												(15,000)
Gain on liquidation of foreign entity												(8,263)		(8,263)
Other, net				(3,638)				(99)	(1,903)	(19)	(3,146)	(633)	1,260	(1,371)	(239)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable				(106,972)				(64,217)	(79,705)	(79,166)	(39,850)	(108,277)	46,480	(146,516)	83,623
Contract assets				(15,666)				46,534	(68,545)	61,626	(110,565)	51,487	(154,933)	47,842	(283)
Inventories				(207,300)				42,282	(403,396)	75,303	(559,118)	(22,606)	(663,379)	(167,186)	39,564
Prepaid expenses and other assets				(2,939)				(9,400)	(11,334)	1,359	(13,269)	(3,574)	(31,700)	(6,486)	17,798
Accounts payable				234,525				(66,657)	357,176	(99,525)	507,632	61,524	554,492	236,270	(106,640)
Accrued liabilities				68,452				26,057	158,661	2,360	144,363	(60,963)	133,541	(48,302)	(35,410)
Cash provided by operating activities				68,300				61,811	147,273	142,900	248,956	$ 246,621	330,854	338,342	300,555
Investigative Adjustments
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income		$ (2,321)	$ (4,599)	(2,457)		(18,812)		(673)	(7,056)	(17,632)	(9,377)		(14,137)	(19,452)	(6,544)
Adjustments to reconcile net income to cash provided by operating activities:
Deferred income taxes				(648)		(5,196)		(279)	(1,898)	(4,854)	(2,529)		(3,823)	(5,349)	(1,795)
Changes in operating assets and liabilities, net of amounts acquired:
Contract assets				3,064		4,921		(15,009)	4,804	2,768	6,210		(755)	4,272	24,436
Inventories				88		15,187		15,187	4,628	15,187	6,544		19,420	17,472	(15,187)
Prepaid expenses and other assets						706		706		706				706	(706)
Accrued liabilities				(47)		3,194		68	(478)	$ 3,825	(848)		$ (705)	$ 2,351	$ (204)
Other Adjustments
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income								2,210
Adjustments to reconcile net income to cash provided by operating activities:
Deferred income taxes								690
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable				316		269	(167)	(2,744)	397		(426)
Contract assets				(2,791)		(3,177)	328	(2,845)	(3,351)		(8,251)
Inventories				(6,066)					(5,015)		(277)
Accounts payable				6,066					5,015		277
Accrued liabilities				$ 2,475		$ 2,908	$ (161)	$ 2,689	$ 2,954		$ 8,677

SCHEDULE II-VALUATION AND QUA_2

SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS (Details) - Allowance for Accounts Receivables - USD ($) $ in Thousands	12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	$ 6,935	$ 8,570	$ 12,481
Charged to Operations	7,978	(1,635)	(3,911)
Balance at End of Period	$ 14,913	$ 6,935	$ 8,570